-------
Z,
O
5>
3 i
H 58
< «
o
3
fO fH
fH O
\o t-.
fH NO
r* fH
O fS
O\ f*^
fH fH
r- \o
fH fH
\O «S
21
O
1
I-H*
o
fH
00
O
i
2
w
on
P
CQ
PQ
"
•a
<: a
83
-o •<
*S tj
4)
!»
3
4)
WD
i2 o
8. «
& d
a g
A\ Q
a
2
O
OJD
4)
Cucurb
a
o
3
C
A
u
Q
U
-------
d
o
W
"rt
*S
CM
O
d
o
••i
M
•M>
Cfl
• •M
5ty
V
M
CITATIONS
OO
00
OlftO
OO
0
a
00
^>
(S
fS
oo
^HiH
Q O
OO
GAP
328
DATA
10
V
M
.2
1
U
3
cr
0)
0>
d
12
"3
O
M)
d
• M
+4
M
O
a
a
9
C/5
e*
C9
Q
1
o
1
o
3
«
i1 1
8
o
.
V
1
z
s
H
i
0
a
1 1
B
0
1 1
« «
d
O
-------
CITATIONS
z
c*
u
cu
w
EMENT
3
3
a
<*
r
p«
M:
^
»•
o r
i/> c
1 j
r^i <*} o
O r* v«
ON *» r
vo
* 1 2 § TS •?
11 I j f 1 S i j
J!CA«4-^03K ^ ^g
^osososos-r-ooe
— cucuo>4)?:-i2*S<
«55S5.^oo.j
PQj^|^j>|>>5jyC^ft
1 1 1 1 1 ^ 1 1
f
»
H
H
9
>
r »H IH
1 O O
• oo 3
'i ON */)
> fS ON
> r* o
> ^ ^t
> r* IH o o o
1 (S v0 (/) I-H ON
> fO i/) vo ON 00
§O »H r< TT if) iH O i-H 00 iH
"a
a>
u
X
CA1
o
u
OS
cfc
'O TJ PTJ
0 0 « 5
O O 0 sjj
n ^ UH fa *S J3
i c PQ PQ •=» S
i S S g « «? -
m* m f \ *^ *^ .fv ^i
J M ^ CA W5 ^ 5T\
i OD >fi U O CU ^ ^
J
rr
m
iH
iH
- J
00080482, 001
00053150
c
2 .^
2 2
O o
OH
O
^^
H
C
^
^
00
AtfPS
40954401, 42:
CA
(U
CA
CA
^
"o
E
oT
OS
Ui
OS
OJD
S
1
42016701
0)
•*-»
CA
OS
a
CA"
o
I
O
H
-------
fi
O
J3
a
2
^—
CO
1
H
0
o
fceregistrat
^^
-C
M
c2
CA
'S
Q^
§
"3
cr
0>
,g
13
*O
Data Supporting Gui
y
*U
O>
e
o>
O
C/5
z
CITATIO
z
u
e
OH
U
on
H
H
g
j*j
PN
P
0*
i-H
O
o
5
"t
0
vo
iH fO i-T
on o
Sn
o y •*-
« « %
J- J- -5 «- 5
CM CM eQ C ^
1 i I s. 4 i
rzi LU 73 "O 1/3 o3
S S S g Ja 2
o> ^ 2 & »T
1 1 « S & JL
flj • ^r ^^^ • ^^ /* \ P""<
Ss-o ^i-Jssej
|§2 5 S 3 s fi
i CM PH i «S i i i
00053150
Grapes, pomace, dried
1
i-H
*H
00
fs|
^
40954401,
Sugarcane, molasses
i
42016701
Tomatoes, pomace, dried
•
42268901
OJD
1
OS
-C
£
1
ractions, except flour
«**
a
2
U a
•S 2
§ «
? 1
o §
C W
= 1
o w
-------
APPENDIX C. Citations Considered to be Part of the Data
Base Supporting the Reregistration of Ethephon
103
-------
104
-------
GUIDE TO APPENDIX C
1. CONTENTS OF BIBLIOGRAPHY. This bibliography contains citations of all studies
considered relevant by EPA in arriving at the positions and conclusions stated
elsewhere in the Reregistration Eligibility Document. Primary sources for studies in
this bibliography have been the body of data submitted to EPA and its predecessor
agencies in support of past regulatory decisions. Selections from other sources
including the published literature, in those instances where they have been considered,
are included.
2. UNITS OF ENTRY. The unit of entry in this bibliography is called a "study". In the
case of published materials, this corresponds closely to an article. In the case of
unpublished materials submitted to the Agency, the Agency has sought to identify
documents at a level parallel to the published article from within the typically larger
volumes in which they were submitted. The resulting "studies" generally have a
distinct title (or at least a single subject), can stand alone for purposes of review and
can be described with a conventional bibliographic citation. The Agency has also
attempted to unite basic documents and commentaries upon them, treating them as a
single study.
3. IDENTIFICATION OF ENTRIES. The entries in this bibliography are sorted
numerically by Master Record Identifier, or "MRID number". This number is unique
to the citation, and should be used whenever a specific reference is required. It is not
related to the six-digit "Accession Number" which has been used to identify volumes of
submitted studies (see paragraph 4(d)(4) below for further explanation). In a few
cases, entries added to the bibliography late in the review may be preceded by a nine
character temporary identifier. These entries are listed after all MRID entries. This
temporary identifying number is also to be used whenever specific reference is needed.
4. FORM OF ENTRY. In addition to the Master Record Identifier (MRID), each entry
consists of a citation containing standard elements followed, in the case of material
submitted to EPA, by a description of the earliest known submission. Bibliographic
conventions used reflect the standard of the American National Standards Institute
(ANSI), expanded to provide for certain special needs.
a Author. Whenever the author could confidently be identified, the Agency has
chosen to show a personal author. When no individual was identified, the
Agency has shown an identifiable laboratory or testing facility as the author.
When no author or laboratory could be identified, the Agency has shown the
first submitter as the author.
b. Document date. The date of the study is taken directly from the document.
When the date is followed by a question mark, the bibliographer has deduced
the date from the evidence contained in the document. When the date appears
105
-------
as (19??), the Agency was unable to determine or estimate the date of the
document.
c. Title. In some cases, it has been necessary for the Agency bibliographers to
create or enhance a document title. Any such editorial insertions are contained
between square brackets.
d. Trailing parentheses. For studies submitted to the Agency in the past, the
trailing parentheses include (in addition to any self-explanatory text) the
following elements describing the earliest known submission:
(1) Submission date. The date of the earliest known submission appears
immediately following the word "received."
(2) Administrative number. The next element immediately following the
word "under" is the registration number, experimental use permit
number, petition number, or other administrative number associated
with the earliest known submission.
(3) Submitter. The third element is the submitter. When authorship is
defaulted to the submitter, this element is omitted.
(4) Volume Identification (Accession Numbers). The final element in the
trailing parentheses identifies the EPA accession number of the volume
in which the original submission of the study appears. The six-digit
accession number follows the symbol "CDL," which stands for
"Company Data Library." This accession number is in turn followed by
an alphabetic suffix which shows the relative position of the study within
the volume.
106
-------
BIBLIOGRAPHY
MRID
CITATION
00009181 Atkins, E.L., Jr; Anderson, L.D.; Greywood, E.A. (1969) Effect of Pesticides
on Apiculture: Project No. 1499. (Unpublished study received Jul 29, 1976
under 352-342; prepared by Univ. of California-Riverside, Dept. of
Entomology, submitted by E.I. du Pont de Nemours & Co., Wilmington, Del.;
CDL: 224800-C)
00026040 Beavers, J.B.; Fink, R.; Brown, R. (1979) Final Report: Acute Oral
LD50~Mallard Duck: Project No. 113-146. (Unpublished study received Dec
19, 1979 under 264-267; prepared by Wildlife International, Ltd. in
cooperation with Washington College, submitted by Union Carbide Agricultural
Products Co., Ambler, Pa.; CDL: 099158-A)
00026041 Beavers, J.B.; Fink, R.; Brown, R. (1979) Final Report: Acute Oral
LD50~Bobwhite Quail: Project No. 113-145. (Unpublished study received Dec
19, 1979 under 264-267; prepared by Wildlife International, Ltd. in
cooperation with Washington College, submitted by Union Carbide Agricultural
Products Co.,. Ambler, Pa.; CDL: 099158-B)
00027493 Beavers, J.B.; Fink, R.; Brown, R. (1978) Final Report: Acute Oral
LD50~Bobwhite Quail: Project No. 164-104. (Unpublished study received Apr
3, 1980 under 1529-EX-2; prepared by Wildlife International, Ltd. in
cooperation with Washington College, submitted by GAP Corp., Chemical
Div., New York, N.Y.; CDL: 099355-A)
00027495 Bentley, R.E. (1974) Acute Toxicity of CPGR Formulation and CPGR 100% to
Bluegill (Lepomis macrochirus) and Rainbow Trout (Salmo gairdneri).
(Unpublished study received Apr 3, 1980 under 1529-EX-2; prepared by
Bionomics, EG&G Environmental Consultants, submitted by GAP Corp.,
Chemical Div., New York, N.Y.; CDL:099355-D)
00027496 Foote, K.C. (1978) Toxicity Test of GAF's Corporation: Teceth 75 8065-20:
Contract No. LI362-05. (Unpublished study received Apr 3, 1980 under
1529-EX-2; prepared by Syracuse Research Corp., submitted by GAP Corp.,
Chemical Div., New York, N.Y.; CDL:099355-E)
107
-------
BIBLIOGRAPHY
MRID
CITATION
00029509 Griffiths, J.T.; Parent, R.A. (1979) The Approximate Acute Oral Toxicity
(LD50) of GAP CPD 71921/L9 in Male Sprague-Dawley Rats: Laboratory No.
2-6153. (Unpublished study received Apr 3, 1980 under 1529-EX-2; prepared
by Food and Drug Research Laboratories, Inc., submitted by GAP Corp.,
Chemical Div., New York, N.Y.; CDL:099356-A)
00029510 Deprospo, J.R. (1975) Acute Dermal LD50 Test in Rabbits: Contract No.
120-2544-35. (Unpublished study received Apr 3, 1980 under 1529-EX-2;
prepared by Affiliated Medical Research, Inc., submitted by GAP Corp.,
Chemical Div., New York, N.Y.; CDL: 099356-B)
00029513 Stevens, K.R. (1979) Primary Skin Irritation Study with Rabbits: Laboratory
No. 6153. (Unpublished study received Apr 3, 1980 under 1529-EX-2;
prepared by Food and Drug Research Laboratories, Inc., submitted by GAP
Corp., Chemical Div., New York, N.Y.; CDL:099356-E)
00030190 Hegidio, J.; Dyson, D.; Thomas, N.B.; et al. (1979) Residues. Includes
method dated Oct 1979. (Unpublished study received Dec 19, 1979 under
264-267; prepared in cooperation with Salyer Land Co. and others, submitted
by Union Carbide Agricultural Products Co., Ambler, Pa.; CDL:099158-C)
00032573 Harrison, S.L.; Nygren, R.E.; Gross, S.M.; et al. (1980) Residues: Ethrel(R)
Sugarcane: Project No. 10223. (Unpublished study received May 15, 1980
under 264-EX-59; prepared in cooperation with Hawaiian Sugar Planters'
Association, submitted by Union Carbide Agricultural Products Co., Ambler,
Pa.;CDL:099427-A)
00036500 Obenauf, G.L. (1973) Residues: Ethephon. (Unpublished study received Mar
19, 1974 under 4F1490; prepared in cooperation with Greenwood Laboratories,
Inc., submitted by Union Carbide Agricultural Products Co., Ambler, Pa.;
CDL:093944-B)
00036510 Reese, W.H., Jr. (1972) Final Report-Phase H: Evaluation of Ethrel in Human
Volunteers: BRL Project No. 7223. (Unpublished study received on unknown
date under 4F1490; prepared by Litton Industries, submitted by Union Carbide
Agricultural Products Co., Ambler, Pa.; CDL:093946-D)
00038793 Union Carbide Agricultural Products Company (1972) Metabolism: The Nature
and Quantities of Residues and Metabolic Degradation Products Resulting from
108
-------
BIBLIOGRAPHY
MRID
CITATION
the Treatment of Walnuts with Ethephon. (Unpublished study received Dec 20,
1972 under 3F1344; CDL: 093599-C)
00038795
00038796
00038797
00038880
00038881
00040268
00040269
Sibbett, S.; Hendricks, L.; Schraeder, W. (1972) Residues: Ethephon.
(Unpublished study received Dec 20, 1972 under 3F1344; prepared in
cooperation with Morse Laboratories, Inc., submitted by Union Carbide
Agricultural Products Co., Ambler, Pa.; CDL:093599-E)
Union Carbide Agricultural Products Company (1970) Metabolism: The Nature
and Quantities of Residues and Metabolic Degredation Products Resulting from
the Treatment of Filberts with Ethephon. (Unpublished study received Dec 20,
1972 under 3F1344; CDL: 093599-F)
Lagerstedt, H. (1972) Residues: Ethephon. (Unpublished study received Dec
20, 1972 under 3F1344; prepared in cooperation with Oregon State Univ.,
submitted by Union Carbide Agricultural Products Co., Ambler, Pa.-
CDL:093599-G)
Amchem Products, Incorporated (1972) Detailed Method of Analysis for
Residues of (2-Chloroethyl)phosphonic acid (Ethephon) in Walnuts. Method
dated Nov 1972. (Unpublished study received Dec 20, 1972 under 3F1344;
submitted by Union Carbide Agricultural Products Co., Ambler, Pa.-
CDL:093596-A)
Amchem Products, Incorporated (1972) Detailed Method of Analysis for
Residues of (2-Chlorethyl)phosphonic acid (Ethephon) in Filberts. Method
dated Nov 1972. (Unpublished study received Dec 20, 1972 under 3F1344;
submitted by Union Carbide Agricultural Products Co., Ambler Pa •
CDL:093596-B)
Union Carbide Agricultural Products Company (19??) Effect of Temperature on
the Level of Ethephon Residue in Pineapple Shell. (Unpublished study received
Aug 27, 1971 under 2G1195; CDL: 095928-A)
Union Carbide Agricultural Products Company (1970) Relevance of Laboratory
Branning Study to a Commercial Branning Operation. (Unpublished study
received Aug 27, 1971 under 2G1195; CDL: 095928-B)
109
-------
BIBLIOGRAPHY
MRID
CITATION
00041465 Valenzuela, C.; Sarin, G.; Uribe, ?; et al. (1973) Residue: Ethephon. Includes
method dated Oct 1973. (Unpublished study received on unknown date under
4E1440; prepared in cooperation with Centre Agricola Valenzuela and
Rorer—Hormoquimica, Ltda., submitted by Union Carbide Agricultural
Products Co., Ambler, Pa.; CDL:093839-A)
00042977 Union Carbide Agricultural Products Company (19??) Analysis of Pineapple
Tissue for Residues of 2-Chloroethylphosphonic acid. Undated method.
(Unpublished study received Dec 23, 1969 under 264-257; CDL:100700-D)
00047911 Westwood, M.; Anderson, J.L.; Edgerton, L.; et al. (1971) Validation of
Analytical Method. (Unpublished study including letter dated Aug 4, 1971
from S.L. Harrison to Richard J. Otten, received Jun 16, 1971 under 1G1172;
prepared in cooperation with Oregon State Univ. and others, submitted by
Union Carbide Agricultural Products Co., Ambler, Pa.; CDL:093494-A)
00047913 Amchem Products, Incorporated (1971) Detailed Method of Analysis for
Residues of 2-Chloroethylphosphonic acid (Ethephon) in Cherries. Method
dated May 1971. (Unpublished study received Jun 16, 1971 under 1 Gil72;
submitted by Union Carbide Agricultural Products Co., Ambler, Pa.;
CDL:093494-C)
00051353 Harrison, S.L. (1976) Letter sent to Warren A. Davis dated Aug 20, 1976:
Ethrel(TM)~Grapes: Ethephon Residues Resulting from Aerial Application.
(Unpublished study received Sep 21, 1976 under 264-267; prepared in
cooperation with San Joaquin Sulphur and San Joaquin Valley Agricultural
Research and Extension Center, submitted by Union Carbide Agricultural
Products Co., Inc., Ambler, Pa.; CDL:095290-H)
00053149 Amchem Products, Incorporated (1976) Detailed Method of Analysis for
Residues of (2-Chloroethyl) phosphonic acid (Ethephon) in Grapes, Grape
Juice, Grape Wine and Dried Grape Pomace. Method dated Jul 1976.
(Unpublished study received Sep 21, 1976 under 264-267; submitted by Union
Carbide Agricultural Products Co., Inc., Ambler, Pa.; CDL:095290-E)
00053150 Amchem Products, Incorporated (1976) Results of Analyses of Grapes for
Ethephon Residues. (Reports by various sources; unpublished study received
Sep 21, 1976 under 264-267; submitted by Union Carbide Agricultural
Products Co., Inc., Ambler, Pa.; CDL: 095290-F)
-------
BIBLIOGRAPHY
MRID
CITATION
00053153 Martin, G.C.; Weaver, R.J.; Abdel-Gawad, H.A. (19??) Translocation,
Breakdown and Metabolic Fate of l,2-14C-(2-Chloroethyl) phosphonic acid in
Grapes and Walnuts. (Unpublished study received Sep 21, 1976 under
264-267; prepared by Univ. of California-Davis, Departments of Pomology and
Viticulture & Enology, submitted by Union Carbide Agricultural Products Co.,
Inc., Ambler, Pa.; CDL:095290-J)
00054013 Bentley, R.E. (1974) Acute Toxicity of Technical Ethrel to Grass Shrimp
(Palaemonetes vulgaris), Mud Crab (Neopanope texana) Water Flea (Daphnia
magna), Midge Larvae (Chironomus tentans), and Scud (Gammarus fasciatus).
(Unpublished study received Dec 5, 1974 under 264-292; prepared by
Bionomics, EG&G, Inc., submitted by Union Carbide Agricultural Products
Co., Inc., Ambler, Pa.; CDL:230425-R)
00054018 Yamaguchi, M.; Chu, C.W.; Yang, S.F. (1971) Metabolism of Ethephon in
Tomatoes. (Unpublished study received Jun 7, 1972 under 2G1195; prepared
by Univ. of California-Davis, Dept. of Vegetable Crops, submitted by Union
Carbide Agricultural Products Co., Inc., Ambler, Pa.; CDL:091010-B)
00054021 Union Carbide Agricultural Products Company, Incorporated (1969)
2-Chloroethylphosphonic acid (Ethephon),!, 2-C14 Metabolism Study.
(Unpublished study received Jun 7, 1972 under 2G1195; CDL:091010-E)
00054022 Union Carbide Agricultural Products Company, Incorporated (1970) Residues:
Ethrel in Pineapples. (Reports by various sources; unpublished study received
Jun 7, 1972 under 2G1195; CDL: 091010-F)
00056480 Hinkle, S.; Cameron, J.T. (1979) Final Report: Avian Dietary Toxicity (LC50)
Study in Mallard Ducks: Project No. 257-107. (Unpublished study received
Apr 3, 1980 under 1529-EX-2; prepared by Hazleton Laboratories America,
Inc., submitted by GAP Corp., Chemical Div., New York, N.Y.;
CDL:099355-C)
00060359 Reno, F.E.; Voelker, R.W. (1977) Final Report: A Two-Year Dietary Study in
Dogs: Project No. 141-260. (Unpublished study received Aug 30, 1978 under
264-267; prepared by Hazleton Laboratories America, Inc., submitted by Union
Carbide Agricultural Products Co., Inc., Ambler, Pa.; CDL:235115-A)
111
-------
BIBLIOGRAPHY
MRID
CITATION
00061717 Union Carbide Agricultural Products Company, Incorporated (1976) Ethephon
Analyses: Ethrel(TM)-Treated Apples. (Reports by various sources;
unpublished study, including letter dated Aug 11, 1976 from S.L. Harrison to
W.A. Davis, received Sep 21, 1976 under 264-267; CDL:228350-B)
00061719 Union Carbide Agricultural Products Company, Incorporated (1976) Ethephon
Analyses: Peppers Treated Aerially with Ethrel(TM). (Reports by various
sources; unpublished study, including letter dated Aug 30, 1976 from S.L.
Harrison to W.A. Davis, received Sep 21, 1976 under 264-267;
CDL:228351-B)
00063745 Rodwell, D.E.; Spencer, A.G.; Allen, S.; et al. (1980) Teratology Study in
Rats: IRDC No. 369-042. (Unpublished study received Dec 1, 1980 under
264-267; prepared by International Research and Development Corp.,
submitted by Union Carbide Agricultural Products Co., Inc., Ambler, Pa.;
CDL:099767-A)
00066931 Weir, R.J. (1977) Final Report: Evaluation of Ethephon in Human Volunteers:
LBI Project No. 2416. (Unpublished study received Aug 30, 1978 under
264-267; prepared by Litton Bionetics, Inc., submitted by Union Carbide
Agricultural Products Co., Inc., Ambler, Pa.; CDL:235116-A)
00067489 Abdel-Gawad, H.A.; Martin, G.C. (1973) The fate of
l,2-14C-(2Chloroethyl)phosphonic acid (Ethephon) in peach. Hortscience
8(2): 125-126. (Also In unpublished submission received Jan 5, 1981 under
1529-EX-2; submitted by GAP Corp., Chemical Div., New York, N.Y.;
CDL:099880-E)
00080482 Harrison, S.L. (1979) Letter sent to Warren A. Davis dated Feb 9, 1979:
Residues of Ethephon in Grapes and Related Foods and Feeds. (Unpublished
study received Mar 2, 1979 under 264-267; submitted by Union Carbide
Agricultural Products Co., Inc., Ambler, Pa.; CDL:097830-G)
00081782 Union Carbide Agricultural Products Company, Incorporated (1971) Residues:
Ethephon. (Unpublished study received May 7, 1971 under 1G1172;
CDL:090971-D)
00081783 Edgerton, L.J.; Hatch, A.H. (1970) Metabolism of
14C-2-Chloroethylphosphonic Acid in Cherries. (Unpublished study, including
112
-------
BIBLIOGRAPHY
MRID
CITATION
submitter summary, received May 7, 1971 under 1 Gil72; prepared by Cornell
Univ., submitted by Union Carbide Agricultural Products Co., Inc., Ambler,
Pa.;CDL:090971-G)
00083773
00085446
00085755
00088983
00097422
00100517
00103287
Huhtanen, K.; Parkins, M.D.; Heintzelman, R.W. (1981) Analysis of Cow
Tissues for Possible Residues of Monochloroacetic Acid. (Unpublished study
received May 28, 1981 under 264-267; submitted by Union Carbide
Agricultural Products Co., Inc., Ambler, Pa.; CDL:070122-A)
Fink, R.; Beavers, J.B.; Brown, R. (1977) Final Report: Eight-day Dietary
LC50--Bobwhite Quail: Project No. 113-139. (Unpublished study received
Mar 2, 1979 under 264-267; prepared by Wildlife International, Ltd. and
Washington College, submitted by Union Carbide Agricultural Products Co.,
Inc., Ambler, Pa.; CDL:097830-F)
Weatherholtz, W.M.; Mistretta, L.H.; Wolfe, G.W.; et al. (1981) Teratology
Study in Rabbits: Technical Ethephon: Project No. 400-635. Final rept.
(Unpublished study received Oct 19, 1981 under 264-267; prepared by
Hazleton Laboratories America, Inc., submitted by Union Carbide Agricultural
Products Co., Inc., Ambler, Pa.; CDL:246064-B)
Heintzelman, R.W.; Madgwick, G.G. (1981) A Review of the Metabolism of
2-Chloroethylphosphonic Acid (Ethephon): Project No. 866C51. (Unpublished
study received Dec 22, 1981 under 264-EX-62; submitted by Union Carbide
Agricultural Products Co., Inc., Ambler, Pa.; CDL:070579-C)
Harrison, S.L. (1974) Letter sent to R.J. Otten dated Mar 19, 1974:
Metabolism of ethephon in figs. (Unpublished study received Mar 19, 1974
under 4F1490; submitted by Union Carbide Agricultural Products Co., Inc.,
Ambler, Pa.; CDL:093944-A)
Huhtanen, K.L.; Heintzelman, R.W. (1982) Ethephon Residue Transfer to
Meat and Milk in Cows: File No. 30081. (Unpublished study received Apr 20,
1982 under 264-257; submitted by Union Carbide Agricultural Products Co.,
Inc., Ambler, Pa.; CDL: 070813-A)
Harrison, S.; Madgwick, G. (1982) Residues of Ethephon in Wheat, Barley and
Oats Resulting from Application of Ethrel as an Anti-lodging Agent: File No.
30263. (Unpublished study received Jun 17, 1982 under 264^376; submitted by
113
-------
BIBLIOGRAPHY
MRID
CITATION
Union Carbide Agricultural Products Co., Inc., Research Triangle Park, NC;
CDL: 070929-D)
00107428 Fink, R.; Reno, F. (1974) Final Report: Eight-day Dietary LC50-Mallard
Ducks: CPGR: Project No. 257-102. (Unpublished study received Mar 15,
1974 under 1529-20; prepared by Truslow Farms, Inc., and Environmental
Sciences Corp., submitted by GAP Corp., Chemical Div., New York, NY;
CDL:132053-A)
00108992 Fritz, D.; Barden, J.; Edgerton, L. (1971) Residues: Ethepon in Apples.
(Unpublished study received Jul 15, 1972 under 2G1217; prepared in
cooperation with Virginia Polytechnic Institute and Cornell Univ., submitted by
Amchem Products, Inc., Ambler, PA; CDL:091045-A)
00108993 Edgerton, L.; Hatch, A. (1969) Metabolism of 14C-2-Chloroethylphosphonic
Acid in Apples. (Unpublished study received Jul 15, 1972 under 2G1217;
prepared by Cornell Univ., submitted by Amchem Products, Inc., Ambler, PA;
CDL:091045-B)
00116123 Amchem Products, Inc. (1970) Residue and Metabolism: Ethephon in
Pineapples. (Compilation; unpublished study received Jul 30, 1970 under
1F1016; CDL:091065-A)
00117752 Amchem Products, Inc. (1971) Ethephon: Residues in Walnuts, Grapes, and
Rats. (Compilation; unpublished study received May 5, 1971 under 1 Gil67;
CDL:090965-B)
00117893 Amchem Products, Inc. (1972) Metabolism and Residue Data: Ethephon in
Cantaloupes, Grapes, Raisins. (Compilation; unpublished study received Oct 7,
1972 under 2F1275; CDL:091811-A)
00118508 Chib, J.; Heintzelman, R. (1982) Ethephon, 2-Chloroethylphosphonic Acid,
Metabolism in Lactating Goat: File No. 30388. (Unpublished study received
Dec 17, 1982 under 2F2711; submitted by Union Carbide Agricultural Products
Co., Inc., Research Triangle Park, NC; CDL:071263-A)
00121613 Union Carbide Agricultural Products Co., Inc. (1974) Ethephon Residue in
Cranberries & Tomatoes. (Compilation; unpublished study received Jul 2,
1974 under 5F1524; CDL:094038-A; 094039)
114
-------
BIBLIOGRAPHY
MRID
CITATION
00122410 Union Carbide Agricultural Prodcts Co., Inc. (1974) Residue and Metabolism
Data: Ethephon in Tobacco. (Compilation; unpublished study received Dec 5,
1974 under 264-292; CDL:028295-A)
00122412 Sleight, B. (1971) The Acute Toxicity of Ethrel to Bluegill ... and ... Salmo
gairdneri. (Unpublished study received Dec 5, 1974 under 264-292; prepared
by Bionomics, Inc., submitted by Union Carbide Agricultural Products Co.,
Inc., Research Triangle Park, NC; CDL:028299-B)
00122414 Fink, R. (1972) Eight-day Dietary LC50--Mallard Ducks: Ethephon: Project
No. 141-246. Final rept. (Unpublished study received Dec 5, 1974 under
264-292; prepared by Hazleton Laboratories, Inc., submitted by Union Carbide
Agricultural Products Co., Inc., Research Triangle Park, NC; CDL:028299-D)
00122421 Union Carbide Agricultural Products Co., Inc. (1973) Residues: Ethrel in
Various Crops and Chicken Tissues. (Compilation; unpublished study received
1973 under 2F1275; CDL:095926-C)
00122423 Gross, S.; Scott, A.; Smith, T.; et al. (1978) Residues of Ethrel in Cotton
Seed, Oil and Meal: Document No. 378A3. (Unpublished study received Mar
16, 1978 under 264-EX-55; prepared in cooperation with Rio Farms and
others, submitted by Union Carbide Agricultural Products Co., Inc., Research
Triangle Park, NC; CDL:096972-B)
00122429 Interregional Research Project No. 4 (1976) The Results of Tests on the
Amount of Ethephon Residues Remaining in or on Cucumbers Including a
Description of the Analytical Method Used. (Compilation; unpublished study
received Jun 20, 1979 under 9E2225; CDL: 098344-A)
00122433 Amchem Products, Inc. (1970) Detailed Method of Analysis for Residues of
2-Chloroethylphosphonic Acid (Ethephon) in Pineapples. (Unpublished study
received 1970 under 1F1016; submitted by Union Carbide Agricultural
Products Co., Inc., Research Triangle Park, NC; CDL:098469-A)
00122435 Union Carbide Agricultural Products Co., Inc. (1974) Ethephon Residue in
Grapes and Related Items. (Compilation; unpublished study received 1974
under 5F1524; CDL:098573-B)
115
-------
BIBLIOGRAPHY
MRID
CITATION
00122448 Pitcher, F. (1974) Cepha-Daphnia magna: Test No. 672. (Unpublished study
received Mar 13, 1974 under 1529-20; prepared by Pesticides Regulation Div.,
Animal Biology Laboratory, submitted by U.S. Environmental Protection
Agency, Beltsville, MD; CDL: 132055-A)
00122452 Union Carbide Agricultural Products Co., Inc. (1975) Residues: Ethrel-treated
Pineapples. (Compilation; unpublished study received Sep 4, 1975 under
264-257; CDL:221823-B)
00122717 Union Carbide Agricultural Products Co., Inc. (1981) The Results of Tests on
the Amount of Ethephon Residues Remaining in or on Pumpkins.
(Compilation; unpublished study received Dec 21, 1982 under 264-263;
CDL:071299-A)
00123222 Union Carbide Agricultural Products Co., Inc. (1972) Ethephon: Residues in
Apples and Other Subjects. (Compilation; unpublished study received Oct 24,
1972 under 3F1325; CDL:093555-B)
00123237 Union Carbide Agricultural Products Co., Inc. (1973) Detailed Method of
Analysis for Residues of ... Ethephon in Cranberries. (Compilation;
unpublished study received Feb 5, 1973 under 3F1353; CDL:093617-A)
00128726 Interregional Research Project No. 4 (1975) The Results of Tests on the
Amount of Ethephon Residues Remaining in or on Macadamia Nuts, Including
a Description of the Analytical Method Used. (Unpublished study received Jun
10, 1983 under 3E2909; CDL: 071698-A)
00136287 Amchem Products, Inc. (1972) Residues: Ethephon. (Compilation; unpublished
study received Oct 3, 1972 under 3F1321; CDL: 092129-B)
00141506 Heintzelman, R. (1984) Ethephon Goat Metabolism: V5007. Unpublished
study prepared by Union Carbide Agricultural Products Co., Inc. lip.
00142265 Huhtanen, K. (1984) Cerone: Detailed Methods of Analysis for Residue of
(2-Chloroethyl) Phosphonic Acid (Ethephon) in Milk and Cow Liver, Muscle,
Kidney and Fat Tissues: Project Number: 866R10. Unpublished study prepared
by Union Carbide Agricultural Products Co., Inc. 20 p.
116
-------
BIBLIOGRAPHY
MRID
CITATION
00144559 Fletcher, D. (1983) 42-Day Neurotoxicity Study with Ethephon:Base 250 in
Mature White Leghorn Chickens: BLAL No. 83 DN 102. Unpublished study
prepared by Bio-Life Assoc., Ltd. 52 p.
00145613 Union Carbide Agricultural Products Co. (1984?) Residue Summary: Ethephon
Residue Data. Unpublished compilation. 59 p.
00147357 Weatherholtz, W. (1984) Two Year Dietary Study in Dogs: Ethrel: Addendum
to Final Report: Project No. 141-260. Unpublished study prepared by Hazleton
Laboratories America, Inc. 5 p.
00151127 Union Carbide Agricultural Products Co. Inc. (1985) Residues of Ethephon in
Sugarcane and Rotational Crops. Unpublished compilation. 11 p.
00165339 Huhtanen, K.; Storm, J.; Heintzelman, R. (1984) Ethrel: Metabolism of
Carbon 14-ethephon in Lactating Goats: Project No. 866R10: File No. 32452.
Unpublished study prepared by Union Carbide Agricultural Products Co., Inc.
39 p.
40412401 Jagannath, D. (1987) Mutagenicity Test on Ethephon Base 250 in the Ames
Salmonella/Microsome Reverse Mutation Assay: HLA Study No.:
10065-0-401. Unpublished study prepared by Hazleton Laboratories America,
Inc. 33 p.
40555201 Cifone, M. (1988) Mutagenicity Test on Ethepon in the Rat Primary
Hepatocyte Unscheduled DNA Synthesis Assay: HLA Study No. 10065-0-447.
Unpublished study prepared by Hazleton Laboratories America, Inc. 31 p.
40555301 Murli, H. (1988) Mutagenicity Test on Ethephon Base 250 in an in vitro
Cytogenetic Assay Measuring Chromosomal Aberration Frequencies in Chinese
Hamster Ovary (CHO) Cells: HLA Study No. 10065-0-437. Unpublished study
prepared by Hazleton Laboratories America, Inc. 33 p.
40954401 Nygren, R. (1988) Ethephon Residues in Mill Fractions of Treated Sugarcane:
Project No. 866R10: File No. 40289. Unpublished study prepared by
Rhone-Poulenc Ag Co. 54 p.
117
-------
BIBLIOGRAPHY
MRID
CITATION
41050801 Van Miller, J. (1988) Lifetime Dietary Oncogenicity Study with Ethephon in
Alnino Mice: Laboratory Project ID: 51-502. Unpublished study prepared by
Bushy Run Research Center. 1347 p.
41103001 Henwood, S. (1989) Teratology Study with Ethephon Technical Base 250 in
Rats: Proj. ID HLA 6224-125. Unpublished study prepared by Hazleton
Laboratories America, Inc. 286 p.
41135001 Hamada, N. (1989) One-Year Oral Toxicity Study in Beagle Dogs with
Ethephon: Final Report: HLA Study No. 400-722. Unpublished study prepared
by Hazleton Laboratories America, Inc. 557 p.
41139001 Van Miller, J. (1989) Lifetime Dietary Combined Chronic Toxicity and
Oncogenicity Study with Ethephon in Albino Rats: Laboratory Project ID:
51-501. Unpublished study prepared by Union Carbide, Bushy Run Research
Center. 2427 p.
41154503 Rush, R. (1989) Dermal Sensitization Study in Guinea Pigs with Base A-250:
Final Report: SLS Study No. 3147.44. Unpublished study prepared by
Springborn Life Sciences, Inc. 32 p.
41154505 Helfant, L.; Castillo, M. (1989) Ethephon Manufacturing Use Product Base
250: Product Indentity and Composition: Unpublished compilation prepared by
Rhone-Poulenc Ag Co. 96 p.
41154506 Helfant, L. (1989) Ethephon Manufacturing Use Product Base 250: Physical
and Chemical Characteristics: Project No. 866/C10. Unpublished Compilation
prepared by Rhone-Poulenc Ag Co. 214 p.
41267001 Helfant, L. (1989) Ethephon Manufacturing Use Product: Base 250: Analysis
and Certification of Product Ingredients: Laboratory Project No. 866 CIO:
Study No. AC-89-005. Unpublished study prepared by Rhone-Poulenc AG Co.
in cooperation with Lancaster Laboratories, Inc. 321 p.
41295901 Henwood, S. (1989) 3-Week Dermal Toxicity Study with Ethephon Technical
in Rabbits: Lab Project Number: HLA/6224/141. Unpublished study prepared
by Hazleton Laboratories America, Inc. 247 p.
118
-------
BIBLIOGRAPHY
MRID
CITATION
41296201 Rhoads, W. (1988) Determination of the Characteristics of Ethephon When
Subjected to Analysis by the United States Food and Drug Administration
(FDA) Multi-residue Protocols I, H, IE and IV: Rhone Poulenc Report 1087A.
Unpublished study prepared by Colorado Analytical Research & Development
Corp. 142 p.
41296202 Dionne, E. (1989) Ethephon-Acute Toxicity to Eastern Oyster (Crassostrea
virginica) under Flow-through Conditions: Final: SLI Report No. 89-10-3121;
SLI Study 10566.1288.6123.504. Unpublished study prepared by Springborn
Laboratories, Inc., Environmental Sciences Div. 37 p.
41403301 Giddings, J. (1990) Ethephon-Toxicity to the Marine Diatom Skeletonema
costatum: Lab Project Number: 90-1-3207: 10566-0389-6131450. Unpublished
study prepared by Springborn Laboratories, Inc. 36 p.
41403302 Giddings, J. (1990) Ethephon-Toxicity to the Freshwater Diatom Navicula
pelliculosa: Lab Project Number: 90-2-3234: 10566-03896131-440.
Unpublished study prepared by Springborn Laboratories Inc. 36 p.
41403303 Giddings, J. (1990) Ethephon-Toxicity to the Freshwater Bluegreen Alga
Anabaena flos-aquae: Lab Project Number: 90-1-3206: 105660389-6131-420.
Unpublished study prepared by Springborn Laboratories, Inc. 35 p.
41403304 Giddings, J. (1990) Ethephon-Toxicity to the Freshwater Green Alga
Selenastrum capricornutum: Lab Project Number: 90-1-3197:
105660389-6131-430. Unpublished study prepared by Springborn
Laboratories, Inc. 36 p.
41403305 Hoberg, J. (1990) Ethephon-Determination of Effects on Seedling
Germination, Shoot Emergence and Seedling Vigor of Ten Plant Species: Lab
Project Number: 90-2-3220: 10566-1288-6124-610. Unpublished study
prepared by Springborn Laboratories, Inc. 311 p.
41508701 Neeper-Bradley, T.; Tyl, R. (1990) Two-generation Reproduction Study in CD
Albino Rats exposed to Ethephon by Dietary Inclusion: Lab Project I.D.:
51-539. Unpublished study prepared by Union Carbide Bushy Run Research
Center. 760 p.
119
-------
BIBLIOGRAPHY
MRID
CITATION
41509001 Giddings, J. (1990) Ethephon-Toxicity to the Freshwater Plant Lemna gibba
G3: Final Report: SLI Report No.: 90-04-3302; SLI Study No.:
10566.0389.6131.410. Unpublished study prepared by Springborn
Laboratories, Inc., Environmental Sciences Div. 42 p.
41545601 Das, Y. (1990) Photodegradation of Ethyl(U)-carbon HEthephon in Aqueous
Solution Buffered at pH 5 under Sunlight: Lab Project Number: 89151.
Unpublished study prepared by Innovative Scientific Services, Inc. 95 p.
41545701 Das, Y. (1990) Hydrolysis of Ethyl(U)-carbon HEthephon in Aqueous
Solutions Buffered at pH 5, 7 and 9: Lab Project Number: 89150. Unpublished
study prepared by Innovative Scientific Services, Inc. 113 p.
41557201 Kenwood, S. (1990) Teratology Study with Ethephon Technical-Base 50 in
Rabbits: Lab Project I.D.: HLA 6224-158. Unpublished study prepared by
Hazleton Laboratories America, Inc. 166 p.
41659401 Hoberg, J. (1990) Ethephon-Supplemental Report: Determination of Effects on
Carrot and Ryegrass Emergence and Carrot Seedling Vegetative Vigor: Lab
Project Nos.: 90-3-3244: 10566-12886124-610. Unpublished study prepared by
Springborn Labs., Inc. 107 p.
41668201 Eckert, J. (1990) Ethephon-Plant Regulator: Storage Stability Study in Wheat
Grain: Interim Report: Lab Project Number: RP-01-891. Unpublished study
prepared by Enviro-Bio-Tech, Ltd. 29 p.
41668202 Eckert, J. (1990) Ethephon-Plant Regulator: Storage Stability Study in Wheat
Straw: Interim Report: Lab Project Number: RP-01-89H. Unpublished study
prepared by Enviro-Bio-Tech, Ltd. 29 p.
41668203 Eckert, J. (1990) Ethephon-Plant Regulator: Storage Stability in Apples:
Interim Report: Lab Project Number: RP-01-89C. Unpublished study prepared
by Enviro-Bio-Tech, Ltd. 33 p.
41668204 Eckert, J. (1990) Ethephon-Plant Regulator: Storage Stability Study in
Blackberries: Interim Report: Lab Project Number: RP-01-89B. Unpublished
study prepared by Enviro-Bio-Tech, Ltd. 33 p.
120
-------
BIBLIOGRAPHY
MRID
CITATION
41668205
41668206
41668207
41668208
41668209
41668210
41668211
41668212
41668213
Nygren, R. (1990) Ethephon-Plant Regulator: Residues in Blackberries: Lab
Project Number: USA89E41: 40843. Unpublished study prepared by
Rhone-Poulenc Ag Co., in cooperation with McKenzie Laboratories, Inc., and
Others. 96 p.
Eckert, J. (1990) Ethephon-Plant Regulator: Storage Stability Study in
Cantaloupe: Interim Report: Lab Project Number: RP-01-89G. Unpublished
study prepared by Enviro-Bio-Tech, Ltd. 34 p.
Nygren, R. (1990) Ethephon-Plant Regulator: Residues in Cantaloupe: Lab
Project Number: USA89E42: 40844. Unpublished study prepared by
Rhone-Poulenc Ag Co., in cooperation with McKenzie Labs and others. 95 p.
Nygren, R. (1990) Storage Stability Study of Ethephon in/on Whole Fresh
Cherries: Interim Report: Lab Project Number: 89-REN-CH-S: 40836.
Unpublished study prepared by Rhone-Poulenc Ag Co. 24 p.
Eckert, J. (1990) Ethephon-Plant Regulator: Storage Stability Study in Grapes:
Interim Report: Lab Project Number: RP-01-89D. Unpublished study prepared
by Enviro-Bio-Tech, Ltd. 33 p.
Nygren, R. (1990) Ethephon-Storage Stability Study in/on Whole Fresh
Peppers: Interim Report: Lab Project Number: 89-REN-P-S: 40845.
Unpublished study prepared by Rhone-Poulenc Ag Co. 24 p.
Eckert, J. (1990) Ethephon-Plant Regulator: Storage Stability Study in
Tomatoes: Interim Report: Lab Project Number: RP-01-89A. Unpublished
study prepared by Enviro-Bio-Tech, Ltd. 33 p.
Nygren, R. (1990) Storage Stability of Ethephon in/on Walnut Nutmeats:
Interim Report: Lab Project Number: 89-REN-WA-S: 40848. Unpublished
study prepared by Rhone-Poulenc Ag Co. 20 p.
Eckert, J. (1990) Ethephon-Plant Regulator: Storage Stability Study in
Pineapple Fruit: Interim Report: Lab Project Number: RP-01-89E.
Unpublished study prepared by Enviro-Bio-Tech, Ltd. 33 p.
121
-------
BIBLIOGRAPHY
MRID
CITATION
41668215 Eckert, J. (1990) Ethephon-Plant Regulator: Storage Stability Study in
Cottonseed: Lab Project Number: RP-01-89J. Unpublished study prepared by
Enviro-Bio-Tech, Ltd. 29 p.
41681401 Das, Y. (1990) Photodegration of Ethyl(U)-carbon 14Ethephon on Soil Under
Artificial Sunlight: Lab Project Number: 90032. Unpublished study prepared
by Innovative Scientific, Inc. 106 p.
41685901 Nachreiner, D.; Klonne, D. (1989) Addendum to Inhalation Study for Base 250
Ethephon: Lab Project Number: 52-580. Unpublished study prepared by Bushy
Run Research Laboratories. 13 p.
41704501 Nygren, R. (1990) Prep/Cotton/Residues: Lab Project No: USA89I03: 40859.
Unpublished study prepared by Rhone Poulenc Ag Co., inn cooperation with
McKenzie Laboratories, Inc. 299 p.
41746501 Johnson, T. (1991) A Tobacco Pyrolysis Study with carbon 14-Ethephon Using
Flue Cured Tobacco (Nicontiana tabacum): Lab Project Number: 1299: 446.
Unpublished study prepared by PTRL East, Inc. 59 p.
41757701 Das, Y. (1991) Metabolism of Ethyl(U)-carbon 14Ethephon Under Aerobic Soil
Conditions: Lab Project Number: EC-90-111: 90031. Unpublished study
prepared by Innovative Scientific Services, Inc. 82 p.
41757702 Das, Y. (1991) Metabolism of Ethyl(U)-carbon 14Ethephon Under Anaerobic
Aquatic Soil Conditions: Lab Project No: EC-90-112. Unpublished study
prepared by Innovative Scientific Services, Inc. 92 p.
41872501 Nygren, R. (1990) Ethrel/Grape/Residue: Lab Project Nos: USA89E25; 40869.
Unpublished study prepared by Rhone-Poulenc Ag Co., in cooperation with
Mckenzie Laboratories, Inc. 141 p.
41872502 Nygren, R. (1990) Ethrel Apple 1989 Residue Program: Lab Project Nos:
USA89E32; 40891. Unpublished study prepared by RhonePoulenc Ag Co., in
cooperation with Mckenzie Laboratories, Inc. 150 p.
41906101 Savage, E.; (1990) Carbon 14-Ethephon: Absorption, Distribution,
Metabolism, and Excretion in the Rat: Lab Project No: RP P89/ 366.
Unpublished study prepared by Hazleton, UK. 626 p.
122
-------
BIBLIOGRAPHY
MRID
CITATION
42010401
42011501
42016701
42116501
42126001
42236701
42268901
42268902
Nygren, R. (1991) Storage Stability of Ethephon in/on Walnut Nutmeats: Lab
Project Number: 89-REN-WA-S: 41007. Unpublished study prepared by
Rhone-Poulenc Ag Co. 34 p.
Norris, F. (1991) A Terrestrial Field Soil Dissipation Study with Ethephon:
Lab Project Number: EC-89-070: R092-079: R094-052. Unpublished study
prepared by Rhone-Poulenc Ag Co., A & L Eastern Agriculteral Labs and A &
L Western Agriculteral Labs. 250 p.
Nygren, R. (1991) Ethrel Tomato Residues: Lab Project Number: USA89E30:
40941. Unpublished study prepared by Rhone-Poulenc Ag Co. and McKenzie
Labs, Inc. 246 p.
Nygren, R. (1991) Ethrel: Magnitude of the Residue/Crop Field Trials on
Grapes: Amended Report: Lab Project Number: USA89E25: 41024.
Unpublished study prepared by Rhone Poulenc Ag Co. in coop with McKenzie
Labs, Inc., Cal State Univ., Viticulture and Enology Research Ctr. and others
182 p.
Das, Y. (1991) Soil Adsorption and Desorption of carbon 14 Ethephon: Lab
Project Number: ISSI 91020: EC-91-166. Unpublished study prepared by
Innovative Scientific Services, Inc. 182 p .
Byrd, J. (1992) A Metabolism Study with carbon 14 Ethephon in Laying Hens
(Callus gallus): Lab Project Number: 9015C. Unpublished study prepared by
Southwest Bio-Labs, Inc. 284 p.
Conn, R. (1992) Magnitude of the Residue of Ethephon in the Processed
Fractions of Wheat: Lab Project Number: SARS-89-2A-24P:
SARS-90-TX-24P: MKL-001-90-02. Unpublished study prepared by Stewart
Agricultural Research Services, Inc., The Texas A&M Univ. System, and
McKenzie Laboratories, Inc. 164 p.
Conn, R. (1992) Magnitude of the Residue of Ethephon and Monochloroacetic
Acid (MCAA) in or on Wheat: SARS-89-24: MKL-001-90-02: SPRA-90-100.
Unpublished study prepared by Stewart Agricultural Research Services, Inc.,
Rhone-Poulenc Ag Co., and McKenzie Laboratories, Inc. 330 p.
123
-------
BIBLIOGRAPHY
MRID
CITATION
42268903 Nygren, R. (1992) Ethrel: Tomato Magnitude of Residue Study: Lab Project
Number: USA90E16: 41067. Unpublished study prepared by Rhone-Poulenc
Ag Co., McKenzie Laboratories, Inc., and Glades Crop Care, Inc. 137 p.
42268904 Upalawanna, S. (1992) Storage Stability of Monochloroacetic Acid (MCAA)
on Cottonseed: Lab Project Number: EC-90-133. Unpublished study prepared
by Rhone-Poulenc Ag Co. 45 p.
42268905 Upalawanna, S. (1992) Storage Stability of Monochloroacetic Acid (MCAA)
on Grapes and Raisin Waste: Lab Project Number: EC-90-136. Unpublished
study prepared by Rhone-Poulenc Ag Co. 56 p.
42268906 Upalawanna, S. (1992) Storage Stability of Monochloroacetic Acid (MCAA)
on Wheat Straw: Lab Project Number: EC-90-135. Unpublished study
prepared by Rhone-Poulenc Ag Co. 49 p.
42268907 Upalawanna, S. (1992) Storage Stability of Monochloroacetic Acid (MCAA)
on Tomatoes: Lab Project Number: EC-90-134. Unpublished study prepared
by Rhone-Poulenc Ag Co. 41 p.
42268908 Upalawanna, S. (1992) Storage Stability of Monochloroacetic Acid (MCAA)
on Cantaloupes: Lab Project Number: EC-90-138. Unpublished study
prepared by Rhone-Poulenc Ag Co. 41 p.
42268909 Upalawanna, S. (1992) Storage Stability of Monochloroacetic Acid (MCAA)
on Blackberries: Lab Project: EC-90-137. Unpublished study prepared by
Rhone-Poulenc Ag Co. 42 p.
42294501 Putt, A. (1992) Ethephon Technical-The Chronic Toxicity to Daphnia magna
Under Flow-through Conditions: Final Report: Lab Project Number:
92-1-4074: 10566.0891.6210.130. Unpublished study prepared by Springborn
Labs., Inc. 98 p.
42298201 Nygren, R. (1992) Ethrel/Pineapple/Residue Magnitude of the Residue Crop
Trials and Processing Fractions: Lab Project Number: USA89E27.
Unpublished study prepared by Rhone-Poulenc Ag Co., Maui Pineapple Co.
Ltd., and Hawaiian Sugar Planters Assoc. 291 p.
124
-------
BIBLIOGRAPHY
MRID
CITATION
42300801 Nygren, R. (1992) Storage Stability Study of Ethephon in/on Whole Fresh
Peppers: Lab Project Number: 89-REN-P-S. Unpublished study prepared by
Rhone-Poulenc Ag Co. 45 p.
42300802 Nygren, R. (1992) Storage Stability Study of Ethephon in/on Whole Fresh
Cherries: Lab Project Number: 89-REN-CH-S. Unpublished study prepared by
Rhone-Poulenc Ag Co. 42 p.
42300803 Eckert, J. (1992) Determination of the Storage Stability of Ethephon in
Pineapple Fruit: Lab Project Number: RP-01-89E. Unpublished study prepared
by Enviro-Bio-Tech, Ltd. 57 p.
42300804 Eckert, J. (1992) Determination of the Storage Stability of Ethephon in Apple
Fruit: Lab Project Number: RP-01-89C. Unpublished study prepared by
Enviro-Bio-Tech, Ltd. 57 p.
42300805 Eckert, J. (1992) Determination of the Storage Stability of Ethephon in Grape
Berries: Lab Project Number: RP-01-89D. Unpublished study prepared by
Enviro-Bio-Tech, Ltd. 57 p.
42300806 Eckert, J. (1992) Determination of the Storage Stability of Ethephon in Tomato
Fruit: Lab Project Number: RP-01-89A. Unpublished study prepared by
Enviro-Bio-Tech, Ltd. 57 p.
42300807 Eckert, J. (1992) Determination of the Storage Stability of Ethephon in
Blackberry Fruit: Lab Project Number: RP-01-89B. Unpublished study
prepared by Enviro-Bio-Tech, Ltd. 57 p.
42300808 Upalawanna, S. (1992) Storage Stability on Monochloroacetic Acid (MCAA)
on Pineapples: Lab Project Number: EC-90-139. Unpublished study prepared
by Rhone-Poulenc Ag Co. 41 p.
42379101 Nygren, R. (1992) Chromatograms and Answers Raised in EPA Reviews for
Ethephon use on Apples: Addendum to MRID No. 41872502: Lab Project
Number: USA89E32: 40891. Unpublished study prepared by McKenzie
Laboratories, Inc. 194 p.
42381701 Nygren, R. (1992) Chromatograms and Answers Raised in EPA Reviews for
Ethephon Use on Sugarcane: Addendum to MRID 40954401: Lab Project
125
-------
BIBLIOGRAPHY
MRID
CITATION
Number: 40289: R87-023-R01. Unpublished study prepared by Rhone-Poulenc
Ag. Co. 62 p.
42410301 Nygren, R. (1992) Chromatograms and Answers Raised in EPA Reviews for
Ethephon Use on Grapes: An Addendum: Lab Project Number: USA89E25:
40869. Unpublished study prepared by McKenzie Laboratories, Inc. 265 p.
42410401 Eckert, J. (1992) Determination of the Storage Stability of Ethephon in Wheat
Straw: Lab Project Number: RP-01-89H. Unpublished study prepared by
Enviro-Bio-Tech, Ltd. 51 p.
42410402 Eckert, J. (1992) Determination of the Storage Stability of Ethephon in
Cottonseed: Lab Project Number: RP-01-89J. Unpublished study prepared by
Enviro-Bio-Tech, Ltd. 52 p.
42410403 Eckert, J. (1992) Determination of the Storage Stability of Ethephon in Wheat
Grain: Lab Project Number: RP-01-891. Unpublished study prepared by
Enviro-Bio-Tech, Ltd. 52 p.
42430501 Helfant, L. (1992) Ethephon Base 250 Storage Stability Study: Lab Project
Number: AC-91-008: 41247. Unpublished study prepared by Rhone Poulenc
AgCo. 50 p.
42464401 Nygren, R. (1992) Ethrel Brand Plant Regulator: Walnut/Magnitude of the
Residue: Lab Project Number: USA91E29. Unpublished study prepared by
Rhone-Poulenc Ag Co. 99 p.
42718101 Eckert, J. (1993) Determination of the Storage Stability of Ethephon in
Cantaloupe Fruit: Lab Project Number: RP-01-89G: 90070: EBT-241.00.
Unpublished study prepared by Enviro-Bio-Tech, Ltd. 59 p.
42926301 Bernard, M. (1993) Product Chemistry: Manufacturing and Analytical Data for
Ethephon Technical Concentrate. Unpublished study compiled by Cedar
Chemical Corp. 31 p.
42957301 Leonard, M. (1993) Storage Stability of Ethephon in/on Frozen Bovine Meat,
Bovine Milk and Chicken Eggs Spiked with Ethephon: Lab Project Number:
EC-92-198: 44198. Unpublished study prepared by Rhone-Poulenc Ag Co. 66
P-
126
-------
BIBLIOGRAPHY
MRID
CITATION
42957302 Nygren, R. (1993) Ethephon--Validation of Ethylene Release Method of
Analysis for Residues of Ethephon in Crop Materials: Lab Project Number:
EC-92-228: 44155. Unpublished study prepared by Rhone-Poulenc Ag Co.
233 p.
43115301 Bernard, M. (1994) Product Chemistry: Manufacturing and Analytical Data for
Ethephon. Unpublished study prepared by Cedar Chemical Corp. 31 p.
43143601 Miller, N. (1994) A Confined Rotational Crop Study with (carbon 14)
Ethephon Using Radishes (Raphanus sativus), Collards (Brassica oleracea), and
Wheat (Triticum aestivum): Lab Project Number: EC/91/158. Unpublished
study prepared by Rhone-Poulenc Ag Co., A&L Great Lakes Lab., Inc. 326 p.
127
-------
-------
APPENDIX D. List of Available Related Documents
129
-------
-------
The following is a list of available documents related to Ethephon. It's purpose is to
provide a path to more detailed information if it is needed. These accompanying documents
are part of the Administrative Record for Ethephon and are included in the EPA's Office of
Pesticide Programs Public Docket.
1. Health and Environmental Effects Science Chapters
2. Detailed Label Usage Information System (LUIS) Report
3. Ethephon RED Fact Sheet
4. PR Notice 86-5 (included in this appendix)
5. PR Notice 91-2 (included in this appendix) pertains to the Label Ingredient
Statement
131
-------
-------
APPENDIX E. PR Notices 86-5 and 91-2
133
-------
-------
PR Notice 86-5
135
-------
-------
\
/ UNITED STATES ENVIRONMENTAL PROTECTION AGENCY
WASHINGTON, D.C. 20460
July 29, 1986
OFFICE OF
PR NOTICE 86-5 PREVENTION, PESTICIDES
AND TOXIC SUBSTANCES
NOTICE TO PRODUCERS, FORMULATORS, DISTRIBUTORS
AND REGISTRANTS
Attention: Persons responsible for Federal registration of pesticides.
Subject: Standard format for data submitted under the Federal Insecticide,
Fungicide, and Rodenticide Act (FIFRA) and certain provisions of the
Federal Food, Drug, and Cosmetic Act (FFDCA).
I. Purpose
To require data to be submitted to the Environmental Protection Agency (EPA) in a
standard format. This Notice also provides additional guidance about, and illustrations of, the
required formats.
II. Applicability
This PR Notice applies to all data that are submitted to EPA to satisfy data
requirements for granting or maintaining pesticide registrations, experimental use permits,
tolerances, and related approvals under certain provisions of FIFRA and FFDCA. These data
are defined in FIFRA §10(d)(l). This Notice does not apply to commercial, financial, or
production information, which are, and must continue to be, submitted differently under
separate cover.
HI. Effective Date
This notice is effective on November 1, 1986. Data formatted according to this notice
may be submitted prior to the effective date. As of the effective date, submitted data packages
that do not conform to these requirements may be returned to the submitter for necessary
revision.
IV. Background
On September 26, 1984, EPA published proposed regulations in the Federal Register
(49 FR 37956) which include Requirements for Data Submission (40 CFR §158.32) and
Procedures for Claims of Confidentiality of Data (40 CFR §158.33). These regulations
specify the format for data submitted to EPA under Section 3 of FIFRA and Sections 408 and
409 of FFDCA, and procedures which must be followed to make and substantiate claims of
confidentiality. No entitlements to data confidentiality are changed, either by the proposed
regulation or by this notice.
OPP is making these requirements mandatory through this Notice to gain resource-
saving benefits from their use before the entire proposed regulation becomes final. Adequate
lead time is being provided for submitters to comply with the new requirements.
137
-------
V. Relationship of this Notice to Other OPP Policy and Guidance
While this Notice contains requirements for organizing and formatting submittals of
supporting data, it does not address the substance of test reports themselves. "Data reporting
guidance is now under development in OPP, and will specify how the study objectives,
protocol, observations, findings, and conclusions are organized and presented within the study
report. The data reporting guidance will be compatible with submittal format requirements
described in this Notice.
OPP has also promulgated a policy (PR Notice 86-4 dated April 15, 1986) that
provides for early screening of certain applications for registration under FIFRA §3. The
objective of the screen is to avoid the additional costs and prolonged delays associated with
handling significantly incomplete application packages. As of the effective date of this Notice,
the screen will include in its criteria for acceptance of application packages the data formatting
requirements described herein.
OPP has also established a public docket which imposes deadlines for inserting into the
docket documents submitted in connection with Special Reviews and Registration Standards
(see 40 CFR §154.15 and §155.32). To meet these deadlines, OPP is requiring an additional
copy of any data submitted to the docket. Please refer to Page 10 for more information about
this requirement.
For several years, OPP has required that each application for registration or other
action include a list of all applicable data requirements and an indication of how each is
satisfied-the statement of-the method of support for the application. Typically, many
requirements are satisfied by reference to data previously submitted-either by the applicant or
by another party. That reguirement is not altered by this notice, which applies only to data
submitted with an application.
VI. Format Requirements
A more detailed discussion of these format requirements follows the index on the next
page, and samples of some of the requirements are attached. Except for the language of the
two alternative forms of the Statement of Data Confidentiality Claims (shown in Attachment 3)
which cannot be altered, these samples are illustrative. As long as the required information is
included and clearly identifiable, the form of the samples may be altered to reflect the
submitter' s preference.
- INDEX-
Text Example
Page Page
A. Organization of the Submittal Package 3 17
B. Transmittal Document 4 11
C. Individual Studies 4
C. 1 Special Considerations for Identifying Studies 5
D. Organization of each Study Volume 6 17
D. 1 Study Title Page 7 12
D. 2 Statement of Data Confidentiality Claims
(based on FIFRA §10(d)(l)) 8 13
D. 3 Confidential Attachment 8 15
D. 4 Supplemental Statement of Data Confidentiality
138
-------
Claims (other than those based on FIFRA §10(d)(l)) 8 14
D. 5 Good Laboratory Practice Compliance Statement 9 16
E. Reference to Previously Submitted Data 9
F. Physical Format Requirements & Number of Copies 9
G. Special Requirements for Submitting Data to the Docket 10
A. Organization of Submittal Package
A "submittal package" consists of all studies submitted at the same time for review in
support of a single regulatory action, along with a transmittal document and other related
administrative material (e.g. the method of support statement, EPA Forms 8570-1, 8570-4,
8570-20, etc.) as appropriate.
Data submitters must organize each submittal package as described in this Notice. The
transmittal and any other administrative material must be grouped together in the first physical
volume. Each study included in the submittal package must then be bound separately.
Submitters sometimes provide additional materials that are intended to clarify,
emphasize, or otherwise comment to help Product Managers and reviewers better understand
the submittal.
- If such materials relate to one study, they should be included as an appendix to that
study.
- If such materials relate to more than one study (as for example a summary of all
studies in a discipline) or to tne submittal in general, they must be included in the
submittal package as a separate study (with title page and statement of confidentiality
claims).
B. Transmittal Document
The first item in each submittal package must be a transmittal document. This
document identifies the submitter or all joint submitters; the regulatory action in support of
which the package is being submitted-i.e., a registration application, petition, experimental
use permit (EUP), §3(c)(2)(B) data call-in, §6(a)(2) submittal, or a special review; the
transmittal date; and a list of all individual studies included in the package in the order of their
appearance, showing (usually by Guideline reference number) the data requirement(s)
addressed by each one. The EPA-assigned number for the regulatory action (e.g. the
registration, EUP, or tolerance petition number) should be included in the transmittal
document as well, if it is known to the submitter. See Attachment 1 for an example of an
acceptable transmittal document.
The list of included studies in the transmittal of a data submittal package supporting a
registration application should be subdivided by discipline, reflecting the order in which data
requirements appear in 40 CFR 158.
The list of included studies in the transmittal of a data submittal package supporting a
petition for tolerance or an application for an EUP should be subdivided into sections A B
£,.... of the petition or application, as defined in 40 CFR 180.7 and 158.125, (petitions') or
Pesticide Assessment Guidelines, Subdivision I (EUPs) as appropriate.
139
-------
When a submittal package supports a tolerance petition and an application for a
registration or an EUP, list the petition studies first, then the balance of the studies. Within
these two groups of studies follow the instructions above.
C. Individual Studies
A study is the report of a single scientific investigation, including all supporting
analyses required for logical completeness. A study should be identifiable and distinguishable
by a conventional bibliographic citation including author, date, and title. Studies generally
correspond in scope to a single Guideline requirement for supporting data, with some
exceptions discussed in section C.I. Each study included in a submittal package must be
bound as a separate entity. (See comments on binding studies on page 9.)
Each study must be consecutively paginated, beginning from the title page as page 1.
The total number of pages in the com-plete study must be shown on the study title page. In
addition (to ensure that inadvertently separated pages can be reassociated with the proper study
during handling or review) use either or the following:
- Include the total number of pages in the complete study on each page (i.e., 1 of 250,
2 of 250, ...250 of 250).
- Include a company name or mark and study number on each page of the study, e g ,
Company Name-1986-23. Never reuse a study number for marking the pages of
subsequent studies. . .
When a single study is extremely long, binding it in mul-tiple volumes is permissible
so long as the entire study is pag-inated in a single series, and each volume is plainly identified
by the study title and its position in the multi-volume sequence.
C.I Special Considerations for Identifying Studies
Some studies raise special problems in study identification, because they address
Guidelines of broader than normal scope or for other reasons.
a. Safety Studies. Several Guidelines require testing for safety in more than one
species. In these cases each species tested should be reported as a separate study, and bound
separately.
Extensive supplemental reports of pathology reviews, feed analyses, historical control
data and the like are often associated with safety studies. Whenever possible these should be
submitted with primary reports of the study, and bound with the primary study as appendices.
When such supplemental reports are submitted independently of the primary report, take care
to fully identify the primary report to which they pertain.
Batteries of acute toxicity tests, performed on the same end use product and covered by
a single title page, may be bound together and reported as a single study.
b. Product Chemistry Studies. All product chemistry data within a submittal package
submitted in support of an end-use product produced from registered manufacturing-use
products should be bound as a single study under a single title page.
Product chemistry data submitted in support of a technical product, other
manufacturing-use product, an experimental use permit, an import tolerance petition, or an
end-use product produced from unregistered source ingredients, should be bound as a single
study for each Guideline series (61, 62, and 63) for conventional pesticides, or for the
equivalent subject range foFblbrational pesticides. The first of the three studies in a complete
product chemistry submittal for a biochemical pesticide would cover Guidelines 151-10,
140
-------
151-11, and 151-12; the second would cover Guidelines 151-13, 151-15, and 151-16; the third
would cover Guideline 151-17. The first study for a microbial pesticide would cover
Guidelines 151-20, 151-21, and 151-22; the second would cover Guidelines 151-23 and
151-25; the third would cover Guideline 151-26.
Note particularly that product chemistry studies are likely to contain Confidential
Business Information as defined in FIFRA §10(d)(l)(A), (B), or (C), and if so must be
handled as described in section D.3. of this notice.
c. Residue Chemistry Studies. Guidelines 171-4, 153-3, and 153-4 are extremely
broad in scope; studies addressing residue chemistry requirements must thus be defined at a
level below that of the Guideline code. The general principle, however, of limiting a study to
the report of a single investigation still applies fully. Data should be treated as a single study
and bound separately for each analytical method, each report of the nature of the residue in a
single crop or animal species, and for each report of the magnitude of residues resulting from
treatment of a single crop or from processing a single crop. When more than one commodity
is derived from a single crop (such as beet tops and beet roots) residue data on all such
commodities should be reported as a single study. When multiple field trials are associated
with a single crop, all such trials should be reported as a single study.
D. Organization of Each Study Volume
Each complete study must include all applicable elements in the list below, in the order
indicated. (Also see Page 17.) Several of these elements are further explained in the following
paragraphs. Entries in the column headed "example" cite the page number of this notice
where the element is illustrated.
Element
Study Title Page
Statement of Data
Confidentiality
Claims
Certification of Good
Laboratory Practice
Flagging statements
Body of Study
Study Appendices
Cover Sheet to Confi-
dential Attachment
CBI Attachment
Supplemental Statement
of Data Confidentiality
Claims
When Required
Always
One of the two alternative
forms of this statement
is always required
If study reports laboratory
work subject to GLP require-
ments
For certain toxicology studies (When
flagging requirements are finalized.)
Always - with an English language
translation if required.
At submitter's option
If CBI is claimed under FIFRA
§10(d)(l)(A), (B), or (C)
If CBI is claimed under FIFRA
§10(d)(l)(A), (B),or(C)
Only if confidentiality is
claimed on a basis other than
FIFRA §10(d)(l)(A), (B), or (C)
Example
Page 12
Page 13
Page 16
Page 15
Page 14
141
-------
D.I. Title Page
A title page is always required for each submitted study, published or unpublished.
The title page must always be freely releasable to requestors; DO NOT INCLUDE CBI ON
THE TITLE PAGE. An example of an acceptable title page is on page 12 of this notice.
The following information must appear on the title page:
a. Study title. The study title should be as descriptive as possible It must clearly identify
the substance(s) tested and correspond to the name of the data requirement as it appears in the
Guidelines.
b. Data requirement addressed. Include on the title page the Guideline number(s) of the
specific requirement(s) addressed by the study.
c. Author(s). Cite only individuals with primary intellectual responsibility for the content
of the study. Identify them plainly as authors, to distinguish them from the performing
laboratory, study sponsor, or other names that may also appear on the title page.
d. Study Date. The title page must include a single date for the study. If parts of the
study were performed at different times, use only the date of the latest element in the study.
e. Performing Laboratory Identification. If the study reports work done by one or more
laboratories, include on the title page the name and address of the performing laboratory or
laboratories, and the laboratory's internal project number(s) for the work. Clearly distinguish
the laboratory's project identifier from any other reference numbers provided by the study
sponsor or submitter.
f. Supplemental Submissions. If the study is a commentary on or supplement to another
previously submitted study, or it it responds to EPA questions raised with respect to an earlier
study, include on the title page elements a. through d. for the previously submitted study,
along with the EPA Master Record Identifier (MRID) or Accession number of the earlier
study if you know these numbers. (Supplements submitted in the same submittal package as
the primary study should be appended to and bound with the primary study. Do not include
supplements to more than one study under a single title page).
g. Facts of Publication. If the study is a reprint of a published document, identity on the
title page all relevant tacts of publication, such as the journal title, volume, issue, inclusive
page numbers, and publication date.
D.2. Statements of Data Confidentiality Claims Under FIFRA §10(d)(l).
Each submitted study must be accompanied by one of the two alternative forms of the
statement of Data Confidentiality Claims specified in the proposed regulation in §158.33 (b)
and (c) (See Attachment 3). These statements apply only to claims of data confidentiality
based on FIFRA §10(d)(l)(A), (B), or (C). Use the appropriate alternative form of the
statement either to assert a claim of §10(d)(l) data confidentiality (§158.33(b)) or to waive
such a claim (§158.33(c)). In either case, the statement must be signed and dated, and must
include the typed name and title of the official who signs it. Do not make CBI claims with
respect to analytical methods associated with pet-itions for tolerances or emergency
exemptions (see NOTE Pg 13).
142
-------
D. 3. Confidential Attachment
If the claim is made that a study includes confidential business information as defined
by the criteria of FIFRA §10(D)(1)(A), (B), or (C) (as described in D.2. above) all such
information must be excised from the body of the study and confined to a separate
study-specific Confidential Attachment. Each passage of CBI so isolated must be identified by
a reference number cited within the body of the study at the point from which the passage was
excised (See Attachment 5).
The Confidential Attachment to a study must be identified by a cover sheet fully
identifying the parent study, and must be clearly marked "Confidential Attachment." An
appropriately annotated photocopy of the parent study title page may be used as this cover
sheet. Paginate the Confidential Attachment separately from the body of the study, beginning
with page 1 of X on the title page. Each passage confined to the Confidential Attachment
must qe associated with a specific cross reference to the page(s) in the main body of the study
on which it is cited, and with a reference to the applicable passage(s) of FIFRA §10(d)(l) on
which the confidentiality claim is based.
D.4. Supplemental Statement of Data Confidentiality Claims (See
Attachment 4)
If you wish to make a claim of confidentiality for any portion of a submitted study
other than described by FIFRA §10(d) (1)(A), (B), or (C), the following provisions apply:
- The specific information to which the claim applies must be clearly marked in the
body of the study as subject to a claim of confidentiality.
- A Supplemental Statement of Data Confidentiality Claims must be submitted,
identifying eachpassage claimed confidential and describing in detail the basis for the
claim. A list of the points to address in such a statement is included in Attachment 4
on Pg 14.
- The Supplemental Statement of Data Confidentiality'Claims must be signed and dated
and must include the typed name and title of the official who signed it.
D.5. Good Laboratory Practice Compliance Statement
This statement is reauired if the study contains laboratory work subject to GLP
requirements specified in 40 CFR 160. Samples of these statements are shown in Attachment
6.
E. Reference to Previously Submitted Data
DO NOT RESUBMIT A STUDY THAT HAS PREVIOUSLY BEEN SUBMITTED
FOR ANOTHER PURPOSE unless EPA specifically requests it. A copy of the title page
plus the MRID number (if known) is sufficient to allow us to retrieve the study immediately
for review. This prevents duplicate entries in the Agency files, and saves you
the cost of sending more copies of the study. References to previously submitted studies
should not be included in the transmittal document, but should be incorporated into the
statement of the method of support for the application.
F. Physical Format Requirements
All elements in the data submittal package must be on uniform 8 1/2 by 11 inch white
paper, printed on one side only in black ink, with high contrast and good resolution. Bindings
for individual studies must be secure, but easily removable to permit disassembly for
143
-------
microfilming. Check with EPA for special instructions before submitting data in any medium
other than paper, such as film or magnetic media.
Please be particularly attentive to the following points:
• Do not include frayed or torn pages.
• Do not include carbon copies, or copies in other than black ink.
• Make sure that photocopies are clear, complete, and fully readable.
• Do not include oversize computer printouts or fold-out pages.
• Do not bind any documents with glue or binding tapes.
• Make sure that all pages of each study, including any attachments or
appendices, are present and in correct sequence.
Number of Copies Required - All submittal packages except those associated with a
Registration Standard or Special Review (See Part G below) must be provided In three
complete, identical copies. (The proposed regulations specified two copies; three are now
being required to expedite and reduce the cost of processing data into the OPP Pesticide
Document Management System and getting it into review.)
G. Special Requirements for Submitting Data to the Docket
Data submittal packages associated with a Registration Standard or Special Review
must be provided in four copies, from one of which all material claimed as CBI has been
excised This fourtlfcopy will become part of the public docket for the RS or SR case. If no
claims of confidentiality are made for the study, the fourth copy should be identical to the
other three. When portions of a study submitted in support of an RS or SR are claimed as
CBI the first three copies will include the CBI material as provided in section D ot this
notice. The following special preparation is required for the fourth copy.
• Remove the "Supplemental Statement of Data Confidentiality Claims".
• Remove the "Confidential Attachment".
• Excise from the body of the study any information you claim as confidential,
even if it does not fall within the scope of FIFRA §10(d)(l)(A), (B), or (C).
Do not close up or paraphrase text remaining after this excision.
• Mark the fourth copy plainly on both its cover and its title page with the phrase
"Public Docket Material - contains no information claimed as confidential".
144
-------
V. For Further Information
For further information contact John Carley, Chief, Information Services Branch,
Program Management and Support Division, (703) 305-5240.
/S/
James W. Akerman
Acting Director,
Registration Division
Attachment 1. Sample Transmittal Document
Attachment 2. Sample Title Page for a Newly Submitted Study
Attachment 3. Statements of Data Confidentiality Claims
Attachment 4. Supplemental Statement of Data Confidentiality Claims
Attachment 5. Samples of Confidential Attachments
Attachment 6. Sample Good Laboratory Practice Statements
Attachment 7. Format Diagrams for Submittal Packages and Studies
145
-------
ATTACHMENT 1
ELEMENTS TO BE INCLUDED IN THE TRANSMIT!AL DOCUMENT*
1. Name and address of submitter (or all joint submitters**)
+Smith Chemical Corporation Jones Chemical Company
1234 West Smith Street -and- 5678 Wilson Blvd
Cincinnati, OH 98765 Covington, KY 56789
+Smith Chemical Corp will act as sole agent for all submitters.
2. Regulatory action in support of which this package is submitted
Use the EPA identification number (e.g. 359-EUP-67) if you know it. Otherwise describe the
type of request (e.g. experimental use permit, data call-in - of xx-xx-xx date).
3. Transmittal date
4. List of submitted studies
Vol 1. Administrative materials - forms, previous corres-pondence with Project
Managers, and so forth.
Vol 2. Title of first study in the submittal (Guideline No.)
Vol n Title of nth study in the submittal (Guideline
No.)
* Applicants commonly provide this information in a tran-smittal letter. This
remains an acceptable practice so long as all four elements are included.
* Indicate which of the joint submitters is empowered to act on behalf of all joint
submitters in any matter concerning data compensation or subsequent use or
release of the data.
Company Official:
Signature Name
Company Name
Company Contact:
Name Phone
146
-------
ATTACHMENT 2
SAMPLE STUDY TITLE PAGE FOR A NEWLY SUBMITTED STUDY
Study Title
(Chemical name) - Magnitude of Residue on Corn
Data Requirement
Guideline 171-4
Author
John C. Davis
Study Completed On
January 5, 1979
Performing Laboratory
ABC Agricultural Laboratories
940 West Bay Drive
Wilmington, CA 39897
Laboratory Project ID
ABC 47-79
147
-------
Pagel ofX
(X is the total number of pages in the study)
148
-------
ATTACHMENT 3
STATEMENTS OF DATA CONFIDENTIALITY CLAIMS
1. No claim of confidentiality under FIFRA §10(d)(l)(A),(B), or (Q.
STATEMENT OF NO DATA CONFIDENTIALITY CLAIMS
No claim of confidentiality is made for any information contained in this
study on the basis of its falling within the scope of FIFRA
6§10(d)(1)(A), (B), or (C).
Company
Company Agent: Typed Name Date:.
Title Signature
2. Claim of confidentiality under FIFRA §10(d)(l)(A), (B), or (Q.
Information claimed confidential on the basis of its falling within the
scope of FIFRA §10(d)(1)(A), (B), or (C) has been removed to a
confidential appendix, and is cited by cross-reference number in the body
of the study.
Company:
Company Agent: Typed Name Date:.
Title Signature
STATEMENT OF DATA CONFIDENTIALITY CLAIMS
NOTE: Applicants for permanent or temporary tolerances should note that it is OPP policy
that no permanent tolerance, temporary tolerance, or request for an emergency exemption
incorporating an analytical method, can be approved unless the applicant waives all claims of
confidentiality for the analytical method. These analytical methods are published in the FDA
Pesticide Analytical Methods Manual, and therefore cannot be claimed as confidential. OPP
implements this policy by returning submitted analytical methods, for which confidentiality
claims have been made, to the submitter, to obtain the confidentiality waiver before they can
be processed.
149
-------
ATTACHMENT 4
SUPPLEMENTAL STATEMENT OF DATA CONFIDENTIALITY CLAIMS
For any portion of a submitted study that is not described by FIFRA §10(d)(l)(A), (B),
or (C), but for which you claim confidential treatment on another basis, the following
information must be included within a Supplemental Statement of Data Confidentiality Claims:
• Identify specifically by page and line number(s) each portion of the study for
which you claim confidentiality.
• Cite the reasons why the cited passage qualifies for confidential treatment.
• Indicate the length of time-until a specific date or event, or permanently--for
which the information should be treated as confidential.
• Identify the measures taken to guard against undesired disclosure of this
information.
• Describe the extent to which the information has been disclosed, and what
precautions have been taken in connection with those disclosures.
• Enclose copies of any pertinent determinations of confidentiality made by EPA,
other Federal agencies, of courts concerning this information.
• If you assert that disclosure of this information would be likely to result in
substantial harmful effects to you, describe those harmful effects and explain
why they should be viewed as substantial.
• If you assert that the information in voluntarily submitted, indicate whether you
believe disclosure of this information might tend to lessen the availability to
EPA of similar information in the future, and if so, how.
150
-------
ATTACHMENT 5
EXAMPLES OF SEVERAL CONFIDENTIAL ATTACHMENTS
Example 1. (Confidential word or phrase that has been deleted from the study)
CROSS REFERENCE NUMBER 1 This cross reference number is used in the study in place of the
following paragraph(s) at the indicated volume and page
references.
DELETED WORDS OR PHRASE: Ethylene Glycol
PAGE LINES REASON FOR THE DELETION FIFRA
REFERENCE "
6 14 Identity of Inert Ingredient S10(d)(C)
28 25 " „
100 19
Example 2. (Confidential paragraph(s) that have been deleted from the study)
CROSS REFERENCE NUMBER 5 This cross reference number is used in the study in place of the
following paragraph(s) at the indicated volume and page
references.
DELETED PARAGRAPH(S):
< )
( Reproduce the deleted paragraph(s) here \
< )
PAGE LINES REASON FOR THE DELETION FIFRA REFERENCE
20• 2-17 Description of the quality control process §10(d)(l)(C)
Example 3. (Confidential pages that have been deleted from the study)
CROSS REFERENCE NUMBER 7 This cross reference number is used in the study in place of the
following paragraph(s) at the indicated volume and page
references.
DELETED PAGES(S): are attached immediately behind this page
PAGES REASON FOR THE DELETION FIFRA REFERENCE
35-41. Description of product manufacturing process § 10(d)( 1 )(A)
151
-------
ATTACHMENT 6.
SAMPLE GOOD LABORATORY PRACTICE STATEMENTS
Example 1.
This study meets the requirements for 40 CFR Part 160
Submitter
Sponsor —.—
Example 2.
This study does not meet the requirements of 40 CFR Part 160, and
differs in the following ways:
1..
2..
3.
Submitter.
Sponsor
Study Director.
Example 3.
The submitter of this study was neither the sponsor of this study nor
conducted it, and does not know whether it has been conducted in
accordance with 40 CFR Part 160.
Submitter
152
-------
ATTACHMENT 7.
FORMAT OF THE SUBMITTAL PACKAGE
Transmfttal Document
Related Administrative Materials
(e.g. Method of Support Statement, etc.)
Other materials about the submittal
(e.g., summaries of groups of studies
to aid in their review).
Studies submitted as unique
to the format below.
FORMAT OF SUBMITTED STUDIES
Study title page.
Statement of Confidentiality Claims.
GLP and flagging* statements - as appropriate.
Body of the study, with English
language translation if required.
. Appendices to the study.
Title Page of the Confidential
:— Attachment.
— Confidential Attachment.
. Supplemental Statement
of Confidentiality Claims
: " * When flagging requirements
are finalised.
Documents which must be submitted as
appropriate to meet established requirements.
Documents submitted at submitter's option.
LEGEND
153
-------
-------
PR Notice 97-2
155
-------
-------
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY
WASHINGTON, D.C. 20460
OFFICE OF
PREVENTION. PESTICIDES
AND TOXIC SUBSTANCES
PR NOTICE 91-2
NOTICE TO MANUFACTURERS, PRODUCERS, FORMULATORS,
AND REGISTRANTS OF PESTICIDES
ATTENTION: Persons Responsible for Federal Registration of Pesticide Products.
SUBJECT: Accuracy of Stated Percentages for Ingredients
Statement
I. PURPOSE:
The purpose of this notice is to clarify the Office of Pesticide Program's policy with
respect to the statement of percentages in a pesticide's label's ingredient statement.
Specifically, the amount (percent by weight) of ingredient(s) specified in the ingredient
statement on the label must be stated as the nominal concentration of such ingredient(s) as that
term is defined in 40 CFR 158.153(i). Accordingly, the Agency has established the nominal
concentration as the only acceptable label claim for the amount of active ingredient in the
product.
H. BACKGROUND
For some time the Agency has accepted two different methods of identifying on the
label what percentage is claimed for the ingredient(s) contained in a pesticide. Some applicants
claimed a percentage which represented a level between the upper and the lower certified
limits. This was referred to as the n9minal concentration. Other applicants claimed the lower
limit as the percentage of the ingredient(s) that would be expected! to be present in their
product at the end of the product's shelf-life. Unfortunately, this led to a great deal of
confusion among the regulated industry, the regulators, and the consumers as to exactly how
much of a given ingredient was in a given product. The Agency has established the nominal
concentration as the only acceptable label claim for the amount of active ingredient in the
product.
Current regulations require that the percentage listed in the active ingredient statement
be as precise as possible reflecting good manufacturing practices 40 CFR 156.10(g)(5). The
certified limits required for each active ingredient are intended to encompass any such "good
manufacturing practice" variations 40 CFR 158.175(c)(3).
The upper and lower certified limits, which must be proposed in connection with a
Product's registration, represent the amounts of an ingredient that may legally be present 40
CFR 158.175. The lower certified limit is used as the enforceable lower limit for the product
composition according to FIFRA section 12(a)(l)(C), while the nominal concentration
appearing on the label would be the routinely achieved concentration used for calculation of
dosages and dilutions.
The nominal concentration would in fact state the greatest degree of accuracy that is
warranted with respect to actual product composition because the nominal concentration would
be the amount of active ingredient typically found in the product.
It is important for registrants 19 note that certified limits for active ingredients are not
considered to be trade secret information under FIFRA section 10(b). In this respect the
157
-------
certified limits will be routinely provided by EPA to States for enforcement purposes, since
the nominal concentration appearing on the label may not represent the enforceable
composition for purposes or section 12(a)(l)(C).
IE. REQUIREMENTS
As described below under Unit V. " COMPLIANCE SCHEDULE," all currently
registered products as well as all applications for new registration must comply with this
Notice by specifying the nominal concentration expressed as a percentage by weight as the
label claim in the ingredient(s) statement and equivalence statements if applicable (e.g.,
elemental arsenic, metallic zinc, salt of an acid). In addition, the requirement for performing
sample analyses of five or more representative samples must be fulfilled. Copies of the raw
analytical data must be submitted with the nominal ingredient label claim. Further information
about the analysis requirement may be found in the 40 CFR 158.170. All products are
required to provide certified limits for each active, inert ingredient, impurities of toxicological
significance(i.e., upper limit(s) only) and on a case by case basis as specified by EPA. These
limits are to be set based on representative sampling and chemical analysis(i.e., quality
control) of the product.
The format of the ingredient statement must conform to 40 CFR 156-Labeling
Requirements For Pesticides and Devices.
After July 1, 1997, all pesticide ingredient Statements must be changed to
nominal concentration.
IV. PRODUCTS THAT REQUIRE EFFICACY DATA
All pesticides are required to be efficacious. Therefore, the certified lower limits may
not be lower then the minimum level to achieve efficacy. This is extremely important for
products which are intended to control pests which threaten the public health, e.g., certain
antimicrobial and rodenticide products. Refer to 40 CFR 153.640.
In those cases where efficacy limits have been established, the Agency will not accept
certified lower limits which are below that level for the shelf life of the product.
V. COMPLIANCE SCHEDULE
As described earlier, the purpose of this Notice is to make the registration process
more uniform and more manageable for both the agency and the regulated community. It is
the Agency's intention to implement the requirements of this notice as smoothly as possible so
as not to disrupt or delay the Agency's high priority programs, i.e., reregistration, new
chemical, or fast track (FIFRA section 3(c)(3)(B). Therefore, applicants/registrants are
expected to comply with the requirements of this Notice as follows:
(1) Beginning July 1, 1991, all new product registrations submitted to the Agency
are to comply with the requirements of this Notice.
(2) Registrants having products subject to reregistration under FIFRA section 4(a)
are to comply with the requirements of this Notice when specific products are
called in by the Agency under Phase V of the Reregistration Program.
158
-------
(3) All other products/applications that are not subject to (1) and (2) above will
have until July 1, 1997, to comply with this Notice. Such applications should
note Conversion to Nominal Concentrations on the application form. These
types Or amendments will not be handled as "Fast Track" applications but will
be handled as routine requests.
VI. FOR FURTHER INFORMATION
Contact Tyrone Aiken for information or questions concerning
this notice on (703) 308-7031.
/s/
Anne E. Lindsay, Director
Registration Division (H-7505C)
159
-------
-------
APPENDIX F. Combined Generic and Product Specific
Data Call-In
161
-------
-------
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY
WASHINGTON, D.C. 20460
GENERIC AND PRODUCT SPECIFIC
DATA CALL-IN NOTICE 28 A''R J°95
CERTIFIED MAIL
Dear Sir or Madam:
This Notice requires you and other registrants of pesticide products containing the
active ingredient identified in Attachment A of this Notice, the Data Call-In Chemical Status
jffg**' to submit certam data as noted herein to the U.S. Environmental Protection Agency
(UFA, the Agency). These data are necessary to maintain the continued registration of your
product(s) containing this active ingredient. Within 90 days after you receive this Notice you
must respond as set forth in Section III below. Your response must state:
1. How you will comply with the requirements set forth in this Notice and its
Attachments 1 through 7; or
2. Why you believe you are exempt from the requirements listed in this Notice and
in Attachment 3 (for both generic and product specific data), the Requirements
Status and Registrant's Response Form, (see section ffl-B); or —
3. Why you believe EPA should not require your submission of data in the manner
specified by this Notice (see section ffl-D).
If you do not respond to this Notice, or if you do not satisfy EPA that you will comply
with its requirements or should be exempt or excused from doing so, then the registration of
your product(s) subject to this Notice will be subject to suspension. We have provided a list of
all of your products subject to this Notice in Attachment 2. All products are listed on both the
generic and product specific Data Call-in Response Forms. Also included is a list of all
registrants who were sent this Notice (Attachment 6)
A D Jhta^tholity for this ?yice is section 3(C)(2>(B) of the Federal Insecticide, Fungicide
and Rodenticide Act as amended (FIFRA), 7 U.S.C. section 136a(c)(2)(B). Collection of this
fmn^^^m0^-^^^ Paperwork Reduction Act by OMB Approval No.
2070-0107 and 2070-0057 (expiration date 3-31-96).
This Notice is divided into six sections and seven Attachments. The Notice itself
contains information and instructions applicable to all Data Call-In Notices. The Attachments
contain specific chemical information and instructions. The six sections of the Notice are-
163
-------
Section I - Why You are Receiving this Notice
Section n - Data Required by this Notice
Section HI - Compliance with Requirements of this Notice
Section IV - Consequences of Failure to Comply with this Notice
Section V - Registrants' Obligation to Report Possible Unreasonable Adverse Effects
Section VI - Inquiries and Responses to this Notice
The Attachments to this Notice are:
1 - Data Call-In Chemical Status Sheet
2 - Generic Data (Jall-ln and Product Specific Data Call-In Response Forms with
Instructions
3 - Generic Data Call-In and Product Specific Data Call-In Requirements Status
and Registrant s Response Forms with Instructions
4- bFA (Jroupmg ot End-Use Products for Meeting Acute Toxicology Data
Kequirements tor Keregistration
5 - fcFA Acceptance Criteria
6 - List ol Registrants Receiving This Notice
7 - Cost Share and Data Compensation horrris
SECTION I. WHY YOU ARE RECEIVING THIS NOTICE
The Agency has reviewed existing data for this active ingredient(s) and reevaluated the
data needed to support continued registration of the subject active ingredient(s). This
reevaluation identified additional data necessary to assess the health and safety of the continued
use of products containing this active ingredient(s). You have been sent this Notice because
you have product(s) containing the subject active ingredients.
SECTION II. DATA REQUIRED BY THIS NOTICE
II-A. DATA REQUIRED
The data required by this Notice are specified in the Requirements Status and
Registrant's Response Forms: Attachment 3 (for both generic and product specific data
requirements). Depending on the results of the studies required in this Notice, additional
studies/testing may be required.
II-B. SCHEDULE FOR SUBMISSION OF DATA
You are required to submit the data or otherwise satisfy the data requirements specified
in the Requirements Status and Registrant's Response Forms (Attachment 3) within the
timeframes provided.
II-C. TESTING PROTOCOL
All studies required under this Notice must be conducted in accordance with test
standards outlined in the Pesticide Assessment Guidelines for those studies for which
guidelines have been established.
These EPA Guidelines are available from the National Technical Information Service
(NTIS), Attn: Order Desk, 5285 Port Royal Road, Springfield, Va 22161 (Telephone number:
703-487-4650).
164
-------
,^T^T aPProved by the Organization for Economic Cooperation and Development
(OECD) are also acceptable if the OECD recommended test standards conform to those
specified in the Pesticide Data Requirements regulation (40 CFR § 158.70). When using the
OECD protocols, they should be modified as appropriate so that the data generated by the
study will satisfy the requirements of 40 CFR § 158. Normally, the Agency will not extend
deadlines for complying with data requirements when the studies were not conducted in
accordance with acceptable standards. The OECD protocols are available from OECD 2001 L
Streut' ^vSf'AoYSSKSS1011' D'C 20036 (TelePh<>ne number 202-785-6323; Fax telephone
number 202-785-0350).
All new studies and proposed protocols submitted in response to this Data Call-In
Notice must be in accordance with Good Laboratory Practices [40 CFR Part 160].
n-D. REGISTRANTS RECEIVING PREVIOUS SECTION 3(c)(2)(B) NOTICES ISSUED
UY Itib AUhJNCJY ~
Unless otherwise noted herein, this Data Call-in does not in any way supersede or
change the requirements of any previous yata uaiMn(s). or any other agreements entered into
with tne Agency pertaining to such prior Notice. Registrants must comply with the
requirements of all Notices to avoid issuance of a Notice of Intent to Suspend their affected
products.
SECTION III. COMPLIANCE WITH REQUIREMENTS OF THIS NOTICE
• SH must use the correct forms and instructions when completing your response to this
Notice. The type of Data Call-In you must comply with (Generic or Product Specific) is
specified in item number 3 on the four Data Call-in forms (Attachments 2 and 3).
III-A. SCHEDULE FOR RESPONDING TO THE AGENCY
The appropriate responses initially required by this Notice for generic and product
specific data must be submitted to the Agency within 90 days after your receipt of this Notice
Failure to adequately respond to this Notice within 90 days of your receipt will be a basis for
issuing a Notice of Intent to Suspend (NOIS) affecting your products. This and other bases for
issuance of NOIS due to failure to comply with this Notice are presented in Section IV-A and
1V-B.
ni-B. OPTIONS FOR RESPONDING TO THE AGENCY
1. Generic Data Requirements
The options for responding to this Notice for generic data requirements are- (a)
voluntary cancellation, (b) delete use(s), (c) claim generic data exemption, (d) agree to satisfy
the generic data requirements imposed by this Notice or (e) request a data waiver(s).
A discussion of how to respond if you choose the Voluntary Cancellation option, the
Delete Use(s) option or the Generic Data Exemption option is presented below. A discussion
ot the various options available for satisfying the generic data requirements of this Notice is
contained in Section ffl-C. A discussion of options relating to requests for data waivers is
contained in Section ffl-D.
Two forms apply to generic data requirements, one or both of which must be used in
responding to the Agency, depending upon your response. These two forms are the
Data-Call-in Response Form, and the Requirements Status and Registrant's Response Form
(contained in Attachments 2 and 3, respectively). ^ '
165
-------
The Data Call-In Response Forms must be submitted as part of every response to this
Notice. The Requirements Status and Registrant's Response Forms also must be submitted if
you do not quality tor a Uenenc Data Exemption or are not requesting voluntary cancellation
of your registration(s). Please note that the company's authorized representative is required to
sign the first page of both Data Call-in Response Forms and the Requirements Status and
Registrant's Response Forms (it this torm is required) and initial any subsequent pages. The
forms contain separate detailed instructions on the response options. Do not alter the printed
material. If you have questions or need assistance in preparing your response, call or write the
contact person(s) identified in Attachment 1.
a. Voluntary Cancellation -
You may avoid the requirements of this Notice by requesting voluntary cancellation of
your product(s) containing the active ingredient that is the subject of this Notice. If you wish
to voluntarily cancel your product, you must submit completed Generic and Product Specific
Data Call-In Response Forms (Attachment 2), indicating your election of this option.
Voluntary cancellation is item number 5 on both Data Call-in Response Fprm(s). If you
choose this option, these are the only forms that you are required to complete.
If you chose to voluntarily cancel your product, further sale and distribution of your
product after the effective date of cancellation must be in accordance with the Existing Stocks
provisions of this Notice, which are contained in Section IV-C.
b. Use Deletion -
You may avoid the requirements of this Notice by eliminating the uses of your product
to which the requirements apply. If you wish to amend your registration to delete uses, you
must submit the Requirements Status and Registrant's Response Form (Attachment 3), a
completed application tor amendment, a copy of your proposed amended labeling, and all
other information required for processing the application. Use deletion is option number 7
under item 9 in the instructions for the Requirements Status and Registrant's Response Forms.
You must also complete a Data Call-In Response horm by signing the certification, item
number 8. Application forms tor amending^ registrations may be obtained from the
Registration Support Branch, Registration Division, Office of Pesticide Programs, EPA, by
calling (703) 308-8358.
If you choose to delete the use(s) subject to this Notice or uses subject to specific data
requirements, further sale, distribution, or use of your product after one year from the due
date of your 90 day response, is allowed only if the product bears an amended label.
c. Generic Data Exemption -
Under section 3(c)(2)(D) of FIFRA, an applicant for registration of a product is
exempt from the requirement to submit or cite generic data concerning an active ingredient if
the active ingredient in the product is derived exclusively from purchased, registered pesticide
products containing the active ingredient. EPA has concluded, as an exercise of its discretion,
that it normally will not suspend the registration of a product which would qualify and
continue to qualify for the generic data exemption in section 3(c)(2)(D) of FIFRA. To qualify,
all of the following requirements must be met:
(i). The active ingredient in your registered product must be present solely because of
incorporation of another registered product which contains the subject active ingredient
and is purchased from a source not connected with you;
166
-------
(ii). Every registrant who is the ultimate source of the active ingredient in your
product subject to this DCI must be in compliance with the requirements of this Notice
and must remain in compliance; and
(iii). You must have provided to EPA an accurate and current "Confidential Statement
or formula tor each of your products to which this Notice applies.
To apply for the Generic Data Exemption you must submit a completed Data Call-In
Response Form Attachment 2 and all supporting documentation. The Generic Data Exemption
is item number 6a on the Data Call-in Response Form. If you claim a generic dato
ou are not re '
.
you are not required to complete the Requirements Status and Registrant's Response Forn
(jenenc Data Exemption cannot be selected as an option tor responding to product specific
?! y?uu a[e 8rante(! a Generic Data Exemption, you rely on the efforts of other persons
to provide the Agency with the required data. If the registrant(s) who have committed to
generate and submit the required data fail to take appropriate steps to meet requirements or are
no longer in compliance with this Data Call-in Notice, the Agency will consider that both thev
and you are not compliance and will normally initiate proceedings to suspend the registrations
of both your and their product(s), unless you commit to submit and do submit the required
data within the specified time. In such cases the Agency generally will not grant a time
extension for submitting the data. 6
d- Satisfying the Generic Data Requirements of this Notice
XT *• TJlere are Yarious options available to satisfy the generic data requirements of this
Notice These options are discussed in Section m-C.l. of this Notice and comprise options 1
forough 6 of item 9 in the instructions for the Requirements Status and Registrant's Response
Form and item 6b on the Data Call-in Response form. It you choose .te^ frh ^r.*fn™"?c%
tfie-generic data requirements), you must submit the Data Call-in Response Form and the
Requirements Status and Registrant's Response Form as well as any other information/data
be on the
Request for Generic Data Waivers.
Waivers for generic data are discussed in Section IH-D.l. of this Notice and are
fra«7o°£!!0nS r 9 °fTitem 9 JP ** instructions for the Requirements Status and
rants Response Form. If you choose one of these options, you must submit both forms
as wen as any other information/data pertaining to the option chosen to address the data
requirement.
2. Product Specific Data Requirements
T-he °ftl°ns for/esP9nding to this Notice for product specific data are: (a) voluntary
re^rements imP°sed by this NoTice
A discussion of how to respond if you choose the Voluntary Cancellation option is
presented below. A discussion of the various options available for satisfying the product
specific data requirements of this Notice is contained in Section IH-C.2. A discussion of
options relating to requests for data waivers is contained in Section IH-D 2
167
-------
Two forms apply to the product specific data requirements one or both of which must
be used in responding to the Agency, depending upon your response. These forms are the
Data-Call-in Response Form, and the Requirements Status and Registrant's Response Form,
tor product specinc data (contained in Attachments 2 and 3, respectively). The Date (Jall-Tn
Response Form must be submitted as part of every response to this Notice. In addition, one
copy ot the Requirements Status and Registrant's Response Form also must be submitted for
each product listed on the Data Uall-ln Response Form unless the voluntary cancellation option
is selected. Please note that the company's authorized representative is required to sign the
first page of the Data Call-in Response Form and Requirements Status and Registrant s
Response Form (it this torm is required) ana initial any subsequent pages. The forms contain
separate detailed instructions on the response options. Do not alter the printed material. If you
have questions or need assistance in preparing your response, call or write the contact
person(s) identified in Attachment 1.
a. Voluntary Cancellation
You may avoid the requirements of this Notice by requesting voluntary cancellation of
your product(s) containing the active ingredient that is the subject of this Notice. If you wish
to voluntarily cancel your product, you must submit a completed Data Call-In Response Form,
indicating your election of this option. Voluntary cancellation is item number S on both the
Generic and Product Specific Data Call-In Response Forms. If you choose this
option, you must complete both Data Call-In response torms. These are the only forms that
you are required to complete.
If you choose to voluntarily cancel your product, further sale and distribution of your
product after the effective date of cancellation must be in accordance with the Existing Stocks
provisions of this Notice which are contained in Section IV-C.
b. Satisfying the Product Specific Data Requirements of this Notice.
There are various options available to satisfy the product specific data requirements of
this Notice. These options are discussed in Section ffl-C.2. of this Notice and comprise
options 1 through 6 of item 9 in the instructions for the product specific Requirements Status
and Registrant's Response Form and item numbers 7a and 7b (agree to satisfy the product
specific data requirements tor an MUP or EUP as applicable) on the product specinc Data
Call-in Response Form. Note that the options available for addressing product specific data
requirements ditter slightly from those options for fulfilling generic data requirements.
Deletion of a use(s) and the low volume/minor use option are not valid options for fulfilling
product specific data requirements. It is important to ensure that you are using the correct
forms and instructions when completing your response to the Reregistration Eligibility
Decision document.
c. Request for Product Specific Data Waivers.
Waivers for product specific data are discussed in Section ffl-D.2. of this Notice and
are covered by option 7 of item 9 in the instructions for the Requirements Status and
Registrant's Response Form. If you choose this option, you must submit the Data (Jail-In
Response Form and the Requirements Status and Registrant's Response Form as well as any
other mtormation/data pertaining to the option chosen to address the data requirement. Your
response must be on the forms marked "PRODUCT SPECIFIC" in item number 3.
168
-------
m-C SATISFYING THE DATA REQUIREMENTS OF THIS NOTICE
1. Generic Data
If you acknowledge on the Generic Data Call-In Response Form that you agree to
satisfy the generic data requirements (i.e. you select item number 6b), then you must select
one of the six options on the Generic Requirements Status and Registrant's Response Form
related to data production for each daia requirement. Vour option selection should be entered
under item number 9, Registrant Response." The six options related to data production are
the first six options discussed under item 9 in the instructions for completing the Requirements
Status and Registrant's Response Form. These six options are listed 6 M
immediately below with information in parentheses to guide you to additional instructions
provided in this Section. The options are:
0) J. will generate and submit data within the specified timeframe (Developing
(2) I have entered into an agreement with one or more registrants to develop data
jointly (Cost Sharing) ^
(3) I have made offers to cost-share (Offers to Cost Share)
(4) I am submitting an existing study that has not been submitted previously to the
Agency by anyone (Submitting an Existing Study)
(5) I am submitting or citing data to upgrade a study classified by EPA as partially
acceptable and upgradeable (Upgrading a Study)
(6) I am citing an existing study that EPA has classified as acceptable or an existing
study that has been submitted but not reviewed by the Agency (Citing an
Existing Study) 6
Option 1 . Developing Data
A Ar If you, drop86*0 develop the required data it must be in conformance with Agency
deadlines and with other Agency requirements as referenced herein and in the attachments All
?^D^n5?^aud s^™^ must comply with the Good Laboratory Practice (GLP) rule (40
C^K Fart 160), be conducted according to the Pesticide Assessment Guidelines (PAG) and be
in conformance with the requirements of PR Notice 86-5. In addition, certain studies require
Agency approval of test protocols in advance of study initiation. Those studies for which a
grotocol must be submitted have been identified in the Requirements Status and Registrant's
Response Form and/or footnotes to the form. If you wish to use a protocol which differs trom
me options discussed in Section E-C of this Notice, you must submit a detailed description of
the proposed protocol and your reason for wishing to use it. The Agency may choose to reject
a protocol not specified in Section H-C. If the Agency rejects your protocol you will be J
notified in writing, however you should be aware that rejection of a proposed protocol will
not be a basis for extending the deadline for submission of data.
A progress report must be submitted for each study within 90 days from the date vou
are required to commit to generate or undertake some other means to address that studv
requirement such as making an offer to cost share or agreeing to share in the cost of
developing that study. This 90-day progress report must include the date the study was or will
be initiated and for studies to be started within 12 months of commitment, the name and
address of the laboratory(ies) or individuals who are or will be conducting the study
169
-------
In addition, if the time frame for submission of a final report is more than 1 year,
interim reports must be submitted at 12 month intervals from the date you are required to
commit to generate or otherwise address the requirement for the study. In addition to the other
information specified in the preceding paragraph, at a minimum, a brief description of current
activity on and the status of the study must be included as well as a full
description of any problems encountered since the last progress report.
The time frames in the Requirements Status and Registrant's Response Form are the
time frames that the Agency is allowing lor me submission oi completed study reports or
protocols. The noted deadlines run from the date of the receipt of this Notice by the registrant.
If the data are not submitted by the deadline, each registrant is subject to receipt of a Notice of
Intent to Suspend the affected registration(s).
If you cannot submit the data/reports to the Agency in the time required by this Notice
and intend to seek additional time to meet the requirements(s), you must submit a reauest to
the Agency which includes: (1) a detailed description of the expected difficulty and (2) a
proposed schedule including alternative dates for meeting such requirements on a step-by-step
oasis. You must explain any technical or laboratory difficulties and provide documentation
from the laboratory performing the testing. While EPA is considering your request, the
original deadline remains. The Agency will respond to your request in writing. If EPA does
not grant your request, the original deadline remains. Normally, extensions can be requested
only in cases of extraordinary testing problems beyond the expectation or control of the
registrant. Extensions will not be given in submitting the 90-day responses. Extensions will
not be considered if the request for extension is not made in a timely fashion; in no event shall
an extension request be considered if it is submitted at or after the lapse of the subject
deadline.
Option 2. Agreement to Share in Cost to Develop Data
If you choose to enter into an agreement to share in the cost of producing the required
data but will not be submitting the data yourself, you must provide the name of the registrant
who will be submitting the data. You must also provide EPA -with documentary evidence that
an agreement has been formed. Such evidence may be your letter offering to join in an
agreement and the other registrant's acceptance of your offer, or a written statement by the
parties that an agreement exists. The agreement to produce the data need not specify all of the
terms of the final arrangement between the parties or the mechanism to resolve the terms.
Section 3(c)(2)(B) provides that if the parties cannot resolve the terms of the agreement they
may resolve their differences through binding arbitration.
170
-------
Option 3. Offer to Share in the Cost of Data Development
If you have made an offer to pay in an attempt to enter into an agreement or amend an
existing agreement to meet the reguirements of this Notice and have been unsuccessful you
may request EPA (by selecting this option) to exercise its discretion not to suspend your
registration(s), although you do not comply with the data submission requirements of this
Notice. EPA has determined that as a general policy, absent other relevant considerations it
will not suspend the registration of a product of a registrant who has in good faith sought and
continues to seek to enter into a joint data development/cost sharing program, but the other
registrant(s) developing the data has refused to accept the offer. To qualify for this option you
must submit documentation to the Agency proving that you have made an offer to another
registrant (who has an obligation to submit data) to share in the burden of developing that
data. You must also submit to the Agency a completed EPA Form 8570-32, Certification of
Otter to Cost Share in the Development of Data, Attachment 7. In addition, you must
demonstrate that the other registrant to whom the offer was made has not accepted your offer
to enter into a C9st-sharmg agreement by including a copy of your offer and proof of the other
registrant s receipt of that offer (such as a certified mail receipt). Your offer must, in addition
to anything else, offer to share in the burden of producing the data upon terms to be agreed to
or, failing agreement, to be bound by binding arbitration as provided by FIFRA section
3(c)(2)(B)(iii) and must not qualify this offer. The other registrant must also inform EPA of its
election of an option to develop and submit the data required by this Notice by submitting a
Data Call-in Response Form and a Requirements Status and Registrant's Response Form
committing to develop and submit the data required by this Notice.
In order for you to avoid suspension under this option, you may not withdraw your
otter to share in the burden of developing the data. In addition, the other registrant must fulfill
its commitment to develop and submit the data as required by this Notice. If the other
registrant fails to develop the data or for some other reason is subject to suspension your
registration as well as that of the other registrant normally will be subject to initiation of
suspension proceedings, unless you commit to submit, and do submit, the required data in the
specified time frame. In such cases, the Agency generally will not grant a time extension for
submitting the data.
Option 4. Submitting an Existing Study
If you choose to submit an existing study in response to this Notice, you must
determine that the study satisfies the requirements imposed by this Notice. You may only
submit a study that has not been previously submitted to the Agency or previously cited by
anyone Existing studies are studies which predate issuance of this Notice. Do not use this
option if you are submitting data to upgrade a study. (See Option 5).
You should be aware that if the Agency determines that the study is not acceptable the
Agency will require you to comply with this Notice, normally without an extension of the'
required date of submission. The Agency may determine at any time that a study is not valid
and needs to be repeated.
To meet the requirements of the DCI Notice for submitting an existing study, all of the
following three criteria must be clearly Met: —^-^
a. You must certify at the time that the existing study is submitted that the raw
data and specimens from the study are available for audit and review and you
must identify where they are available. This must be done in accordance with
the requirements of the Good Laboratory Practice (GLP) regulation 40 CFR
Part 160. As stated in 40 CFR 160.3 'Raw data' means any laboratory
worksheets, records, memoranda, notes, or exact copies thereof, that are the
result ot original observations and activities of a study and are necessary for the
171
-------
reconstruction and evaluation of the report of that study. In the event that exact
transcripts of raw data have been prepared (e.g., tapes which have been
transcribed verbatim, dated, and verified accurate by signature), the exact copy
or exact transcript may be substituted for the original source as raw data. 'Raw
data' may include photographs, microfilm or microfiche copies, computer
printouts, magnetic media, including dictated observations, and recorded data
from automated instruments." The term "specimens", according to 40 CFR
160.3, means "any material derived from a test system for examination or
analysis."
b. Health and safety studies completed after May 1984 also must also contain all
GLP-required quality assurance and quality control information, pursuant to the
requirements of 40 CFR Part 160. Registrants also must certify at the time of
submitting the existing study that such GLP information is available for post
May 1984 studies by including an appropriate statement on or attached to the
study signed by an authorized official or representative of the registrant.
c. You must certify that each study fulfills the acceptance criteria for the Guideline
relevant to the study provided in the FIFRA Accelerated Reregistration Phase 3
Technical Guidance and that the study has been conducted according to the
Pesticide Assessment Guidelines (PAG) or meets the purpose of the PAG (both
available from NTIS). A study not conducted according to the PAG may be
submitted to the Agency for consideration if the registrant believes that the
study clearly meets the purpose of the PAG. The registrant is referred to 40
CFR 158.70 which states the Agency's policy regarding acceptable protocols. If
you wish to submit the study, you must, in addition to certifying that the
purposes of the PAG are met by the study, clearly articulate the rationale why
you believe the study meets the purpose of the PAG, including copies of any
supporting information or data. It has been the Agency's experience that studies
completed prior to January 1970 rarely satisfied the purpose of the PAG and
that necessary raw data usually are not available for such studies.
If you submit an existing study, you must certify that the study meets all requirements
of the criteria outlined above.
If EPA has previously reviewed a protocol for a study you are submitting, you must
identify any action taken by the Agency on the protocol and must indicate, as part of your
certification, the manner in which all Agency comments, concerns, or issues were addressed
in the final protocol and study.
If you know of a study pertaining to any requirement in this Notice which does not
meet the criteria outlined above but does contain factual information regarding unreasonable
adverse effects, you must notify the Agency of such a study. If such study is in the Agency's
files, you need only cite it along with me notification. If not in the Agency's files, you must
submit a summary and copies as required by PR Notice 86-5.
172
-------
Option 5. Upgrading a Study
If a study has been classified as partially acceptable and upgradeable, you may submit
data to upgrade that study. The Agency will review the data submitted and determine if the
requirement is satisfied. If the Agency decides the requirement is not satisfied, you may still
be required to submit new data normally without any time extension. Deficient but
upgradeable studies will normally be classified as supplemental. However, it is important to
note that not all studies classified as supplemental are upgradeable. If you have questions
regarding the classification of a study or whether a study may be upgraded, call or write the
contact person listed in Attachment 1. If you submit data to upgrade an existing study you
must satisfy or supply information to correct all deficiencies in the study identified by EPA
You must provide a clearly articulated rationale of how the deficiencies have been remedied or
corrected and why the study should be rated as acceptable to EPA. Your submission must also
specify the MRID number(s) of the study which you are attempting to upgrade and must be in
conformance with PR Notice 86-5.
Do not submit additional data for the purpose of upgrading a study classified as
unacceptable and determined by the Agency as not capabfe of being upgraded.
This option also should be used to cite data that has been previously submitted to
upgrade a study, but has not yet been reviewed by the Agency. You must provide the MRID
number of the data submission as well as the MRID number of the study being upgraded.
The criteria for submitting an existing study, as specified in Option 4 above, apply to
all data submissions intended to upgrade studies. Additionally, your submission of data
intended to upgrade studies must be accompanied by a certification that you comply with each
of those criteria, as well as a certification regarding protocol compliance with Agency
requirements.
Option 6. Citing Existing Studies
If you choose to cite a study that has been previously submitted to EPA, that study
must have been previously classified by EPA as acceptable, or it must be a study which has
not yet been reviewed by the Agency. Acceptable toxicology studies generally will have been
classified as core-guideline" or "core-minimum." For ecological effects studies the
classification generally would be a rating of "core." For all other disciplines the classification
would be acceptable." With respect to any studies for which you wish to select this option
you must provide the MRID number of the study you are citing and, if the study has been '
reviewed by the Agency, you must provide the Agency's classification of the study.
If you are citing a study of which you are not the original data submitter, you must
submit a completed copy of EPA Form 8570-31, Certification with Respect to Data
Compensation Requirements.
2. Product Specific Data
If you acknowledge on the product specific Data Call-In Response Form that you agree
to satisfy the product specific data requirements (i.e. you select option 7a or 7b) then you
must select one of the six options on the Requirements Status and Registrant's Response Form
related to data production for each data requirement. Vour option selection should be entered
under item number 9, "Registrant Response." The six options related to data production are
the first six options discussed under item 9 in the instructions for completing the Requirements
Status and Registrant's Response Form. These six options are listed immediately below with
inlormation in parentheses to guide registrants to additional instructions provided in this
Section. The options are:
173
-------
(1) I will generate and submit data within the specified time-frame (Developing
Data)
(2) I have entered into an agreement with one or more registrants to develop data
jointly (Cost Sharing)
(3) I have made offers to cost-share (Offers to Cost Share)
(4) I am submitting an existing study that has not been submitted previously to the
Agency by anyone (Submitting an Existing Study)
(5) I am submitting or citing data to upgrade a study classified by EPA as partially
acceptable and upgradeable (Upgrading a Study)
(6) I am citing an existing study that EPA has classified as acceptable or an existing
study that has been
submitted but not reviewed by the Agency (Citing an Existing Study)
Option 1. Developing Data -- The requirements for developing product specific data are the
same as those described tor generic data (see Section ffl.C.l, Option 1) except that normally
no protocols or progress reports are required.
Option 2. Agree to Share in Cost to Develop Data - If you enter into an agreement to cost
share, the same requirements apply to product specific data as to generic data (see Section
HI.C.I, Option 2). However, registrants may only choose this option for acute toxicity data
and certain efficacy data and only if EPA has indicated in the attached data tables that your
product and at least one other product are similar for purposes of depending on
the same data. If this is the case, data may be generated tor just one of the products in the
group. The registration number of the product for which data will be submitted must be noted
in the agreement to cost share by the registrant selecting this option.
Option 3. Offer to Share in the Cost of Data Development -The same requirements for
generic data (Section 111.(J.I., Option 3) apply to this option. This option only applies to acute
toxicity and certain efficacy data as described in option 2 above.
Option 4. Submitting an Existing Study - The same requirements described for generic data
(see Section Ul.CJ.lT, Uption 4) apply to this option for product specific data.
Option 5. Upgrading a Study - The same requirements described for generic data (see Section
llf.C.l., Uption 5) apply to this option for product specific data.
Option 6. Citing Existing Studies — The same requirements described for generic data (see
Section W.CJ.ir, Uption o) apply to this option for product specific data.
Registrants who select one of the above 6 options must meet all of the requirements
described in the instructions for completing the Data Call-In Response Form and the
Requirements Status and Registrant's Response Form, and in me generic data requirements
section (W.CJ.l.), as appropriate.
m-D REQUESTS FOR DATA WAIVERS
1. Generic Data
There are two types of data waiver responses to this Notice. The first is a request for a
low volume/minor use waiver and the second is a waiver request based on your belief that the
data requirement(s) are not appropriate for your product.
174
-------
a. Low Volume/Minor Use Waiver
Option 8 under item 9 on the Requirements Status and Registrant's Response
Form. Section 3(c)(2)(A) of FIFRA requires tFA to consider the appropriateness ot
requiring data for low volume, minor use pesticides. In implementing this provision,
EPA considers low volume pesticides to be only those active ingredients whose total
production volume for all pesticide registrants is small. In determining whether to grant
a low volume, minor use waiver, the Agency will consider the extent, pattern and
volume of use, the economic incentive to conduct the testing, the importance of the
pesticide, and the exposure and risk from use of the pesticide. If an active ingredient is
used for both high volume and low volume uses, a low volume exemption will not be
approved. If all uses of an active ingredient are low volume and the combined volumes
for all uses are also low, then an exemption may be granted, depending on review of
other information outlined below. An exemption will not be granted if any registrant of
the active ingredient elects to conduct the testing. Any registrant receiving a low
volume minor use waiver must remain within the sales figures in their forecast
supporting the waiver request in order to remain qualified for such waiver. If granted a
waiver, a registrant will be required, as a condition of the waiver, to submit annual
sales reports. The Agency will respond to requests for waivers in writing.
To apply for a low volume, minor use waiver, you must submit the following
information, as applicable to your product(s), as part of your 90-day response to this
Notice:
(i). Total company sales (pounds and dollars) of all registered product(s)
containing the active ingredient. It applicable to the active ingredient, include foreign
sales for those products that are not registered in this country but are applied to sugar
(cane or beet), coffee, bananas, cocoa, and other such crops. Present the above
information by year for each of the past five years.
(ii) Provide an estimate of the sales (pounds and dollars) of the active
ingredient for each major use site. Present the above information by year for each of
the past five years.
(iii) Total direct production cost of product(s) containing the active ingredient
by year for the past five years. Include information on raw material cost, direct labor
cost, advertising, sales and marketing, and any other significant costs listed separately.
(iv) Total indirect production cost (e.g. plant overhead, amortized plant and
equipment) charged to product(s) containing the active ingredient by year for the past
five years. Exclude all non-recurring costs that were directly related to the active
ingredient, such as costs of initial registration and any data development.
(v) A list of each data requirement for which you seek a waiver. Indicate the
type of waiver sought and the estimated cost to you (listed separately for each data
requirement and associated test) of conducting the testing needed to fulfill each of these
data requirements.
(vi) A list of each data requirement for which vou are not seeking any waiver
and the estimated cost to you (listed separately for each data requirement and associated
test) of conducting the testing needed to fulfill each of these data requirements.
(vii) For each of the next ten years, a year-by-year forecast of company sales
(pounds and dollars) of the active ingredient, direct production costs of product(s)
containing the active ingredient (following the parameters in item 2 above), indirect
production costs of product(s) containing the active ingredient (following the
175
-------
parameters in item 3 above), and costs of data development pertaining to the active
ingredient.
(viii) A description of the importance and unique benefits of the active
ingredient to users. Discuss the use patterns and the effectiveness of the active
ingredient relative to registered alternative chemicals and non-chemical control
strategies. Focus on benefits unique to the active ingredient, providing information that
is as quantitative as possible. If you do not have quantitative data upon which to base
your estimates, then present the reasoning used to derive your estimates. To assist the
Agency in determining the degree of importance of the active ingredient in terms of its
benefits, you should provide information on any of the following factors, as applicable
to your product(s): (a) documentation of the usefulness of the active ingredient in
Integrated Pest Management, (b) description of the beneficial impacts on the
environment of use of the active ingredient, as opposed to its registered alternatives,
(c) information on the breakdown of the active ingredient after use and on its
persistence in the environment, and (d) description of its usefulness against a pest(s) of
public health significance.
Failure to submit sufficient information for the Agency to make a determination
regarding a request for a low volume/minor use waiver will result in denial of the
request tor a waiver.
b. Request for Waiver of Data
Option 9, under Item 9, on the Requirements Status and Registrant's Response
Form. This option may be used if you believe that a particular data requirement should
not apply because the requirement is inappropriate. You must submit a rationale
explaining why you believe the data requirements should not apply. You also must
submit the current label(s) of your product(s) and, if a current copy of your
Confidential Statement of Formula is not already on file you must submit a current
copy.
You will be informed of the Agency's decision in writing. If the Agency
determines that the data requirements of this Notice are not appropriate to your
product(s), you will not be required to supply the data pursuant to section 3(c)(2)(B). If
EPA determines that the data are required for your prpduct(s), you must choose a
method ot meeting the requirements ot this Notice within the time trame provided by
this Notice. Within 3U days ot your receipt ot the Agency's written decision, you must
submit a revised Requirements Status and Registrant s Response Form indicating the
option chosen.
2. Product Specific Data
If you request a waiver for product specific data because you believe it is
inappropriate, you must attach a complete justification for the request including
technical reasons, data and references to relevant EPA regulations, guidelines or
policies. (Note: any supplemental data must be submitted in the format required by PR
Notice 86-5). This will oe the only opportunity to state the reasons or provide
information in support of your request. If the Agency approves your waiver request,
you will not be required to supply the data pursuant to section 3(c)(2)(B) of FIFRA. If
the Agency denies your waiver request, you must choose an option for meeting the data
requirements of this Notice within 30 days of the receipt of the Agency's decision.
You must indicate and submit the option chosen on the product specific Requirements
Status and Registrant's Response Form. Product specific data requirements tor product
chemistry, acute toxicity and etlicacy (where appropriate) are required for all products
and the Agency would grant a waiver only under extraordinary circumstances. You
176
-------
should also be aware that submitting a waiver request will not automatically extend the
due date for the study in question. Waiver requests submitteS"without adequate
supporting rationale will be denied and the original due date will remain in force.
SECTION IV. CONSEQUENCES OF FAILURE TO COMPLY WITH THIS
INUTICE
IV-A NOTICE OF INTENT TO SUSPEND
The Agency may issue a Notice of Intent to Suspend products subject to this Notice due
to failure by a registrant to comply with the requirements of this Data Call-In Notice, pursuant
to FIFRA section 3(c)(2)(B). Events which may be the basis for issuance of a Notice of Intent
to Suspend include, but are not limited to, the following:
1. Failure to respond as required by this Notice within 90 days of your receipt of
this Notice.
2. Failure to submit on the required schedule an acceptable proposed or final
protocol when such is required to be submitted to the Agency for review.
3. Failure to submit on the required schedule an adequate progress report on a
study as required by this Notice.
4. Failure to submit on the required schedule acceptable data as required by this
Notice.
5. Failure to take a required action or submit adequate information pertaining to
any option chosen to address the data requirements (e.g., any required action or
information pertaining to submission or citation of existing studies or offers,
arrangements, or arbitration on the sharing of costs or the formation of Task
Forces, failure to comply with the terms of an agreement or arbitration
concerning joint data development or failure to comply with any terms of a data
waiver).
6. Failure to submit supportable certifications as to the conditions of submitted
studies, as required oy Section III-C of this Notice.
7. Withdrawal of an offer to share in the cost of developing required data.
8. Failure of the registrant to whom you have tendered an offer to share in the cost
of developing data and provided proof of the registrant's receipt of such offer
or failure of a registrant on whom you rely for a generic data exemption either
to:
i. Inform EPA of intent to develop and submit the data required by this Notice
on a Data Call-In Response Form and a Requirements Status and Registrant's
Response Form.
ii. Fulfill the commitment to develop and submit the data as required by this
Notice; or
iii. Otherwise take appropriate steps to meet the requirements stated in this
Notice,
177
-------
unless you commit to submit and do submit the required data in the specified
time frame.
9. Failure to take any required or appropriate steps, not mentioned above, at any
time following the issuance of this Notice.
IV-B. BASIS FOR DETERMINATION THAT SUBMITTED STUDY IS
UNACCEPTABLE
The Agency may determine that a study (even if submitted within the required time) is
unacceptable and constitutes a basis for issuance of a Notice of Intent to Suspend. The grounds
for suspension include, but are not limited to, failure to meet any of the following:
1) EPA requirements specified in the Data Call-In Notice or other documents
incorporated by reference (including, as applicable, EPA Pesticide Assessment
Guidelines, Data Reporting Guidelines, and GeneTox Health Effects Test Guidelines)
regarding the design, conduct, and reporting of required studies. Such requirements
include, but are not limited to, those relating to test material, test procedures, selection
of species, number of animals, sex and distribution of animals, dose and effect levels to
be tested or attained, duration of test, and, as applicable, Good Laboratory Practices.
2) EPA requirements regarding the submission of protocols, including the
incorporation or any changes required by the Agency following review.
3) EPA requirements regarding the reporting of data, including the manner of
reporting, the completeness of results, and the adequacy of any required supporting (or
raw) data, including, but not limited to, requirements referenced or included in this
Notice or contained in PR 86-5. All studies must be submitted in the form of a final
report; a preliminary report will not be considered to fulfill the submission
requirement.
IV-C EXISTING STOCKS OF SUSPENDED OR CANCELLED PRODUCTS
EPA has statutory authority to permit continued sale, distribution and use of existing
stocks of a pesticide product which has been suspended or cancelled if doing so would be
consistent with the purposes of the Act.
The Agency has determined that such disposition by registrants of existing stocks for a
suspended registration when a section 3(c)(2)(B) data request is outstanding generally would
not be consistent with the Act's purposes. Accordingly, the Agency anticipates granting
registrants permission to sell, distribute, or use existing stocks of suspended product(s) only in
exceptional circumstances. Ifypu believe such disposition of existing stocks of your product(s)
which may be suspended for failure to comply with this Notice should be permitted, you have
the burden of clearly demonstrating to EPA that granting such permission would be consistent
with the Act. You also must explain why an "existing stocks" provision is necessary, including
a statement of the quantity of existing stocks and your estimate of the time required for their
sale, distribution, and use. Unless you meet this burden, the Agency will not consider any
request pertaining to the continued sale, distribution, or use of your existing stocks after
suspension.
If you request a voluntary cancellation of your product(s) as a response to this Notice
and your product is in full compliance with all Agency requirements, you will have, under
most circumstances, one year from the date your 90 day response to this Notice is due, to sell,
distribute, or use existing stocks. Normally, the Agency will allow persons other than the
registrant such as independent distributors, retailers and end users to sell, distribute or use
such existing stocks until the stocks are exhausted. Any sale, distribution or use of stocks of
178
-------
voluntarily cancelled products containing an active ingredient for which the Agency has
particular risk concerns will be determined on a case-by-case basis.
Requests for voluntary cancellation received after the 90 day response period required
by this Notice will not result in the agency granting any additional time to sell, distribute, or
use existing stocks beyond a year from the date the 90 day response was due, unless you
demonstrate to the Agency that you are in full compliance with all Agency requirements,
including the requirements of this Notice. For example, if you decide to voluntarily cancel
your registration six months before a 3-year study is scheduled to be submitted, all progress
reports and other information necessary to establish that you have been conducting the study in
an acceptable and good faith manner must have been submitted to the Agency, before EPA
will consider granting an existing stocks provision.
SECTION V. REGISTRANTS' OBLIGATION TO REPORT POSSIBLE
UNREASONABLE ADVERSE EFFECTS -
Registrants are reminded that FIFRA section 6(a)(2) states that if at any time after a
pesticide is registered a registrant has additional factual information regarding unreasonable
adverse effects on the environment by the pesticide, the registrant shall submit the information
to the Agency. Registrants must notify the Agency of any tactual information they have, from
whatever source, including but not limited to interim or preliminary results of studies,
regarding unreasonable adverse effects on man or the environment. This requirement
continues as long as the products are registered by the Agency.
SECTION VI. INQUIRIES AND RESPONSES TO THIS NOTICE
If you have any questions regarding the requirements and procedures established by
this Notice, call the contact person(s) listed in Attachment 1, the Data Call-In Chemical Status
Sheet.
All responses to this Notice must include completed Data Call-in Response Forms
(Attachment 2)and completed Requirements Status and Registrant's Response horms
(Attachment 3), for both (generic and product specitic data) and any other documents required
by this Notice, and should be submitted to the contact person(s) identified in Attachment 1 . If
the voluntary cancellation or generic data exemption option is chosen, only the Generic and
Product Specific Data Call-In Response Forms need be submitted.
The Office of Compliance (OC) of the Office of Enforcement and Compliance
Assurance (OECA), EPA, will be monitoring the data being generated in response to this
Notice.
Sincerely yours,
Peter Caulkins, Acting Director
Special Review and
Reregistration Division
Attachments
The Attachments to this Notice are:
179
-------
1 - Data Call-In Chemical Status Sheet
2 - Generic Data Call-In and Froduct Specific Data Call-In Response Forms with
Instructions "
3 - Generic Data Call-In and Product Specific Data Call-In Requirements Status
ana Registrant s Response Forms with instructions
4- HP A Grouping ot End-Use products for Meeting Acute Toxicology Data
Requirements tor Keregistration
5 - fcFA Acceptance uritena
6 - List ot Registrants Receiving This Notice
7 - Confidential Statement ot formula, Uost Share and Data Compensation Forms
180
-------
Attachment 1. Chemical Status Sheets
181
-------
-------
ETHEPHON DATA CALL-IN CHEMICAL STATUS SHEET
INTRODUCTION
You have been sent this Generic Data Call-In Notice because you have product(s)
containing Ethephon.
This Generic Data Call-In Chemical Status Sheet, contains an overview of data
required by tnis notice, and point ot contact tor inquiries pertaining to the reregistration of
Ethephon. This attachment is to be used in conjunction with (1) the Generic Data Call-In
Notice, (2) the Generic Data Call-In Response Form (Attachment 2), (3) the Requirements
Status and Registrant's Form (Attachment 2), (4) a list of registrants receiving this DCI
(Attachment 4), (5) the EPA Acceptance Criteria (Attachment 5), and (6) the Cost Share and
Data Compensation Forms in replying to this Ethephon Generic Data Callln (Attachment F)
Instructions and guidance accompany each form.
DATA REQUIRED BY THIS NOTICE
ihe additional data requirements needed to complete the generic database for Ethephon
are contained in the Requirements Status and Registrant's Response, Attachment C. The
Agency has concluded that additional product chemistry data on Ethephon are needed These
data are needed to folly complete the reregistration of all eligible Ethephon products.
INQUIRIES AND RESPONSES TO THIS NOTICE
If you have any questions regarding the generic data requirements and procedures
established by this Notice, please contact Judy Loranger at (703) 308-8056.
All responses to this Notice for the generic data requirements should be submitted to:
Judy Loranger, Chemical Review Manager
Reregistrati9n Branch
Special Review and Registration Division (H7508W)
Office of Pesticide Programs
U.S. Environmental Protection Agency
Washington, D.C. 20460
RE: Ethephon
183
-------
ETHEPHON DATA CALL-IN CHEMICAL STATUS SHEET
INTRODUCTION
You have been sent this Product Specific Data Call-In Notice because you have
product(s) containing Ethephon.
This Product Specific Data Call-In Chemical Status Sheet, contains an overview of data
required by this notice, and point ot contact tor inquiries pertaining to the reregistration of
Ethephon. This attachment is to be used in conjunction with (1) the Product Specific Data
Call-In Notice, (2) the Product Specific Data Call-In Response Form (Attachment 2), (3) the
Requirements Status and Registrant's Form (Attachment 3), (4) EPA's Grouping of End-Use
Products for Meeting Acute Toxicology Data Requirement (Attachment 4), (5) the EPA
Acceptance Criteria (Attachment 5), (6) a list of registrants receiving this DCI (Attachment 6)
and (7) the Cost Share and Data Compensation Forms in replying to this Ethephon Product
Specific Data Call-In (Attachment 7). Instructions and guidance accompany each form.
DATA REQUIRED BY THIS NOTICE
The additional data requirements needed to complete the database for Ethephon are
contained in the Requirements Status and Registrant's Response, Attachment 3. The Agency
has concluded that additional data on fcthephqn are needed lor specific products. These data
are required to be submitted to the Agency within the time frame listed. These data are
needed to fully complete the reregistration of all eligible Ethephon products.
INQUIRIES AND RESPONSES TO THIS NOTICE
If you have any questions regarding the generic database of Ethephon, please contact
Judy Loranger at (703) 308-8056.
If you have any questions regarding the product specific data requirements and
procedures established by this Notice, please contact Wanda Daughtry at (703) 308-8171.
All responses to this Notice for the Product Specific data requirements should be
submitted to:
Wanda Daughtry
Chemical Review Manager
Product Reregistration Branch
Special Review and Reregistration Branch 7508W
Office of Pesticide Programs
U.S. Environmental Protection Agency
Washington, D.C. 20460
RE: Ethephon
184
-------
Attachment 2. Combined Generic and Product Specific
Data Call-in Response Forms (Form A inserts) Plus
Instructions
185
-------
-------
Instructions For Completing The "Data Call-In Response Forms" For The Generic And
Product Specific Data Call-In
INTRODUCTION
These instructions apply to the Generic and Product Specific "Data Call-In Response Forms"
and are to be used by registrants to respond to generic and product specific Data Call-Ins as
part of EPA's Reregistration Program under the Federal Insecticide, Fungicide, and
Rodenticide Act. The type of data call-in (generic or product specific) is indicated in item
number 3 ("Date and Type of DCI") on each form. BOTH "Data Call-In Response" forms
must be completed.
Although the form is the same for both generic and product specific data, instructions for
completing these forms are different. Please read these instructions carefully before filling out
the forms.
EPA has developed these forms individually for each registrant, and has preprinted these
forms with a number of items. DO NOT use these forms for any other active ingredient.
Items 1 through 4 have been preprinted on the form. Items 5 through 7 must be completed by
the registrant as appropriate. Items 8 through 11 must be completed by the registrant before
submitting a response to the Agency.
The public reporting burden for this collection of information is estimated to average 15
minutes per response, including time for reviewing instructions, searching existing data
sources, gathering and maintaining the data needed, and completing and reviewing the
collection of information. Send comments regarding the burden estimate or any other aspect of
this collection of information, including suggestions for reducing this burden, to Chief,
Information Policy Branch, Mail Code 2136, U.S. Environmental Protection Agency, 401 M
St., S.W., Washington, D.C. 20460; and to the Office of Management and Budget,
Paperwork Reduction Project 2070-0107, Washington, D.C. 20503.
187
-------
INSTRUCTIONS FOR COMPLETING THE DATA CALL-IN RESPONSE FORMS
Generic and Product Specitic Data (Jail-In
Item 1 .ON BOTH FORMS: This item identifies your company name, number and address.
Item 2.ON BOTH FORMS: This item identifies the case number, case name, EPA chemical
number and chemical name.
Item 3.ON BOTH FORMS: This item identifies the type of Data Call-In. The date of
issuance is date stamped.
Item 4.ON BOTH FORMS: This item identifies the EPA product registrations relevant to
the data call-in. Please note that you are also responsible for informing the Agency of your
response regarding any product that you believe may be covered by this Data Call-In but that
is not listed by the Agency in Item 4. You must bring any such apparent omission to the
Agency's attention within the period required for submission of this response form.
Item 5.ON BOTH FORMS: Check this item for each product registration you wish to cancel
voluntarily. If a registration number is listed for a product for which you previously requested
voluntary cancellation, indicate in Item 5 the date of that request. Since this Data Call-In
requires both generic and product specific data, you must complete item 5 on both Data Call-
in response forms. You do not need to complete any item on the Requirements Status and
Registrant's Response Forms.
Item 6a.ON THE GENERIC DATA FORM: Check this Item if the Data Call-In is for
generic data as indicated in Item 3 and you are eligible for a Generic Data Exemption for the
chemical listed in Item 2 and used in the subject product. By electing this exemption, you
agree to the terms and conditions of a Generic Data Exemption as explained in the Data
Call-in Notice.
If you are eligible for or claim a Generic Data Exemption, enter the EPA registration Number
of each registered source of that active ingredient that you use in your product.
Typically, if you purchase an EPA-registered product from one or more other producers
(wno, with respect to the incorporated product, are in compliance with this and any other
outstanding Data Call-In Notice), and
INSTRUCTIONS FOR COMPLETING THE DATA CALL-IN RESPONSE FORMS
Ueneric and Product Specitic Data Call-In
incorporate that product into all your products, you may complete this item for all products
listea on this form. If, however, you produce the active ingredient yourself, or use any
unregistered product (regardless of the fact that some of your sources are registered), you may
not claim a Generic Data Exemption and you may not select this item.
Item 6b.ON THE GENERIC DATA FORM: Check this Item if the Data Call-In is for
generic data as indicated in Item 3 and if you are agreeing to satisfy the generic data
requirements of this Data Call-In. Attach the Requirements Status and Registrant's Response
Form that indicates how you will satisfy those requirements.
188
-------
NOTE: Item 6a and 6b are not applicable for Product Specific Data.
Item 7a.ON THE PRODUCT SPECIFIC DATA FORM: For each manufacturing use
product (MUP) for which you wish to maintain registration, you must agree to satisfy the data
requirements by responding "yes."
Item Tb.For each end use product (EUP) for which you wish to maintain registration, you
must agree to satisfy the data requirements by responding "yes."
FOR BOTH MUP and EUP products
You should also respond "yes" to this item (7a for MUP's and 7b for EUP's) if your product
is identical to another product and you qualify for a data exemption. You must provide the
EPA registration numbers of your source(s); do not complete the Requirements Status and
Registrant's Response form. Examples of such products include repac
O * 1 T 1 V T 1/fl j * /% .J V 1 .. 1*1 • i • i f* «
ickaged products and
Special Local Needs (Section 24c) products which are identical to federally registered
products.
If you are requesting a data waiver, answer "yes" here; in addition, on the "Requirements
Status and Registrant's Response" form under Item 9, you must respond with option 7 (Waiver
Request) for each study for which you are requesting a waiver.
NOTE: Item 7a and 7b are not applicable for Generic Data.
INSTRUCTIONS FOR COMPLETING THE DATA CALL-IN RESPONSE FORMS
Uenenc and Product Speciric Data Call-in
Item 8.ON BOTH FORMS: This certification statement must be signed by an authorized
representative of your company and the. person signing must include his/her title. Additional
pages used in your response must be initialled and dated in the space provided for the
certification.
Item 9.ON BOTH FORMS: Enter the date of signature.
Item 10.ON BOTH FORMS: Enter the name of the person EPA should contact with
questions regarding your response.
Item 11 .ON BOTH FORMS: Enter the phone number of your company contact.
Note: You may provide additional information that does not fit on this form in a signed letter that accompanies your response. For example, you
may wish to report that your product has already been transferred to another company or that you have already voluntarily cancelled this
product. For these cases, please supply all relevant details so that EPA can ensure that its records are correct.
189
-------
-------
-.
<4-4
O
^J
^*
0)
10
0-
>
Q^
hN
O
CJ
EH
b*
a
a
,
^
w
S
N.N.
Ot/> «
*"* O 4J
OO u
1 iil
& * •
* S *
i I 1
u
c •
Q)
1 Protection
C. 20460
ESPONSE
(tt , Qg
•U MM)
4J Q
C Z
Q) - H
SCI
C 0 J
O 4J M
•H ? 3
cS <
W 09 fri
id <
W*» Q
law IBBV
0)
(TJ
4->
T3
0)
•H
C
D
9
M
E
S
V
\
u
S
1
g
^^
C
fgl
£
1
|
U
•
w
f.
**
•>.
<^>
•
c
u
Tl
5
1.
|
^**
2
.£ >L
C
U
•*.
l!
si
ii
M •
23
5 •:>
CD
CD
V-""
*^^^^
Q.
u e^C
a ^^
•S QO
• CQ
H
* W
g] P*J
a O
i and HaM
2 Ethephon
^ GO
da W
3 o
,
«M
0
o
CO O
CO O
wo
?8| .
| W £ S
J-D. CO U
|S 0 0
• u
-'
0
u
I
i
c
f^
aj
o
u
L.
9
*o
?Js
^3 O C
!• ^Lt 9 V
u • •* 8 *
* * h c
•1 41 3 f»
^h ^c B* «w
A *** •"* W ^*
— • « •
-SS1 «
gs-i*
9 ** — •
° E .-"?*.
• i c 8
p « o 2 2
Q V Ql
i % "5 c
Or *• i "
5 « *« « -
* 5 • - c
• « 3 i
XJE a«-
« •*. W « «4
1 5 s f "
8 a ^ ""* ^ s
>s!i i
* o> 5 • 2 a
• 5 o *• «»
r*. — u ••-«/» at
o-j
u • -<
e u ^
6b. 1 agree to satis1
Data requirements as
on the attached fona
"Requi r eaten ts Status
Registrant 'a Reaponsi
U C X
V "" "H H
J • 5 f *
• a^
u a. •
f* J5 5 *** 3
'• c ^ u t.
"5 -2 it i J|
^^ w O li
"" • '• • "Z
• * +* o m
• a) ja u u
•o o o <»• **
1 1
Illl
* ^ S -2 £
-. u •€ *< — •
.812 i
«n u & ** **
1 C
5-|
o7 •
< *•
a. •
UJ *•*
•* at
Z
•
>4!
v
Z
Z
I
1
Z
Z
Z
Z
Z
Z
V
a
^
—
. c
"a. -A
S'jL
-------
-------
H
0
H
0)
CU
>H
CU
o
u
EH
fc
«
Q
?
i
ro
fefc°
oo c.
1 lit
S • CD
< 0 >
a o
o 1 ft
u. 8 <
U
c
d)
<
C
0
-H
al Protect
. C. 20460
RESPONSE
-P Q
C SB
0) - H
i c i
O 4J 3
-H f? 0
^ *iH
CJC <
W W EH
(d •<
CO £ Q
Q)
4J
(d
•P
CO
73
4J
-H
C
£
o
CO
JC
§
•p
V
i
l_
g
f
o
««-
JC
X
I
1
M
iched instruction
«w
CO
JC
t*
z
"3
t>
c«
o
1
(.
i
cu
J
-
£ x
s i
QV O
V
H-
4-* CO
M 5
5 «
- CO
^'1
g.2
i— i 4-«
I!
n a>
r co
U
H
fe
- H
0 W
"S cu ,
xw ^
1 g :
CD Q
« o ^ .
w CC
0 Cu
M
c
O
Q)
* (N
«, 00
g n
3 o
Ol
O
O
CO 0
CO O
«o ^ 3 °
8 g Q
3 < Q X
S PM < X
c o EH
g W JH
1 W tf EH
e iJ EH H
£CU CO U
M ^P<
ia o o
2 CO S5 55
*~
'
CO
o
u
£
C/I
Q.
^
a
CD
0
u
«
•o
-* ** & w
f a u 4-1
S*J ••- c
« 2. CD
X£ (r «-
(0 «»- 4J « 4J
— CO (KM
H- C * —
4J 4J O Ol
u a -a V
3 M CO « CK
o o c ** TZ *
X w _«- 5 M S
• CD fr C CD CO
.O V O 4-* «
C •-• L. H- CO Of
^s-ls
ai*ii
a. 4-> g cfl
a cu ** * •»
* £ " .- c
CD v "5 a
X£ fr C
4J ** § * '»
U CD *D «
3 co co « oc
•H <-• — •
o o c «-> -a s
t_ 4^ 0) ••- C •
a. 1 4- a «
^ yl f | 1
CO « O 4J •)
N. •— t- H- > oe
H 4-» S
« co _,
xlll'.
Isl2i
CO W H- CO Q.
CO 4J 4J M
6b. I agree to
Data requiremen
on the attached
"Requirements S
Registrant's Re
4-< •
2 £ . i!
[_ •!•• 0) M«
J^? f-8
« 1— <4?
O
x — ^ o o x>
• O L. 1. Q
in u Q. +* **
ii
O. CD
< *-•
a. co
UJ ••-
. i?
>»• ae
^
<
55
^
s
g
I
(•jV
55
525
ej
a
t
°*
4-
« «
4-> E
w E
|r
"M «^
8"
aT —
4J <«-
CO
u at
3
5 to
•j C
i_
* *
CO
P
J 4-.
CO w
** n
•S .?
— » CO
a c
1^ s
EJS i!-
o co oe
(0 «
— L. N
f O —
4-> C.
CM x:
"eo 3
* H- <
"w "x
§•; J i
5 g —• g
« xS H-
*-• c — —
^ CO Q. 4-
O 4-» CO 1—
— 4->
4-> a « <. TI
n ^ _» «j C
•*- x— ' 5 w
•-•*-* c.
M — O JC 3
u (. .* o a
u eu u £ c
0 CD 01
CO* ~ — i O (A
X
•g
•
Q.
f^*
«-
^
u
a
§
^
1
j
o
|
o
-------
-------
Attachment 3. Generic and Product Specific Requirement
Status and Registrant's Response Forms (Form B inserts)
and Instructions
191
-------
-------
Instructions For Completing
The
"Requirements Status and Registrant's Response Forms"
For The Generic and Product Specific Data Call-In
INTRODUCTION
These instructions apply to the Generic and Product Specific "Requirements Status and
Registrant's Response Forms" and are to be used by registrants to respond to generic and
product specific Data Call-in's as part of EPA's reregistration program under the Federal
Insecticide, Fungicide, and Rodenticide Act. The type of Data Call-In (generic or product
specific) is indicated in item number 3 ("Date and Type of DCI") on each form. Both
"Requirements Status and Registrant's Response" forms must be completed.
Although the form is the same for both product specific and generic data, instructions
for completing the forms differ slightly. Specifically, options for satisfying product specific
data requirements do not include (1) deletion of uses or (2) request for a low volume/minor
use waiver. Please read these instructions carefully before filling out the forms.
EPA has developed these forms individually for each registrant, and has preprinted
these forms to include certain information unique to this chemical. DO NOT use these forms
for any other active ingredient.
Items 1 through 8 have been preprinted on the form. Item 9 must be completed by the
registrant as appropriate. Items 10 through 13 must be completed by the registrant before
submitting a response to the Agency.
The public reporting burden for this collection of information is estimated to average
30 minutes per response, including time for reviewing instructions, searching existing data
sources, gathering and maintaining the data needed, and completing and reviewing the
collection of information. Send comments regarding the burden estimate or any other aspect of
this collection of information, including suggestions for reducing this burden, to Chief
Information Policy Branch, Mail Code 2136, U.S. Environmental Protection Agency, 401 M
St., S.W., Washington, D.C. 20460; and to the Office of Management and Budget
Paperwork Reduction Project 2070-0107, Washington, D.C. 20503
193
-------
INSTRUCTIONS FOR COMPLETING THE "REQUIREMENTS STATUS AND
KfcUlS 1 KANT' S RfcSFON Sb hORMS "
Ueneric and Product Specitic Data (Jail-In
Item 1. ON BOTH FORMS: This item identifies your company name, number and
address.
Item 2. ON THE GENERIC DATA FORM: This item identifies the case number,
case name, EPA chemical number and chemical name.
ON THE PRODUCT SPECIFIC DATA FORM: This item identifies the
case number, case name, and the EPA Registration Number of the product for
which the Agency is requesting product specific data.
Item 3. ON THE GENERIC DATA FORM: This item identifies the type of Data
Call-in. The date of issuance is date stamped.
ON THE PRODUCT SPECIFIC DATA FORM: This item identifies the type
of Data Call-In. The date of issuance is also date stamped. Note the unique
identifier number (ID#) assigned by the Agency. This ID number must be used
in the transmittal document for any data submissions in response to this Data
Call-In Notice.
Item 4. ON BOTH FORMS: This item identifies the guideline reference number of
studies required. These guidelines, in addition to the requirements specified in
the Data Call-In Notice, govern the conduct of the required studies. Note that
series 61 and 62 in product chemistry are now listed under 40 CFR 158.155
through 158.180, Subpartc.
Item 5. ON BOTH FORMS: This item identifies the study title associated with the
guideline reference number and whether protocols and 1, 2, or 3-year progress
reports are required to be submitted in connection with the study. As nptea in
Section IQ of the Data Call-In Notice, 90-day progress reports are required for
all studies.
If an asterisk appears in Item 5, EPA has attached information relevant to this
guideline reference number to the Requirements Status and Registrant's
Response Form.
INSTRUCTIONS FOR COMPLETING THE "REQUIREMENTS STATUS AND
REGISTRANT'S RESPONSE FORMS"
Ueneric and Product Specitic Data Call-in
Item 6. ON BOTH FORMS: This item identifies the code associated with the use
pattern of the pesticide. In the case of efficacy data (product specific
requirement), the required study only pertains to products which have the use
sites and/or pests indicated. A brier description of each code follows:
A Terrestrial food
B Terrestrial feed
C Terrestrial non-food
194
-------
Item 7.
Item 8.
D Aquatic food
E Aquatic non-food outdoor
F Aquatic non-food industrial
G Aquatic non-food residential
H Greenhouse food
I Greenhouse non-food crop
J Forestry
K Residential
L Indoor food
M Indoor non-food
N Indoor medical
O Indoor residential
ON BOTH FORMS: This item identifies the code assigned to the substance
that must be used for testing. A brief description of each code follows:
End-Use Product
Manufacturing-Use Product
Manufacturing-Use Product and Technical Grade Active
Ingredient
Pure Active Ingredient
Pure Active Ingredient and Metabolites
Pure Active Indredient or Pute Active
Ingredient Radiolabelled
Pure Active Ingredient Radiolabelled
Pure Active Ingredient Radiolabelled and Metabolites
Pure Active Ingredient Radiolabelled and Plant
Metabolites
Typical End-Use Product
Typical End-Use Product, Percent Active Ingredient
Specified
Typical End-Use Product and Metabolites
Typical End-Use Product or Pure Active Ingredient and
Metabolites
Technical Grade Active Ingredient
Technical Grade Active Ingredient or Pure Active
Ingredient
Technical Grade Active Ingredient or Pure Active
Ingredient Radiolabelled
Technical Grade Active Ingredient or Typical End-Use
Product
Metabolites
Impurities
Degradates
* See: guideline comment
This item completed by the Agency identifies the time frame allowed for
submission of the study or protocol identified in item 5.
ON THE GENERIC DATA FORM: The time frame runs from the date of
your receipt of the Data Call-In notice.
ON THE PRODUCT SPECIFIC DATA FORM: The due date for
submission of product specific studies begins from the date stamped on the letter
transmitting the Reregistration Eligibility Decision document, and not from the
EUP
MP
MP/TGAI
PAI
PAI/M
PAI/PAIRA
PAIRA
PAIRA/M
PAIRA/PM
TEP
TEP %
TEP/MET
TEP/PAI/M
TGAI
TGAI/PAI
TGAI/PAIRA
TGAI/TEP
MET
IMP
DEGR
195
-------
date of receipt. However, your response to the Data Call-In itself is due 90
days from the date of receipt.
Item 9. ON BOTH FORMS: Enter the appropriate Response Code or Codes to show
how you intend to comply with each data requirement. Brief descriptions of
each code f9llow. The Data Call-In Notice contains a fuller description of each
of these options.
Option 1. ON BOTH FORMS: (Developing Data) I will conduct a new study and
submit it within the time frames specitied in item 8 above. By indicating
that I have chosen this option, I certify that I will comply with all the
requirements pertaining to the conditions for submittal of this study as
outlined in the Data Call-In N9tice and that I will provide the protocols
and progress reports required in item 5 above.
Option 2. ON BOTH FORMS: (Agreement to Cost Share) I have entered into an
agreement with one or more registrants to develop data jointly. By
indicating that I have chosen this option, I certify that I will comply with
all the requirements pertaining to snaring in the cost of developing data
as outlined in the Data Call-In Notice.
However, for Product Specific Data, I understand that this
option is available for acute toxicity or certain efficacy data ONLY if
the Agency indicates in an attachment to this notice that my product is
similar enough to another product to qualify for this option. I certify that
another party in the agreement is committing to submit or provide the
required data; if the required study is not submitted on time, my product
may be subject to suspension.
Option 3. ON BOTH FORMS: (Offer to Cost Share) I have made an offer to
enter into an agreement with one or more registrants to develop data
jointly. I am also submitting a completed "Certification of offer to Cost
Share in the Development of Data" form. I am submitting evidence that
I have made an offer to another registrant (who has an obligation to
submit data) to share in the cost of that data. I am including a copy of
my offer and proof of the other registrant's receipt of that offer. I am
identifying the party which is committing to submit or provide the
required data; if the required study is not submitted on time, mv product
may be subject to suspension. I understand that other terms under Option
3 in the Data Call-In Notice apply as well.
However, for Product Specific Data, I understand that this
option is available only for acute toxicity or certain efficacy data and
only if the Agency indicates in an attachment to this Data Call-in Notice
that my product is similar enough to another product to qualify for this
option.
Option 4. ON BOTH FORMS: (Submitting Existing Data) I will submit an
existing study by the specified due date that has never before been
submitted to EPA. By indicating that I have chosen this option, I certify
that this study meets all the requirements pertaining to the conditions for
submittal of existing data outlined in the Data Call-in Notice and I have
attached the needed supporting information along with this response.
196
-------
Options. ON BOTH FORMS: (Upgrading a Study) I will submit by the
specified due date, or will cite data to upgrade a study that EPA has
classified as partially acceptable and potentially uperadeable. By
indicating that I have chosen this option, I certify that I have met all the
requirements pertaining to the conditions for submitting or citing
existing data to upgrade a study described in the Data Call-in Notice. I
am indicating on attached correspondence the Master Record
Identification Number (MRID) that EPA has assigned to the data that I
am citing as well as the MRID of the study I am attempting to upgrade.
Option 6. ON BOTH FORMS: (Citing a Study) I am citing an existing study
that has been previously classified by fcPA as acceptable, core, core
minimum, or a study tnat has not yet been reviewed by the Agency. If
reviewed, I am providing the Agency's classification of the study.
However, for Product Specific Data, I am citing another
registrant's study. I understand that this option is available ONLY for
acute toxicity or certain efficacy data and ONLY if the cited study was
conducted on my product, an identical product or a product which the
Agency has "grouped" with one or more other products for purposes of
depending on the same data. I may also choose this option if I am citing
my own data. In either case, I will provide the MRID or Accession
number (s). If I cite another registrant's data, I will submit a completed
"Certification With Respect To Data Compensation Requirements
form.
FOR THE GENERIC DATA FORM ONLY: The following three options
(Numbers 7, 8, and 9) are responses that apply only to the "'Requirements Status
and Registrant's Response Form" for generic data.
Option 7. (Deleting Uses) I am attaching an application for amendment to my
registration deleting the uses for which the data are required.
Option 8. (Low Volume/Minor Use Waiver Request) I have read the statements
concerning low volume-minor use data waivers in the Data Call-In
Notice and I request a low-volume minor use waiver of the data
requirement. I am attaching a detailed justification to support this waiver
request including, among other things, all information required to
support the request. I understand that, unless modified by the Agency in
writing, the data requirement as stated in the Notice governs.
Option 9. (Request for Waiver of Data) I have read the statements concerning data
waivers otner than lowvolume minor-use data waivers in the Data
Call-In Notice and I request a waiver of the data requirement. I am
attaching a rationale explaining why I believe the data requirements do
not apply. I am also submitting a copy of my current labels. (You must
also submit a copy of your Confidential Statement of Formula if not
already on file with EPA). I understand that, unless modified by the
Agency in writing, the data requirement as stated in the Notice governs.
FOR PRODUCT SPECIFIC DATA: The following option (number 7) is a
response that applies to the "Requirements Status and Registrant's Response
Form" for product specific data.
197
-------
Option 7. (Waiver Request) I request a waiver for this study because it is
inappropriate lor my product. I am attaching a complete justification for
this request, including technical reasons, data and references to relevant
EPA regulations, guidelines or policies. [Note: any supplemental data
must be submitted in the format required by P.R. Notice 86-5]. I
understand that this is my only opportunity to state the reasons or
provide information in support of my request. If the Agency approves
my waiver request, I will not be required to supply the data pursuant to
Section 3(c) (2) (B) of FIFRA. If the Agency denies my waiver request,
I must choose a method of meeting the data requirements of this Notice
by the due date stated by this Notice. In this case, I must, within 30
days-of my receipt of the Agency's written decision, submit a revised
"Requirements Status" form specifying the option chosen. I also
understand that the deadline for submission of data as specified by the
original Data Call-In notice will not change.
Item 10. ON BOTH FORMS: This item must be signed by an authorized representative
of your company. The person signing must include his/her title, and must initial
and date all other pages of this form.
Item 11. ON BOTH FORMS: Enter the date of signature.
Item 12. ON BOTH FORMS: Enter the name of the person EPA should contact with
questions regarding your response.
Item 13. ON BOTH FORMS: Enter the phone number of your company contact.
NOTE: You may provide additional information that does not fit on this form in a signed letter that accompanies this your response. For example,
you may wish to report that your product has already been transferred to another company or that you have already voluntarily cancelled
198
-------
§
K»
OlA CO
7 ?? ~
« OO O.
^ 1^ ^^ 9C
O OO Ul
(- (MDJ
9- —
* o 5
3E O
(-00 Q.
OZ £
u. O <
U CO
c 2
Q) O
< &
H
§ •
-H CO
-P *
* ° i
o o S
^H r\i 6^
CU CO
. H
r~1 QJ ^y
•y Q «
c
Q) ^ Q
1 1 *
2 ft co
O* 25?
^ C s~
ii i
n 5 *
0) * CO
4J M
CO Z "
T3 tf
Q) H
-H °
•C M
D OS
E
o
•*-
CO
.c
§
1
c_
§
•^
4-1
L.
O
>*-
c
01
4^
^
1
CO
1
to
§
4J
0
3
4-»
CO
c
"8
-C
o
co
4->
4^
a
.c
4->
X
"3
*jj
c.
co
u
To
u
CO
CO
a.
^
c
c
(.
C M
— CO
fc.S
^ co
» Ol
a a*
01 -C
— • CO
a.
0-
1 INSTRUCT I
Use add it
LO
CD
0>
s ce: :
? Qu
|o oo
^i0^
* 25
£ W
2 o
M
H
0
CO
ON
ON
C 0
O
JG g
o) i
* w *
• rM « §
« £J o ^
« n if
«5 o i5 £
~
o
0
CO 0
CO 0
wo
S x «
158s,
3 rtj Q X
3 Oj < X
^ S
1 0 H
• u w -
1 w ^
? iJ E-i H
X n. rn r \
C M< wj \j
15 0 0
2 M 55 25
4-1
CO
KB
4-1
00 01
TO C
Ol Q
at a.
CO
<>2
^8
. *
CO it
01
u
«-> C
M CD
Ol 4->
si <«
C
01 c.
CA 01
3 4-*
• CO
>o a.
CO
c- 01
Ol
h-
|
(A
in
•- c
1L
Jli
N
wwwwwwwmwww w w w w
ooooooooooo oooo
COOOCOOOCOCV'^noVDlO ^HHH
H >.
Ills |
O) — rf CO ri*
w c > a co < i«
*^ o ••• x M^
« 'P V — » 1 I t_ UJ _J
WE 4J 4^ Q. Si
iJ.i'^e SS-'f^iirS.co. ''^
'cSc^l 5*M^^~*JltlB ZILT
oiox a co . . 5 -^ 'u 5S
— c5o4J-8'o'^^*t»2g2lzS
*«-K*«**«««« * * * *
•Q O ^3 Q) *n ^*
I.I 1 1 InrHHtHHiHH
VOVOVOVOVOHfHHHHHH
co
^
+j
• c
01 cu
4-> £
Ol C
a. M
0
E"
•g —
co «
0)
4rf •*-
CD
t- X
U
U 01
"S
oT.e
3 CO
01 a
l_
M
§1
E
"5 c
co cu
4rf E
*-> V Ol
CO 4J >
— • 4J *3
"in W 2
•gf g
COT! 01
a c.
e«> a.
O CO O£
**~'i -p
co a>
•— (. N
.CO —
4J i_
01 O
C CO f.
O — ' 4->
CO 3
S X co
"w x
CO C • C
4J— 3 CO
c 3 co a.
4) j^ ^flj cj
CO XJ3 H-
4-> c co o
co co u
a» *j m _.
C x: co Q. 4-1
0 4- j; S —
— 4-> CO t—
9 CO 01 L. ^
J £ O) Ol C
- X— 3 Ol
4-> «*- 3 1.
c- — Of 3
Ol 4-> C 4-1 -W
u c. ^ Q CD
01 O ^ C
• u co o)
,- ~ », 0 M
c.
S
2
o
o.
ro
J
D
i
0
u
i
5
u
o
i
M
-------
-------
rs
<4-
c
rs
01
0
(Q
O,
X
dl
0
u
£LJ
**N
DH
Q
^D
£
o
otn co
«-o o»
OO (-
T> • T .-
> gg s-
2 88 •"
Q. —
E • i H
U GO
C 2
Q) O
CP CM
< CD
H
C 0!
O
-H co
•P *
5 s i
o o 8
OH CO
. H
fft ^^ BHi
<0 . H ,
O jj
^ "& CO
•rH f+ ^3
> .g g
W m
(C *0
(u •»
Q) 5 «
fj *
00 §£
H
'Q fl£
Q) H
•M P
«
E
O
H-
(0
x:
4-1
§
2
L.
§
'£
§
t.
0
*c
O)
x:
4^
X
a
(0
"C
<0
(A
o
4->
^
(.
4-1
M
"-
"8
c
n
M
ffl
01
c
3
u
5
u
3
D
U
LI
D
D
^
£
S x
IB
4-> CD
C «
- M
S.S
>
«*-
L ""
Ol *•
(0 Ol
a 01
' ^1
— <0
~ .
• a
2 §
| •»•
H
i 0)
Z CO
— 3
'i«4~-;
•r^TJ; ':
^^*gj ^
f^^Srf '
sr— ° '
u ''""""'' "'
*•" j<5'
1° ^
•n QL
c H
* 2;
Io
•
H
O
00
o\
C 0
o
a) i
z W •
a "So
Ik *^ ^E
CO *S
u f> w x:
r\J
O
O
W 0
WO
w °
S x «
S 2: D
1 OH < X
-o S
1 O E-i
• u w -
ft H >4
" tJ ^ H
^•Oi CQ U
i-
H H
M U U
CQ CQ CQ CQ
> >*
5H !>4
"i
•*-> v E
a a
«- E
C i
~ X
4J «^-
'o •"
"O *X 8
« 4V "S tj "S
JJ 1 1 1 1 1 1
5 8 5 |! •§
*• •< o>
* * * *
fH W W
^ W W
"* 1 1
I oo r*
H 1 I
r* H rsi
H CO CO
01
a
0
01
O)
§.
(0
c
§
S~
g
5 •
~ "S)
"" S
O
4-> 01
O)
a a
§ §
•• CO
D —
£ §
- a
i* U
i c.
> 01
- "o
o *-•
** X
01
— *-•
1
. 3
-------
-------
i
H O 43 -H
H 'H CU43 Q)
0)-P 0)>43
-M Q) O rH
CO) H 0) -H C
•P 43 0)
0) 0) .P rH O
O O O
Q) 0) O C
M W «-H
•H
C W O H
TJ
O
0) -P
P S
W H
0*0)
0) C
O O O Q)
43-H 43
.p -p C.P
0) >i (0
rH C f*
r% „. . JO (0 W O
O Q) 4-» iH O W •
H 43 W -H (0 -H 0) 0) O
•P 43 «H
>,0) Ctl-H >,.p O
0)
-«_
Q)(OCO C4J4J
-04JOS -diJ2
(O-H *T3P
O)
> O W
f-l W-H W
>i-H -H rH
0
43OPM-H 4343Q)«M-H
4-»
C
Q)
W
0)
OU W
0)
W 43
Q) 4J
CIT3
*H ^4
•H
« &
C 0)
•H
4J Q)
•H 43
(0 rH
•H
W *
(0 W
0) 4->
>-H
0)6
0) T3
•H Q)
Q) irH
sl
(0
CC
W
H (0 -H
f»
vo
Q)
-P
4J
•H
W
!js
O
W
P
W
W TJ
Q) O
•H43
4J 4J
•H Q)
(0 O
o o
•H TJ.H
CCQ)
0 Q) -H
O Q) O
•fH 3 d)
CF 0)
•H Vi 4J
W
(0 O
(0 W O
-H -H 0)
rH rH 4J
0) (0
«M(UC
r»
I
VO
•O
Q)
n
C
•H
H
0)
T3
P
4J
>i
-P
s
W
n
VO
-H4J
4J-H
an
0*43
W O
•d e
o -P
•H
rH Q)
?5
3g
V-l Q)
(*4 Jj
O-H
C O
-H (0
P O
•P 43
o
43
-H >,
4304J
(0 CM
•H-H C
P * W
0)
-H >
0)W-H
vo
H
&
3
P
O
i
•O
p
W
•H
43
H
0)
•H •
WO)
C
§(0
4343
(0 -P
Q) Q)
S2
43
I
-------
m
d
H
CO
Q)
P
CO
ft)
"c
C
o
C £
O ft
XJ ft ft)
Q. g J"J
0>l^
I 43 TJ W
I -P 1
* W "
•g * H
« 01 S oo
Q 00 "E O>
3 o 5 o
o
4J
•d
TJ O
TJ-POTJCQTJttM
ft M Q) O M Q)
co Q) ft+> —x: ft >
Id
CO ft) id
Id Q) ft) i
id
H 4J O
C C rH
-H Q)
ft) id 4J
CO «H
>i-H >iC
ft) 4J
H M ft) ft)
-P g C
id ^ id
CO H M XJ
O ft) C
CO-H >,
id ft) 3 ft)
O rH 4J
\,/ IV
ft) J3
N &
M C rH TJ
ft ft) Id Id
-H >, Id i c
O -Hft)4JH
Id O A Q) -P «J 4-» U
id ft) C -H M X5 X
(d • O 43 ft) Id H 4J
.p Id iH O -H
O
id
TJ
o
o
in co H ft) Q)
H >i
O 4J
id
TJ -H H -H
CO ft) CO -H ^ X)
Q) co co xa <* id
•H CO -H Id -P
TJ ft) g -P • CO
-p O 3 U ft)
CO M CO ft) -H D>
*~* j^ o
M M TJ CO ft
(4-1 CP 0) ft IP
•• M ^* id C
ft) ft) U 4-) TJ -P
•H ftX2 • (d O
> 0) — ft
(D CO C ft) 4J -H P
Q)
ft) C
id u
ft)
•H
TJ CO
Q)
CO O g TJ ft)
O H M ft) Id
•H r> -H CO A
o d1 o P
TJ O ft) -P CO
C O M 4-> P
O O g
>•
-P CO
TJ 0-H
TJ
Q) -H -H Q) VO -H «H CO
Id -H C
4J TJ -H H X» Id C
CO C O Id CO -H
O ft) O -P TJ
ft) O d> CO TJ ft)
d****» g p id
ft) O O 4J CT-H
XJ ^O M O ft) M
EH H O «M C M -P
ft)
I
H
r^
g
•H
X
g
ft)
.p
X
o
X
X*
id
TJ
ft)
4J
u
TJ
C
o
u
ft)
4J
CO
i
CO
ft)
lOO^CP 10 TJ
4->
CO
TJ ft)
ft) TJ
ft) M
O ft)
TJ
Id Id
U
4J-H
C -P
Id ft)
C M
•H O
g Q)
P XJ
K 4J
•d
Q)
Q)
4J
CO
&>
ft)
STJ
g ft)
*X-H
ft)
P ft)
g o
4J g
4J-H
O C
O-H
g
o <
ft) -p
M I *
•H O
3 O
d1
ft) G
M O
ft) C
M O
id 43
ft
EH id ft)
EH 4JXJ
O id 4J
U Q 0)
2
O
-------
0)
trt
(0
&
o
•H
P
a o
$ VO
C
o
C £
o a
43 -, 0)
ft !•£
0) 54J
£ ? w
S "
* 01 55 co
w co •£ o>
2 n « CK
3 o g o
(0
•O
•P »O
C
c I
Q) 0)
-•—I ^f
&w
o
u
)H
0)
(0
c
-
'*-•
n ,
"
W
w
O
b
a
0)
292" ^
-H4J(0
sc
w <
(0
0 0) >,
-H T3 W -P
X-H-H
OQJO
4J>M-H
o ^ o) x
M fl) -H o
pCTJ^
b) S o
c u -P v-i
JG -H
0)
•H
>i
•H
4J
0)
fl)
O
O
-M.P
ow
LJ
O Q)
ox:
4J
•P (0
o c
2 3
-------
-------
OU1 M
«-o i
oo «-
• i ••-
i §
• a
o
>i H
U CO
c *
0) p
& s
< CO
§ 3
•H CO
.p o *
4J O 2
o H d>
•H C
>-H
C A
» w
f
S t
I
a
Q)
H
« 00
So
o
ro
0 ac
4)
82
M
S2
L. (_
U (0
o o
6 P
00 00
(0
O
wwwwwwwww
ooooooooo
686668666
00 00 00 00 OQ 00 CQ CO 00 CO
H H
H H H
C
If
7
ii
ii
?•= *
8-Q S
oe
H
EJ:
o »
ll<
II;
« X -O H-
*- C fl O
(0 • U
: £ a "o. ^M
X **€ fr ^
*-> *-•
fl « 41 L. -n
c 5 5 c
- ^x— 3 41
I Z> C -H 4->
J c. ^ o g
. s,-8 I
-------
-------
Q
n
04
KN.
om co
oo c_
eei
U CO
§ B
C
o
•H
•P O
O O
0) •<*
-P o
O CN
04 •
•w - i^^
•P Q «
H d> co
•H c p
> -H EH
CJ3 <
W 0) EH
P_
K XN
<-• M
41 4J
I S!
-2-5
i1
O
A
0)
£•*
S i i
r
« CM
w CO
2 co
5 o
Q)
04
H
w
s&
«£
« «5
*l
oooooooooooooo
seseeeseesssee
cooocoeotococococoeocoeocooo
H H M
P* 04 0*
H H l-l
•d
H
oooooooooooooo
MHHHHHHHMHHHWH
pppppppppppppo
88888888888888
W « W W
o o o o
86 SB
CO CO CO CO
H H
II
C C
«
0 « 0 X
« «t *K « •
*j ti ° U *
3 3 4^ a ••-
o 5 S c.
i i i i i
i i
II II
H rH »-l H
CO GO CO CO
s
«- eg
) u
!H-
- O
-------
-------
r>
(^
O
n
C
n
X
O4
O
CJ
EH
f*4
*•
«
Q
S
*
M
I
N.K 8
om co
oo «-
(- CMCM
1 d 1
3K O
! § I
>i pa
U CO
C 35
0) 0
tr* w
< CO
£d OH
o
•H CO
4J 0 %
U vo EH
4J o 2
O Q S
C
Q) *• P
1 o 2
M t7> CO
•H C D
>-H EH
C.C <
H U EH
(d CO
u as
Q) CO
-p H
(d z
CO S
3
*O 05
3 B
C fi
E
o
(0
f
§
requested
S
0
c
01
**
X
1
I
c
2
2
5
^
B
•n
D
C
D
j
C
•I
5
X
3
U
D
U
1
l»
|
|
z it
: M
t!
L^
' CA
41 *^
i 8
01 f
-^ co
•*• _^
! T
il
! "
' 3
g
CJ 2
H g
M H q
*g?
JL^I
| D S
* O*H»
« OS Q
° a* H
w
z
z
1
1
1
C fe
M *-4
o
»c *
QJ O
{r*
ii
* W tP
1 Q)
« CM
41 co <;
5 o H
rJ
O
O
CO 0
CO 0
to W °
8^4 Gu
«-5Q
s •< Q X
JE d< «< X
-g S
* CJ W ••
g W X
1 W 04 EH
c *J EH H
^•gj CO CJ
l§ 0 0
8 co z z
<-T
^
c.
W 4»
c> ee.
|
CO u.
85
*~ s?
^1
li
• a
S
^5
?
Z S
?* *i3
'** N
5 *"*
-8 1
11
c «
a. o
in vo
I 1
«-» H
CO 00
01
«
o
4»
n
CO
c
5
5
^
S
5 .
: 5
j f
o>
5S
5.2
^s
' 4->
• ff
01 O
0 •-
41 •—
<-• 4->
eg c.
> 01
2
- o
O 4->
-8
i
» _<
"• 3
C •*-
-------
-------
u
c
Q)
CP
O
•H
-P
U O
0) vo
o o
V4 O)
•H a
C
C-H
H A
(0
U) c a
ded
I
I -i
11
5 8| -
3 k -0 .
(roc E
< u. « C
o
8-
u
'•5 I! M fi
(U t. 4V k
4v k « U
u « «. «
4J a s
*"fc fc>»
« ° g H
(A 4*
• O) O <
jz a 4v ae
O Jrf w _
C. U 4V < ._
3.1*1* i;
« £3;;
S? "I
a at 4v -p
s s §1
l*fl
H- O O)
o «
»- 09 >
k *^
01 4) 4V
> « S 8
o •—
Q. 4v «T at
-a" ^
4v -H 3 a.
U O O S
IS:
o. «- <
H- 41 Q.
• ui 'a 'c
'B 2.5
2^^
II • C k
O.S '?
"In
"»-l5
rres
Greenh
or
end-
eed crop
sidential
Terrest
Aquatic
Indoor
oduc
pr
ased
he pur
the ac
use
urc
th
HP = manufacturing
pertaining to the
differ from those of
= technical grade of
— )
o o
-$£? ^ag^*
«-g ? - « B * s
££££ •2*^ <
g a-S 5 g
*c| f
U _l 4V
o —•
4V OJ •
4V —• O "D
k c a -n •»- £
O g ' 4V C C 4V
6 « 4V o •**
l« t 9 E •- OJ E
•- «- « » V
u (M in 8 4v ^ .Z
45 i «- •- c a TJ
«9 ^ « 4V C 2 ft
-I "•
'O d
585 ^
« H- 5 o •-•
t- c-
2 a S • ••
«k 4V
4V U C
«- « — 5
k 0) 4V -O
f^'i g
STT" 5
if < u-
Q)
8
gw
i
u
x
?
Jt v> n k a
*o t. N —• -v g '«3
•*- O-J. « 9 O
| SI
* s-s
o •— u
^i
•O k 4v o •- « 7
41 k C T) k
u g o (o a w*o
• B k "• . « 4-
| ?£ 3 J .ii £
*'5ic '« ? I "5
•^ k K. —- o O >
(A
in"
volatile
n or has
s a gas or
s corrosive
8 55
i Si
Chem
est
est
•= .i. .;.
I 22
i II
8 -*
H 4V 4V
O O
in«or^eoo>o<-(MKi^a-ino
-------
OJ
C
C-H
CO
to id
Q) £
4J
id
+>
c/5
Tl
0)
•H
D
CO
H
E
J£
1
«
i
s
p^
Hi
^ 0
Q fl
H y
o
Sw CO
s
w
g *
* 1
|V^ PN
Q M*^
^
S Q)
E w
p
z
*
M
s
SB
p^
s
i l!
«•> u o
C •- f
— * 4-» **
39 It
v lE
** "B
t- c- C
&« «o
f
•v, 4^ CO
— • O — •
o o
8 "8 8
t. <0 4-»
"O
« M
— • it c.
CO
1 1|
«r i «?
s, t *,
0 f
O» Of
«»- 4J
in'5
L. 4-1
!H g."3
'C aTc
i « °
« x|
"8 w
1 Is
g 4?S
• CO »-
• « O. o>
C M (0 «
— • 'i3 to
— '5 O — •
* 5 "" 3
« 0 ID CO
<5 -^ *
H- TJ "5 «U
° 3 8"5
?L. *" 4J
3 » 0
4J O H-
— O ^* ««-
•Q U «
. 1 1 g i
* L. (0 f CO
H- 3 O "D
SO
4->
•^ « O
4-> H- Q. •— •
CO O X U CO
'n 4^ — • 5 c
u « g L. <5
-lll^
•• 18*1.
^^ >- 9
u 4-> cv • T
S CO (. S" 0 4^
O Q. u +* M
^ X o» v> o> 5
— ** ^ i; -1
WC H- C M
». .- 3 L. L. "S
S*» o ••- »^ ••- f
O. 3 3 O O
14. Q) W Q_ f
§ """
„
4->
ae
4J U.
ll
B *^
.?3
4J •*-
8 'u
-§.
f (0
•i
*o «
4^ — <
^ .*
•^
« w
JC H-
4- O
•f C
a o
4W 4-1
*5
1-
'o «.
••- o
*> *••
g.
— cu
^ 4-<
C L-
o u
S.,
4.1
IS o
c ^
rl
H- rJ
— in
•—
Hz
_c
^3
il
< $
S g.
>— w
•u «
• o
*l
oT o.
« *
O «*^
^
Si
— u
s-k
• X «
8 c S
'IcS
||l
g^r
•— Q. 4J
.? « i?
5 5 II .
c o ^
w- H- H- ^
O ^x
O CO «•*
C *t- v
1. •- W N.
O 4-< 4-> •
"s° •
-------
Attachment 4. EPA Batching of End-Use Products for
Meeting Data Requirements for Registration
199
-------
-------
EPA'S BATCHING OF ETHEPHON PRODUCTS FOR MEETING ACUTE TOXICITY
DATA REQUIREMENTS FOR REREGISTRATION imillNO A^u ^ IUAIUII Y
In an effort to reduce the time, resources and number of animals needed to fulfill the
acute toxicity data requirements for reregistration of products containing ethephon as the
active ingredient, the Agency has batched products which can be considered similar for
purposes of acute toxicity. Factors considered in the sorting process include each product's
active and inert ingredients (identity, percent composition and biological activity) type of
formulation (e.g., emulsifiable concentrate, aerosol, wettable powder, granular, etc ) and
labeling (e.g., signal word, use classification, precautionary labeling, etc.). Note that the
Agency is not describing batched products as "substantially similar" since some products
within a batch may not be considered chemically similar or have identical use patterns.
Using available information, batching has been accomplished by the process described
in the preceding paragraph. Notwithstanding the batching process, the Agency reserves the
right to require, at any time, acute toxicity data for an individual product should the need
arise:
arise.
Registrants of products within a batch may choose to cooperatively generate, submit or
cite a single battery of six acute toxicological studies to represent all the products within that
batch. It is the registrants' option to participate in the process with all other registrants, only
some ot the other registrants, or only their own products within a batch, or to generate all the
required acute toxicological studies For each of their own products. If a registrant chooses to
generate the data for a batch, he/she must use one of the products within the batch as the test
material. If a registrant chooses to rely upon previously submitted acute toxicity data, he/she
may do so provided that the data base is complete and valid by today's standards (see
acceptance criteria attached), the formulation tested is considered by EPA to be similar for
acute toxicity, and the formulation has not been significantly altered since submission and
acceptance of the acute toxicity data. Regardless of whether new data is generated or existing
data is referenced, registrants must clearly identify the test material by EPA Registration
Number. If more than one confidential statement of formula (CSF) exists for a product the
registrant must indicate the formulation actually tested by identifying the corresponding CSF.
.u A- In.decid!ng how to meet the product specific data requirements, registrants must follow
the directions given in the Data Call-In Notice and its attachments appended to the RED The
DCI Notice contains two response forms which are to be completed and submitted to the
Agency within 90 days of receipt. The first form, "Data Call-in Response," asks whether the
registrant will meet the data requirements for each product. The second form, "Requirements
Status and Registrant's Response," lists the product specific data required for each product
including the standard six acute toxicity tests. A registrant who wishes to participate in a '
batch must decide whether he/she will provide the data or depend on someone else to do so
It a registrant supplies the data to support a batch of products, he/she must select one of the
following options: Developing Data (Option 1), Submitting an Existing Study (Option 4)
Upgrading an Existing Study (Option 5) or Citing an Existing Study (Option 6). If a registrant
depends on another s data, he/she must choose among: Cost Sharing (Option 2), Offers to
Cost Share (Option 3) or Citing an Existing Study (Option 6). If a registrant does not want to
participate in a batch, the choices are Options 1, 4, 5 or 6. However, a registrant should
know that closing not to participate in a batch does not preclude other registrants in the batch
trom citing his/her studies and offering to cost share (Option 3) those studies.
Twenty products were found which contain ethephon as the active ingredient The
products have been placed into 5 batches in accordance with the active and inert ingredients
type of formulation and current labeling. Table 1 identifies the products in each batch
201
-------
Table 1
Batch
1
2
3
4
5
EPA Reg. No.
264-263
264-543
CA90002800
264-267
264-292
264-376
AZ87002100
CA76019400
CA83003400
VA83001700
264-257
264-377
264-380
HI84000400
ffl94000400
PR89000200
264-418
56077-49
264-511
56077-50
% Active Ingredient
3.9
3.9
3.9
21.7
21,7
21.7
21.7
21.7
21.7
21.7
39.9
39.9
39.9
39.9
39.9
39.9
55.4
55.4
71.3
71.3
Formulation
Type
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
Liq
202
-------
Attachment 5. EPA Acceptance Criteria
203
-------
-------
SUBDIVISION D
Guideline Study Title
Series 61 Product Identity and Composition
Series 62 Analysis and Certification of Product Ingredients
Series 63 Physical and Chemical Characteristics
205
-------
61 Product Identity and Composition
ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?
1 • Name of technical material tested (include product name and trade name, if appropriate).
2- Name, nominal concentration, and certified limits (upper and lower) for each active ingredient and each
intentionally-added inert ingredient.
3- Name and upper certified limit for each impurity or each group of impurities present at > 0.1 % by
weight and for certain lexicologically significant impurities (e.g., dioxins, nitrosaminesfpresent at
^U. 1 fQ .
4. Purpose of each active ingredient and each intentionally-added inert.
5- Chemical name from Chemical Abstracts index of Nomenclature and Chemical Abstracts Service (CAS)
Registry Number for each active ingredient and, if available, for each intentionally-added inert.
6- Molecular, structural, and empirical formulas, molecular weight or weight range, and any company
assigned experimental or internal code numbers for each active ingredient.
7- Description of each beginning material in the manufacturing process.
EPA Registration Number if registered;
for other beginning materials, the following:
Name and address of manufacturer or supplier.
Brand name, trade name or commercial designation.
Technical specifications or data sheets by which manufacturer or supplier describes composition
properties or toxicity. '
8. Description of manufacturing process.
Statement of whether batch or continuous process.
Relative amounts of beginning materials and order in which they are added
Description of equipment.
Description of physical conditions (temperature, pressure, humidity) controlled in each step and
the parameters that are maintained.
Statement of whether process involves intended chemical reactions.
Flow chart with chemical equations for each intended chemical reaction
Duration of each step of process.
_, Description of purification procedures.
Description of measures taken to assure quality of final product.
9- Discussion of formation of impurities based on established chemical theory addressing (1) each impurity
which may be present at > 0.1 % or was found at > 0.1 % by product analyses and (Z) certain
lexicologically significanfTmpurities (see #3).
206
-------
62 Analysis and Certification of Product Ingredients
ACCEPTANCE CRITERIA
The following criteria apply to the technical grade of the active ingredient being reregistered. Use a table to
present the information in items 6, 7, and 8.
Does your study meet the following acceptance criteria?
1 • Five or more representative samples (batches in case of batch process) analyzed for each active ingredient
and all impurities present at > 0.1 %.
2. Degree of accountability or closure > ca98%.
3- Analyses conducted for certain trace~loxic impurities at lower than 0.1 % (examples, nitrosamines in the
case of products containing dinitroanilines or containing secondary or tertiary amines/alkanolamines plus
nitrites; polyhalogenated dibenzodioxins and dibenzofurans). [Note that in the case of nitrosamines Doth
fresh and stored samples must be analyzed.].
4. Complete and detailed description of each step in analytical method used to analyze above samples.
5. Statement of precision and accuracy of analytical method used to analyze above samples.
6. Identities and quantities (including mean and standard deviation) provided for each analyzed ingredient.
/. Upper and lower certified limits proposed for each active ingredient and intentionally added inert along
with explanation of how the limits were determined.
8. Upper certified limit proposed for each impurity present at > 0.1 % and for certain lexicologically
significant impurities at <0.1 % along with explanation of Row limit determined.
9. Analytical methods to verify certified limits of each active ingredient and impurities (latter not required if
exempt from requirement of tolerance or if generally recognized as safe by FDA) are fully described.
!0. Analytical methods (as discussed in #9) to verify certified limits validated as to their precision and
accuracy.
207
-------
63 Physical and Chemical Characteristics
ACCEPTANCE CRITERIA
The following criteria apply to the technical grade of the active ingredient being reregistered.
Does your study meet the following acceptance criteria?
63-2 Color
Verbal description of coloration (or lack of it)
Any intentional coloration also reported in terms of Munsell color system
63-3 Physical State
Verbal description of physical state provided using terms such as "solid, granular, volatile liquid"
Based on visual inspection at about 20-25° C
63-4 Odor
Verbal description of odor (or lack of it) using terms such as "garlic-like, characteristic of aromatic
compounds
Observed at room temperature
63-5 Melting Point
Reported in °C
Any observed decomposition reported
63-6 Boiling Point
Reported in °C
Pressure under which B.P. measured reported
Any observed decomposition reported
63-7 Density, Bulk Density, Specific Gravity
Measured at about 20-25° C
Density of technical grade active ingredient reported in g/ml or the specific gravity of liquids reported
with reference to water at 20° C. [Note: Bulk density of regisfered products may be reported in lbs/ft3
or Ibs/gallon.] r
63-8 Solubility
Determined in distilled water and representative polar and non-polar solvents, including those used in
formulations and analytical methods for the pesticide
Measured at about 20-25° C
Reported in g/100 ml (other units like ppm acceptable if sparingly soluble)
63-9 Vapor Pressure
Measured at 25° C (or calculated by extrapolation from measurements made at higher temperature if
pressure too low to measure at 25° C) or
Experimental procedure described
Reported in mm Hg (torr) or other conventional units
63-10 Dissociation Constant
Experimental method described
Temperature of measurement specified (preferably about
20-25 °C) '
63-11 Octanol/water Partition Coefficient
Measured at about 20-25° C
Experimentally determined and description of procedure provided (preferred method-45 Fed. Register
Data supporting reported value provided
63-12 pH
Measured at about 20-25° C
Measured following dilution or dispersion in distilled water
63-13 Stability
Sensitivity to metal ions and metal determined
Stability at normal and elevated temperatures
Sensitivity to sunlight determined
208
-------
SUBDIVISION F
Guideline Study Title
81-1 Acute Oral Toxicity in the Rat
81-2 Acute Dermal Toxicity in the Rat, Rabbit or Guinea Pig
81-3 Acute Inhalation Toxicity in the Rat
81-4 Primary Eye Irritation in the Rabbit
81-5 Primary Dermal Irritation Study
81-6 Dermal Sensitization in the Guinea Pig
209
-------
81-1 Acute Oral Toxicity in the Rat
ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?
1. _ Identify material tested (technical, end-use product, etc).
2. _ At least 5 young adult rats/sex/group.
3.,, _ Dosing, single oral may be administered over 24 hrs.
4. _ Vehicle control if other than water.
o.
.
Doses tested, sufficient to determine a toxicity category or a limit dose (5000 me/kg).
Individual observations at least once a day.
Observation period to last at least 14 days, or until all test animals appear normal whichever is longer
Individual daily observations. 6 '
_
9. _ Individual body weights.
10. _ Gross necropsy on all animals.
Criteria marked with an * are supplemental and may not be required for every study.
-------
81-2 Acute Dermal toxicity in the Rat, Rabbit or Guinea Pig
ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?
Identify material tested (technical, end-use product, etc).
At least 5 animals/sex/group.
Rats 200-300 gm, rabbits 2.0-3.0 kg or guinea pigs 350-450 gm.
Dosing, single dermal.
Dosing duration at least 24 hours.
Vehicle control, only if toxicity of vehicle is unknown.
Doses tested, sufficient to determine a toxicity category or a limit dose (2000 mg/kg)
Application site clipped or shaved at least 24 hours before dosing.
Application site at least 10% of body surface area.
Application site covered with a porous nonirritating cover to retain test material and to prevent
mgestion. r
Individualobseryations at least once a day.
Observation period to last at least 14 days.
Individual body weights.
Gross necropsy on all animals.
Criteria marked with an * are supplemental and may not be required for every study.
-------
81-3 Acute Inhalation Toxicity in the Rat
ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?
1. Identify material tested (technical, end-use product, etc).
2- Product is a gas, a solid which may produce a significant vapor hazard based on toxicity and expected use
or contains particles of mhalable size for man (aerodynamic diameter 15 urn or less).
3. At least 5 young adult rats/sex/group.
4. Dosing, at least 4 hours by inhalation.
5- Chamber air flow dynamic, at least 10 air changes/hour, at least 19% oxygen content
6. Chamber temperature, 22° C (±2°), relative humidity 40-60%.
7. Monitor rate of air flow.
8. Monitor actual concentrations of test material in breathing zone.
9. Monitor aerodynamic particle size for aerosols.
10- Doses tested, sufficient to determine a toxicity category or a limit dose (5 mg/L actual concentration of
respirable substance).
11. Individual observations at least once a day.
12. Observation period to last at least 14 days.
13. Individual body weights.
14. Gross necropsy on all animals.
212
-------
81-4 Primary Eye Irritation in the Rabbit
ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?
1- Identify material tested (technical, end-use product, etc).
2. Study not required if material is corrosive, causes severe
dermal irritation or has a pH of <2 or > 11.5.
3. 6 adult rabbits. — —
4. Dosing, instillation into the conjunctival sac of one eye
per animal.
5- P0.86' O-1 ml if a liquid; 0.1 ml or not more than 100 mg if a solid, paste or particulate substance
o. bond or granular test material ground to a fine dust.
7. Eyes not washed for at least 24 hours.
8. Eyes examined and graded for irritation before dosing and
at 1, 24, 48 and 72 hr, then daily until eyes are normal
or 21 days (whichever is shorter).
9.* Individual daily observations.
Criteria marked with an * are supplemental and may not be required for every study.
^ 1.3
-------
81-5 Primary Dermal Irritation Study
ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?
1- Identify material tested (technical, end-use product, etc).
2. Study not required if material is corrosive or has a pH of < 2 or > 11.5.
3. 6 adult animals. — —
4. Dosing, single dermal.
5. Dosing duration 4 hours.
6. Application site shaved or clipped at least 24 hours prior to dosing.
7. Application site approximately 6 cm2.
8- Application site covered with a gauze patch held in place with nonirritating tape
9. Material renroved, washed with water, without trauma to application site
10- Application site examined and graded for irritation at 1, 24, 48 and 72 hr, then daily until normal or 14
days (whichever is shorter).
11 .* Individual daily observations.
Criteria marked with an * are supplemental and may not be required for every study.
-------
81-6 Dermal Sensitization in the Guinea Pig
ACCEPTANCE CRITERIA
Does your study meet the following acceptance criteria?
1. Identify material tested (technical, end-use product, etc).
2. Study not required if material is corrosive or has a
pHof <2or >11.5.
3. One ofThe following methods is utilized:
Freund's complete adjuvant test
Guinea pig maximization test
Split adjuvant technique
Buehler test
Open epicutaneous test
Mauer optimization test
Footpad technique in guinea pig.
4. Complete description of test.
5.* Reference for test.
6. Test followed essentially as described in reference document.
7. Positive control included (may provide historical data conducted within the last 6 months).
Criteria marked with an * are supplemental and may not be required for every study.
-------
-------
Attachment 6. List of All Registrants Sent This Data Call-in (insert)
Notice
217
-------
-------
^
u
c
0)
0^
<
c
0
•H
•p
O 0
Q) V£>
4J ,t
0 0
>-l CM
H CJ
(0
.P •
C Q
0)
S *
5 c
o o
M 4-)
•H &
> C
C-H
W
W (0
0) Jat
4.)
(0
•P
CO
TJ
Q)
•P
•H
C
D
U
H
g
S5
J5
H
1
g
^
EH
(rf
Q
CO
H
g
CH
2
W
CO
CO
CH
2
2
P
CO
H
M
U
K
£§
j^
fe
O
CO
H
0
1
2
OJ
00
n
o
••
Q)
19
S5
•g
*Nk
0)
U
CJ
a
•H
Q)
^j
(d
CO
•H
U
W
Ifl
Addre i
Q)
(d
55
•
i~i
C
O
•H
^j
-H-
•o
2
Q)
S
55
.
C
a
o
CJ
^
C)
u
gfc2£
P »— 00 fM
a.
UJ
0
i 2
»- Z O >
5 M | §
01 £ tt Z
CO Z U U
01 Ol < —
of x w> ee
*t
? CO
~ fa
Ol
i-s
co oi ae
UJ
< VI
«* -I X
« ft s •:
o o •" »*
cvj a. s «-
§*~ «- «
«M 3B
i
s « i
z K^ < oa
x 8 8 ~*
S OC CO 01
< 0 **
•J UJ UJ
U < 01 1-
Z U CO <
Ol ^* ^
-J at < to
3 Ol •—
fsi =
01 ae u- >-•
z < — o
o o -J oe
ae 01 < «
Of U U >
NO K in r\j
rvj o
-------
-------
Attachment 7. Cost Share Data Compensation Forms, Confidential
Statement of Formula Form and Instructions
219
-------
-------
I
I
JR
1
s
UJ
«
I
0
8
^
Z
CD
O
|
i
£
in
<0
o
o
^*
Information \
^
,i»
C
g
(0
"•3
C
•i
ej
^
S
a
*•
^
s
usiness Information: DC
QQ
1
I
CO
c
o
I?
o
S
See Instri
1
1
0
1^
•
= i]|
Ir
1 I
1 £.
tm A
A
£ «
5 i
an
JS
••
e
i Si
^ "S
SW O
Ills
1^ E
? c ®
his
united states Envi
Off tee of Post
Wash!
Confidential S
i
- c
S §
II
'1
-.^
.- !
14. C«rt>fi«d Limn
% by Wwghl
JoMrLMTM b UMMT
-
i
«• *
!*'*
13. Each Comp
in Formulati
a. Amount
6
z
cc
£
oi
i
.8
1
(A
£
?5
P
**
5 *
ss
M »
components in Formulation (List a,
th9 formulation. Givt common!)
w. trwfe name. tnd CAS number.)
Ml
Z
O
UJ
0)
<
a.
UJ
i
3
i
!
h
(1
p^
5
otal Weight
t-
K
!
?
|
:
B <
5
i !
*
( \
^ t
> a
o
?
»
»
f
^
S
!
*
"
TS
.E
1
5:
o
u
iT
<
GL
UJ
€
.
|
1
i
«
»-
, please submit ai
JS
£
g
c
O
s=
i
1
o
•
w
•
O
ev. 12-90) Previous editii
K
0570-4
E
6
u.
<
a.
iu
221
-------
-------
Instructions for Completing the Confidential Statement of Formula
The Confidential Statement of Formula (CSF) Form 8570-4 must be used. Two legible, signed copies of the form
are required. Following are basic instructions:
a. All the blocks on the form must be filled in and answered completely.
b. If any block is not applicable, mark it N/A.
c. The CSF must be signed, dated and the telephone number of the responsible party must be provided.
d. All applicable information which is on the product specific data submission must also be reported on the
CSF.
e.All weights reported under item 7 must be in pounds per gallon for liquids and pounds per cubic feet for solids.
f. Flashpoint must be in degrees Fahrenheit and flame extension in inches.
g.For all active ingredients, the EPA Registration Numbers for the currently registered source products must be
reported under column 12.
h. The Chemical Abstracts Service (CAS) Numbers for all actives and inerts and all common names for the trade
names must be reported.
i.For the active ingredients, the percent purity of the source products must be reported under column 10 and must
. A „ ,, ... , op exactly the same as on the source product's label.
j. All the weights m columns 13.a. and 13.b. must be in pounds, kilograms, or grams. In no case will volumes be
accepted. Do not mix English and metric system units (i.e., pounds and kilograms).
k. All the items under column 13.b. must total 100 percent.
1.A11 items under columns 14.a. and 14.b. for the active ingredients must represent pure active form.
m. The upper and lower certified limits for ail active and inert ingredients must follow the 40 CFR 158 175
instructions. An explanation must be provided if the proposed limit? are different than standard certified limits.
n. When new CSFs are submitted and approved, all previously submitted CSFs become obsolete for that specific
formulation.
223
-------
-------
&EPA
United States Environmental Protection Agency
Washington, DC 20460
CERTIFICATION OF OFFER TO COST
SHARE IN THE DEVELOPMENT OF DATA
Form Approved
OMB No. 2070-0106
2070-0057
Approval Explras 3-31-96
Public reporting burden for this collection of information is estimated to average 15 minutes per response including
time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed and
completing and reviewing the collection of information. Send comments regarding the burden estimate or any other
aspect of this collection of information, including suggestions for reducing this burden, to Chief, Information Policy
Branch, PM-223. U.S. Environmental Protection Agency, 401 M St., S.W., Washington, DC 20460; and to the Office
of Management and Budget, Paperwork Reduction Project (2070-0106), Washington, DC 20503.
Please fill in blanks below.
Company Nnme
Company Number
EPA Reg. No.
I Certify that:
My company is willing to develop and submit the data required by EPA under the authority of the Federal
Insecticide, Fungicide and Rodenticide Act (FIFRA), if necessary. However, my company would prefer to
enter into an agreement with one or more registrants to develop jointly or share in the cost of developing
data.
My firm has offered in writing to enter into such an agreement. That offer was irrevocable and included an
offer to be bound by arbitration decision under section 3(c)(2)(B)(Iii) of FIFRA if final agreement on all
terms could not be reached otherwise. This offer was made to the following firm(s) on the following
date(s):
Nam* of Flrnt(t)
Oat* of Offtr
Certification:
I certify that I am duly authorized to represent the company named above, and that the statements that I have made on
this form and all attachments therein are tiue, accurate, and complete. I acknowledge that any knowingly false or
misleading statement may be punishable by fine or Imprisonment or both under applicable law.
Signs tur* of Company's Authorized Rapr*aantativ*
Dal*
Nam* and Tltl« (Picas* Typ* or Print)
EPA Form 8570-32 (5/91) Replace* EPA Form 8580, which Is obsolete
225
-------
-------
United States Environmental Protection Agency
Washington, DC 20460
CERTIFICATION WITH RESPECT TO
DATA COMPENSATION REQUIREMENTS
Form Approved
OMB No. 2070-0107,
2070-0057
Approval Expires
3-31-96
Public reporting! burden for this collection of information is estimated to average 15 minutes per response includina time for
SfflS'Sf^SAJJ881?11!? existing *data 'ources gathering and maintaining the ^Sn^S^^^^f^rS
col ection of information. Send comments regarding the burden estimate or any other aspect of th is collection of Sformation
AnlUn(i!n9/nU^aelt*loncSxS?r E,du£nQthis burden to. Chief Information Policy Branch, PM-213 U S Environm^
' t0 the °ffiCe °f Manaaement and Bud9et- PaperWork 1 Reduction Project
th
Please fill in blanks below.
Company Name
Company Number
Product Name
EPA Reg. No.
Certify that:
*ua?'? study ci.ted- in suPPort of registration or reregistratiion under the Federal Insecticide Funaicide and Rodenticide
m^?ton(£%ra dVl ' 3m the °riginal data submitter- or ' have obtained the wriherP9e?miss1Sn of^heorigin
dy "
of registration or reregistration under FIFRA that is NOT an exclusive use study lam the
"HfA^nJ^wKSf118^0/1 °/ \hloriginal data submitter, or I have notified in writing the
& r«m^L™e«offe*?d*-to: *(aLPav compensation for those data in accordance wrth section
arnA.Tnr^^0^"161!06 n.e9ot!ftlon to determine which data are subject to the compensation
amount of compensation due, if any. The companies I have notified are (check one)
°n the back of this form or attached sheets-
complied with section 3
-------
-------
APPENDIX G. FACT SHEET
229
-------
-------
United States
Environmental Protection
Aflency
Prevention, Pesticide*
And Toxic Substances
(7508 W)
EPA-738-F-95-004
April 1995
R.E.D. FACTS
Ethephon
Pesticide
Reregistration
Use Profile
Regulatory
History
All pesticides sold or distributed in the United States must be
registered by EPA, based on scientific studies showing that they can be used
without posing unreasonable risks to people or the environment. Because of
advances in scientific knowledge, the law requires that pesticides which
were first registered years ago be reregistered to ensure that they meet
today's more stringent standards.
In evaluating pesticides for reregistration, EPA obtains and reviews a
complete set of studies from pesticide producers, describing the human
health and environmental effects of each pesticide. The Agency imposes
any regulatory controls that are needed to effectively manage each
pesticide's risks. EPA then reregisters pesticides that can be used without
posing unreasonable risks to human health or the environment.
When a pesticide is eligible for reregistration, EPA announces this and
explains why in a Reregistration Eligibility Decision (RED) document. This
fact sheet summarizes the information in the RED document for
reregistration case 0382, Ethephon.
Ethephon is a plant growth regulator used to promote fruit ripening,
abscission, flower induction, and other responses. Ethephon is registered
for use on a number of food, feed and nonfood crops, greenhouse nursery
stock, and outdoor residential ornamental plants, but is used primarily on
cotton. Formulations include formulation intermediates and soluble
concentrates/liquids. Ethephon is applied to plant foliage by either ground
or aerial equipment. It also may be applied by hand sprayer to certain home
garden vegetables and ornamentals.
Use practice limitations include prohibitions against applying ethephon
through any type of irrigation system; feeding or grazing livestock in treated
areas; and treating within 2 to 60 days of harvest, depending on the crop.
Ethephon was discovered in 1965, and was first registered as a
pesticide in the U.S. in 1973. EPA issued a Registration Standard for
ethephon in September 1988 (PB89-109427), requiring toxicology, residue
chemistry, and environmental fate and effects data.
-------
Human Health Toxicity
Assessment Ethephon is corrosive in acute dermal irritation studies using rabbits,
has the potential to cause eye irritation, and has been placed in Toxicity
Category I (the highest of four categories) for these effects. It is moderately
acutely toxic by the oral, dermal and inhalation routes (Toxicity Category
IE), and does not cause skin sensitization.
An organophosphate pesticide, ethephon caused plasma cholinesterase
inhibition in a 16-day oral human study and clinical signs of toxicity in a
second study. In a dermal toxicity study using rabbits, skin effects were
observed at all doses.
In a combined chronic/oncogenicity study using rats, plasma and
erythrocyte cholinesterase were inhibited at all doses. At the highest dose
levels, ethephon caused body weight decrease and kidney effects, but no
carcinogenic effects were observed. In a cancer study using mice, no
evidence of treatment related tumors was observed. Ethephon has been
classified as a Group D carcinogen based on "the insufficiency of the weight
of evidence" regarding its cancer-causing potential.
One chronic toxicity study using beagle dogs caused plasma
cholinesterase inhibition at all doses, and smooth muscle atrophy in the gut.
In a second beagle dog study, treatment related effects included decreased
spleen and body weight plus decreased hemoglobin and hematocrit in the
males.
Developmental toxicity studies using rats and rabbits show no
evidence of a potential for developmental effects at doses that are not toxic
to the mother. In a reproductive toxicity study using rats, administration of
the test compound caused decreased survival in the offspring and decreased
body weight gain in adult females, but no effects on fertility, gestation,
mating, organ weights, or histopathology in any generation.
Ethephon was positive in one mutagenicity study and negative in two
others. It does not appear to cause delayed neurotoxicity based on a study
using hens, however studies using mammals are now required as
confirmatory data.
Human poisoning incidents involving ethephon include four cases of
skin injury (irritation) in California as a result of exposure to field residues,
one possible systemic poisoning case, and 29 telephone calls to the National
Pesticides Telecommunications Network reporting eye and skin irritation
from misuse of ethephon, sometimes in combination with other pesticides.
Dietary Exposure
People may be exposed to residues of ethephon through the diet.
Tolerances or maximum residue limits have been established for ethephon in
many raw agricultural commodities, processed foods, and feed. Please see
40 CFR 180.300(a) and (b), 185.2700(a), (b) and (c), and 186.2700(a).
-------
Several additional tolerances, including food and feed additive tolerances,
have been proposed.
Sufficient data are available to assess the adequacy of most established
ethephon tolerances, although some require additional residue chemistry or
animal feeding studies. Some changes are needed; certain tolerances must
be revoked because registrations for these crop uses no longer exist, and a
tolerance for cottonseed must be increased. Several new tolerances may
need to be established.
EPA has assessed the chronic dietary risk posed by ethephon,
evaluating exposure and risk, first, from all uses for which tolerances exist,
have been recommended or have been proposed and, second, excluding uses
for which revocation is recommended. For the overall U.S. population and
22 subgroups, the Anticipated Residue Contribution (ARC) from all current
and proposed ethephon tolerances represents 9% of the Reference Dose
(RfD), an amount believed not to cause adverse effects if consumed daily
over a 70-year lifetime. The ARC of the most highly exposed subgroup,
non-nursing infants less than one year old, represents 49% of the RfD.
Excluding the tolerances recommended for revocation, the ARC for the
overall U.S. population represents 8.6% of the RfD, while the ARC for
non-nursing infants represents 47% of the RfD. Therefore, it appears that
chronic dietary risk is not of concern.
Because ethephon causes neurotoxic effects (cholinesterase inhibition),
an acute dietary exposure analysis also was conducted. Margins of
Exposure (MOEs), which show how closely estimated exposure comes to a
dose of concern, were calculated for several population subgroups. Infants
less than one year old are the only subgroup whose exposure may be of
concern, with 5% of the population estimated to have MOEs of less than 7
(an MOE of 10 or greater is desirable). However, these risk values
represent an unrealistic worst case situation. Many conservative
assumptions were included in calculating these risks, such as: all registered
food crops are treated; maximum residue levels are present on all foods; and
no dilution or degradation of residues has occurred during preparation or
processing of food. EPA believes it is unlikely that infants and children will
be exposed to ethephon-treated commodities at levels that will result in acute
dietary risk.
Several international Codex Maximum Residue Limits (MRLs) have
been established for ethephon. Compatibility between U.S. tolerances and
Codex MRLs exists for apples, blackberries, cherries, pineapples and
walnuts, and may be achieved for tomatoes by raising the U.S. tolerance.
For other crops, the U.S. tolerances are being revoked or additional field
residue data are needed.
-------
Occupational and Residential Exposure
Based on current use patterns, workers may be exposed to ethephon in
agricultural and other settings, during and after applications using open
pouring methods and broadcast (aerial and ground) treatment or hand-held
spray equipment. Ethephon does not pose risks of systemic dermal or
inhalation toxicity. However, since it does pose risks of severe skin and eye
irritation (Toxicity Category I), certain Worker Protection Standard (WPS)
provisions apply.
To protect post-application workers, a 48-hour restricted entry interval
(REI) imposed by the WPS is being retained. This interval must be
increased to 72 hours when ethephon is applied outdoors in arid areas.
Certain personal protective equipment (PPE), including protective eyewear,
is required for early entry into treated areas. In addition, since ethephon is
in Toxicity Category I for primary skin irritation, "double notification" is
required: agricultural workers must be warned orally of its application, and
WPS warning signs must be posted at entrances to treated areas.
Human Risk Assessment
Ethephon has the potential to cause severe skin and eye irritation
(Toxicity Category I), but otherwise is moderately acutely toxic. An
organophosphate pesticide, it has the potential to cause cholinesterase
inhibition. Ethephon is classified as a "Group D" carcinogen because there
is insufficient weight of evidence regarding its cancer-causing potential.
Ethephon is used on many food and feed crops. Its tolerances have
been reassessed, and while they generally are acceptable, some changes are
required. EPA's dietary risk assessments indicate that infants less than one
year old encounter the greatest exposure and risk as a result of ethephon
crop use. However, since the Agency used many conservative assumptions
in calculating these risks, actual dietary exposure and risk to infants as well
as the overall U.S. population are believed to be minimal.
Pesticide handlers may be exposed to ethephon during application, and
post-application workers may be exposed to residues on treated crops. To
reduce workers' skin and eye irritation risks, a 48-hour REI is being
retained and is increased to 72 hours in arid areas, use of certain PPE
including protective eyewear is required for early entry, and double
notification of workers is required.
Environmental Environmental Fate
Assessment Ethephon is not persistent in the environment. The major routes of
dissipation appear to be chemical hydrolysis and microbial degradation.
Although ethephon degrades in somewhat acidic soils (pH 6.1), it does not
hydrolyze in sterile, acidic water (pH 5). The major degradates are
ethylene gas and 2-hydroxy ethyl phosphonic acid. Ethephon has moderate
to low mobility in soil. It has a very low octanol/water partition coefficient
and, therefore, is not expected to accumulate in fish.
-------
In the field, ethephon exhibits the same characteristics of rapid
degradation and moderate to low mobility as seen in the laboratory, At field
sites in southern California, North Carolina, and Washington, ethephon
dissipated with half-lives of about 7 to 25 days.
Ecological Effects
In dietary studies using the bobwhite quail and mallard duck, ethephon
is practically nontoxic to slightly toxic on an acute basis, and practically
nontoxic on a subacute basis. Acute oral studies using rats show that
ethephon is slightly toxic to mammals. Other acute toxicity studies show
that ethephon is practically nontoxic to coldwater fish, and practically
nontoxic to slightly toxic to warmwater fish and freshwater invertebrates.
Ethephon is practically nontoxic to shrimp, and slightly toxic to
estuarine/marine mollusks. It is relatively nontoxic to honeybees.
Regarding effects on terrestrial plants, ethephon reduces plant growth,
resulting in reduced shoot lengths and weights.
Ecological Effects Risk Assessment
Ethephon is expected to have minimal effects on birds and mammals,
as well as on fish, freshwater invertebrates, and marine and estuarine
organisms.
Although minimal effects to aquatic and terrestrial plants (dry land)
are expected, ethephon may pose a risk to semi-aquatic/wetland plants
(including endangered semi-aquatic plants) when it is used on apples in
North Carolina, cotton, tobacco, macadamia nuts, blackberries and
pineapple. However, ethephon is a growth regulator and as such is not
intended to be toxic to plants. Also, the magnitude of this risk is not high.
Therefore, while the potential for risk to semi-aquatic plants exists, it is not
extensive, arises only infrequently during periods of high exposure, and is
geographically limited.
In response to Agency concerns about ethephon's risk to semi-aquatic
plants, the registrant proposed as a risk mitigation measure to reduce the
maximum use rate for blackberries and apples in North Carolina to 2.0
pounds per acre. They also provided information indicating that ethephon is
used only occasionally at maximum rates when certain weather conditions
exist, such as cool temperatures. Considering these factors, EPA believes
that the risk to nontarget plants from use of ethephon will be limited.
Additional Data EPA is requiring the following additional generic data for ethephon to
Required confirm its regulatory assessments and conclusions: Product chemistry;
Animal metabolism (poultry); Residue analytical method in plants and
animals; Storage stability; Magnitude of the residue in plants (peppers,
cantaloupes, grapes, wheat forage and hay, and cotton gin byproducts);
Magnitude of the residue in processed sugarcane; Magnitude of the residue
in poultry and ruminant; Batch equilibrium on the degradate of 2-hydroxy
ethyl phosphonic acid; Acute and subchronic neurotoxicity.
-------
The Agency also is requiring product-specific data including product
chemistry and acute toxicity studies, revised Confidential Statements of
Formula (CSFs) and revised labeling for reregistration.
P rod U Ct La be I i n g All ethephon end-use products must comply with EPA1 s current
Changes pesticide product labeling requirements, and with the following:
Required Worker Protection
Personal Protective Equipment (PPE) for Handlers
PPE for handlers will be based on the toxicity of each end-use product
(see PR Notice 93-7). If PPE is necessary for homeowner uses, it will be
established during end-use product reregistration.
Entry Restrictions for Occupational-Use Products:
Worker Protection Standard (WPS) Uses
EPA is establishing a 48-hour restricted entry interval (REI), which
increases to 72 hours in outdoor areas where average rainfall is less than 25
inches a year. PPE for WPS-permitted early entry into treated areas is
coveralls over long-sleeved shin and long pants, chemical-resistant gloves
such as any waterproof gloves, chemical-resistant footwear plus socks, and
chemical-resistant headgear for overhead exposures. In addition, protective
eyewear is required since ethephon is in Toxicity Category I for eye
irritation potential.
Non-WPS Uses
Products with uses outside the scope of the WPS must bear the
following statement:
"Do not allow people or pets to touch treated plants until the sprays
have dried."
Entry Restrictions for Homeowner-Use Products
Ethephon products with directions for use by homeowners must bear
the following statement:
"Do not allow people or pets to touch treated plants until the sprays
have dried."
Other Labeling Requirements
Reduce PPE when Engineering Controls are Used
"When handlers use closed systems, enclosed cabs, or aircraft in a
manner that meets the requirements listed in the WPS [40 CFR
170.240(d)(4-6)], the handler PPE requirements may be reduced or
modified as specified in the WPS."
User Safety Requirements
"Follow manufacturer's instructions for cleaning/maintaining PPE. If
no such instructions exist for washables, use detergent and hot water.
Keep and wash PPE separately from other laundry."
-------
"Discard clothing and other absorbent materials that have been
drenched or heavily contaminated with this product's concentrate. Do
not reuse them."
User Safety Statements
"Users should wash hands before eating, drinking, chewing gum,
using tobacco, or using the toilet."
"Users should remove clothing immediately if pesticide gets inside."
"Users should remove PPE immediately after handling this product.
As soon as possible, wash thoroughly and change into clean clothing.
Wash the outside of gloves before removing."
Application Restrictions
"Do not apply this product in a way that will contact workers or other
persons, either directly or through drift. Only protected handlers may
be in the area during application."
Notification
"Notify workers of the application by warning them orally and by
posting warning signs at entrances to treated areas."
Environmental Hazard
The following precautionary statement is required to address risks to
wetlands:
"Do not apply directly to water, or to areas where surface water is
present, or to intertidal areas below the mean high water mark."
For residential use sites (ornamental trees, shrubs, vines and herbaceous
plants), the statement, "Do not apply directly to water" may be used instead
of the statement above.
Spray Drift
The following language is required on each product label that can be
applied aerially:
"AVOIDING SPRAY DRIFT AT THE APPLICATION SITE IS
THE RESPONSIBILITY OF THE APPLICATOR."
"The interaction of many equipment-and-weather-related factors
determine the potential for spray drift. The applicator is responsible
for considering all these factors when making decisions."
"The following drift management requirements must be followed to
avoid off-target movement from aerial applications to agricultural field
crops. These requirements do not apply to forestry applications,
public health uses or to applications using dry formulations."
"1. The distance of the outer most nozzles on the boom must not
exceed 3/4 the length of the wingspan or rotor."
"2. Nozzles must always point backward parallel with the air stream
and never be pointed downwards more than 45 degrees."
-------
"Where states have more stringent regulations, they should be
observed."
"The applicator should be familiar with and take into account the
information covered in the Aerial Drift Reduction Advisory
Information."
The following Aerial Drift Reduction Advisory Information must be
contained in the product labeling:
"[This section is advisory in nature and does not supersede the
mandatory label requirements]."
Information on Droplet Size
"The most effective way to reduce drift potential is to apply large
droplets. The best drift management strategy is to apply the largest
droplets that provide sufficient coverage and control. Applying larger
droplets reduces drift potential, but will not prevent drift if
applications are made improperly, or under unfavorable environmental
conditions (See Wind, Temperature and Humidity, and Temperature
Inversions)."
Controlling Droplet Size
o "Volume - Use high flow rate nozzles to apply the highest
practical spray volume. Nozzles with higher rated flows
produce larger droplets."
o "Pressure - Do not exceed the nozzle manufacturer's
recommended pressures. For many nozzle types lower pressure
produces larger droplets. When higher flow rates are needed,
use higher flow rate nozzles instead of increasing pressure."
o "Number of nozzles - Use the minimum number of nozzles that
provide uniform coverage."
o "Nozzle Orientation - Orienting nozzles so that the spray is
released parallel to the airstream produces larger droplets than
other orientations and is the recommended practice. Significant
deflection from horizontal will reduce droplet size and increase
drift potential."
o "Nozzle Type - Use a nozzle type that is designed for the
intended application. With most nozzle types, narrower spray
angles produce larger droplets. Consider using low- drift
nozzles. Solid stream nozzles oriented straight back produce the
largest droplets and the lowest drift."
Boom Length
"For some use patterns, reducing the effective boom length to less
than 3/4 of the wingspan or rotor length may further reduce drift
without reducing swath width."
Application Height
-------
"Applications should not be made at a height greater than 10 feet
above the top of the target plants unless a greater height is required
for aircraft safety. Making applications at the lowest height that is
safe reduces exposure of droplets to evaporation and wind."
Swath Adjustment
"When applications are made with a crosswind, the swath will be
displaced downwind. Therefore, on the up and downwind edges of
the field, the applicator should compensate for this displacement by
adjusting the path of the aircraft upwind. Swath adjustment distance
should increase, with increasing drift potential (higher wind, smaller
drops, etc.)."
Wind
"Drift potential is lowest between winds speeds of 2 - 10 mph.
However, many factors, including droplet size and equipment type
determine drift potential at any given speed. Application should be
avoided below 2 mph due to variable wind direction and high
inversion potential. NOTE: Local terrain can influence wind
patterns. Every applicator should be familiar with local wind patterns
and how they affect spray drift."
Temperature and Humidity
"When making applications in low relative humidity, set up equipment
to produce larger droplets to compensate for evaporation. Droplet
evaporation is most severe when conditions are both hot and dry."
Temperature Inversions
"Applications should not occur during a temperature inversion because
drift potential is high. Temperature inversions restrict vertical air
mixing, which causes small suspended droplets to remain in a
concentrated cloud. This cloud can move in unpredictable directions
due to the light variable winds common during inversions.
Temperature inversions are characterized by increasing temperatures
with altitude and are common on nights with limited cloud cover and
light to no wind. They begin to form as the sun sets and often
continue into the morning. Their presence can be indicated by ground
fog; however, if fog is not present, inversions can also be identified
by the movement of smoke from a ground source or an aircraft smoke
generator. Smoke that layers and moves laterally in a concentrated
cloud (under low wind conditions) indicates an inversion, while
smoke that moves upward and rapidly dissipates indicates good
vertical air mixing."
Sensitive Areas
"The pesticide should only be applied when the potential for drift to
adjacent sensitive areas (e.g. residential areas, bodies of water, known
habitat for threatened or endangered species, non-target crops) is
minimal (e.g, when wind is blowing away from the sensitive areas)."
-------
Regulatory
Conclusion
For More
Information
Residue Chemistry
The following label revisions must be added to pertinent end-use
products:
o Product labels must be amended to reflect a maximum allowable
use rate of 2 Ib ai/A/season for application of ethephon to cotton.
o Label directions for apples, cranberries, carob, and olives that are
for ornamental use only must be clearly designated as such.
o The 0.33 Ib/gal SC/L label (264-263) must be amended to prohibit
the harvesting of any treated pumpkins for human or animal
consumption and must specify that treatments are to be made to
pumpkins for seed production only.
° Labels must be amended to reduce the maximum use rate for
blackberries and apples in N.C. to 2.0 Ib per acre.
A table near the end of the RED document identifies the Food/Feed
Use Patterns Subject to Reregistration for Ethephon. This table lists
currently acceptable use sites, formulations, application rates, methods and
equipment, pre-harvest and reentry intervals, and use limitations for
ethephon products registered by the basic manufacturer. All ethephon end-
use product labels must be amended to be consistent with the basic producer
labels, as reflected in this table.
The use of currently registered products containing ethephon in
accordance with approved labeling will not pose unreasonable risks or
adverse effects to humans or the environment. Therefore, all uses of these
products are eligible for reregistration.
Ethephon products will be reregistered once the required product-
specific data, revised Confidential Statements of Formula, and revised
labeling are received and accepted by EPA.
EPA is requesting public comments on the Reregistration Eligibility
Decision (RED) document for ethephon during a 60-day time period, as
announced in a Notice of Availability published in the Federal Register. To
obtain a copy of the RED document or to submit written comments, please
contact the Pesticide Docket, Public Response and Program Resources
Branch, Field Operations Division (7506C), Office of Pesticide Programs
(OPP), US EPA, Washington, DC 20460, telephone 703-305-5805.
Electronic copies of the RED and this fact sheet can be downloaded
from the Pesticide Special Review and Reregistration Information System at
703-308-7224. They also can be reached on the Internet via
FEDWORLD.GOV, or obtained from EPA's gopher server,
EARTHLEPA.GOV.
10
-------
Printed copies of the RED and fact sheet can be obtained from EPA's
National Center for Environmental Publications and Information
(EPA/NCEPI), PO Box 42419, Cincinnati, OH 45242-0419, telephone
513-489-8190, fax 513-489-8695.
Following the comment period, the ethephon RED document also will
be available from the National Technical Information Service (NTIS), 5285
Port Royal Road, Springfield, VA 22161, telephone 703-487-4650.
For more information about EPA's pesticide reregistration program,
the ethephon RED, or reregistration of individual products containing
ethephon, please contact the Special Review and Reregistration Division
(7508W), OPP, US EPA, Washington, DC 20460, telephone
703-308-8000.
For information about the health effects of pesticides, or for assistance
in recognizing and managing pesticide poisoning symptoms, please contact
the National Pesticides Telecommunications Network (NPTN). Call toll-
free 1-800-858-7378, between 8:00 am and 6:00 pm Central Time, Monday
through Friday.
11
-------
-------